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The research described in this thesis was aimed at 
the characterization of the Candida adhesin, and 
elucidation of the nature of the human epithelial cell 
receptor with which it combines. Previous data have 
shown that the fibrillar mannoprotein layer, produced 
when Candida albicans is grown in high concentrations of 
galactose, contains the proteinaceous adhesin. Different 
Candida species from leukoplakia patients were assayed 
for their ability to adhere to buccal cells. The results 
supported previous conclusions that there is a 
relationship between the ability of different Candida 
albicans strains to adhere to epithelial cells and their 
capacity for cell surface modification.
Extracellular polymeric material (EPM) was isolated 
from culture supernates of C. albicans after growth in 
medium containing 500 mM galactose. When used to 
pretreat buccal epithelial cells, EPM inhibited 
adherence, which suggested that it contains an adhesin 
that binds to, and blocks epithelial cell receptors.
Fractionation of EPM by affinity chromatography was 
performed. An index, the adhesion inhibition index (All) 
was used to compare the various "lectin-like" components 
isolated from crude EPM. These studies indicated that 
use of different buccal cell donors gave different 
results, with the same Ç. albicans strain. Attempts to 
resolve EPM by SDS-polyacrylamide gel electrophonesis had 
previously proved unsuccessful. However here, success
31
was achieved using the silver-stain technique.
Chemical and enzymatic digestion of the EPM indicated 
that the protein portion . of the glycoprotein was more 
important than the carbohydrate at inhibiting adherence. 
N-Glycanase, papain, mild alkali treatment of EPM, 
followed by Synsorb-H-2 affinity adsorption 
chromatography, resulted in a purification of the yeast 
adhesin of more than 220 fold, relative to the crude EPM 
(on a protein weight basis).
The nature of the epithelial cell receptor for C, 
albicans was investigated with potential receptor 
analogues such as sugars, lectins, monoclonal antibodies 
and saliva. The adhesion of Ç. albicans to the buccal 
cells of blood groups A and O, was found to be 
significant with respect to secretor status but not blood 
group. Caution should be shown in the interpretation of 
sugar inhibition tests. Nevertheless, N-acetyl-D- 
galactosamine was the most effective single sugar as an 
inhibitor of adhesion for buccal cell donors of blood 
group A; N-acetyl-D-galactosamine is the immunodominant 
blood group sugar for group A cells and the possibility 
exists that the blood group oligosaccharide on the buccal 
cell surface functions as the receptor for yeast 
adhesion.
Further work would be needed to establish whether the 
purified adhesin had any therapeutic value in treating 
Candida infections.
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1 HISTORICAL ASPECTS
’Candida' derives from the Latin name toaa Candida 
for the special white robe worn by candidates for the 
Senate, and albicans is the present participle of the 
Latin albicare (to whiten). The combination - Candida 
albicans - thus translates as 'whitening white' (Odds, 
1988). The choice between candidosis and candidiasis is 
one of personal preference. The name 'candidosis' was 
originally used to describe infections due to Candida 
albicans, but it has now been shown that other Candida 
species may be involved, although in fewer cases. Even 
yeasts of other genera such as Rhodotorula have been 
described as causes of Candida-like infections, albeit 
very rarely. Candida infections of virtually every 
tissue in the human body have been reported, although the 
most common cases of candidosis are superficial lesions, 
especially of the mucous surfaces of the mouth or vagina, 
which are coimnonly known as 'thrush'. Although there is 
no certain origin for this name, thrush may have arisen 
from the Scandinavian equivalent ’torsk' which is used to 
describe both the disease and the bird (Odds, 1988).
The clinical infection has been recognized since 
antiquity; Hippocrates described two cases of oral apthae 
(Adams, 1939), and Samuel Pepys referred to the disease 
in his diaries on 17th June, 1665 (cited by'Winner and 
Hurley, 1964). In 1839 the fungus was described by 
Langenbeck; the organism had been seen in buccal apthae
35
in a case of typhus, but had been incorrectly implicated 
as the causative agent of typhus. Berg, as cited by Odds 
(1988), described fully the relationship between the 
thrush fungus and mouth lesions in 1846. Descriptions of 
the thrush fungus have all drawn attention to the 
dimorphic nature of the organism.
2 BIOLOGY OF CANDIDA
2.1 Classification
A yeast is defined as a unicellular fungus capable of 
reproducing by budding or fission (Kreger van Rij, 1984). 
This is a refinement of Dodder's more general definition 
(1970) of yeasts as fungi whose predominant morphological 
form is unicellular.
The genus Candida comprises more than 150 species 
whose main feature is the absence of any sexual form. 
Yeasts of this genus are asporogenous (Odds, 1988). 
Generally in microbiology, genera are separated according 
to their physiological properties and this is so with 
yeasts. Candida species can be identified by 
assimilation and fermentation tests. Except for the 
obvious pink colour of the Rhodotorula species, colony 
character is of little value in yeast identification.
The majority of clinical yeast isolates prove to be 
C. albicans. Two rapid and simple tests are available 
for identification of C. albicans : the germ-tube test and
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the chlamydospore test. In the germ-tube test Ç. 
albicans produces hyphae from blastospores after 
incubation in serum for three hours at 37°C (Taschdjian 
et al., 1960). The test for chlamydospore production by 
Ç. albicans is generally carried out by growing the yeast 
on corn meal agar (Benham, 1931) although there are 
several other recommended media e.g. Czapek-Dox (Dawson, 
1962) or maize meal agar (Kligman, 1950). Under 
phase-constrast microscopy, highly retractile 
chlamydospores may be observed.
Serological tests have also been used as a means of 
determining the taxonomy of pathogenic yeasts. 
Hansenclever and Mitchell (1961) demonstrated the 
existence of two antigenic types - serotypes A and B,
The A serotype possesses the same group of antigens as 
serotype B, plus two extra antigens. The two types 
differ in cell wall structure.
Warnock et al. (1979) showed further strain to strain 
variations. Differing strains of C. albicans exhibited 
resistance to six different chemicals in agar media.
2.2 Genetics
Odds (1979) reported that "several Candida mutants 
have been described but genetic studies of yeast 
pathogens are unknown". Since then progress has been 
rapid, as reviewed by Shepherd et aJL. (1985). Indeed,
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Odds (1988) devoted a short chapter to this subject.
It has now emerged that natural isolates of Ç. 
albicans are diploid. Parasexual fusion, and ultraviolet 
irradiation inducing mitotic crossing over have been used 
to analyse the genetic similarity of strains (reviewed by 
Shepherd et ^ .  , 1985). Poulter et (1981) first
suggested that Ç. albicans was naturally diploid, and 
Sarachek and Weber (1984) confirmed this by means of 
parasexual fusion. Whelan (1987) described in detail the 
genetics of Ç. albicans, Ç. glabrata and Ç. tropicalis.
In that review he noted that in an asexual, diploid 
species such as C. albicans. products of mutagenesis may 
arise by ^  novo mutation or by mitotic recombination and 
segregation, and he therefore proposed the term 
'hereditary variant' as preferable to mutant in 
describing strains with abnormal properties to avoid 
implying a process of ^  novo mutation simultaneously in 
two genes.
Variants of Ç, albicans have been isolated, 
complemented with each other, and recombination has been 
performed. Using parasexual genetic procedures, five 
linkage groups have been established (Shepherd ^  al..
1985). C. albicans frequently gives rise to variant 
colony forms. In 1985, two laboratories described colony 
variants. Pomes et aJL. ( 1985) showed rough and smooth 
sectors of a mutant of C. albicans that had been exposed 
to ultraviolet light, and Slutsky et al. (1985)
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characterised seven interconvertible forms of colony 
growth, with high frequency switching taking place 
between them. A second phenotypic switching system was 
described by Slutsky et bJl, ( 1987) between "white" and 
"opaque" colonies.
2.3 Ecological niche
Yeasts are widely distributed in animal, plant and 
terrestial aquatic environments (Do Carmo-Sousa, 1969). 
Yeasts which are the causal agents of human candidosis 
have a wide natural distribution in primates, farm and 
domestic animals, rodents, birds and marsupials. C. 
albicans is by far the most pathogenic, as well as the 
most common species of Candida occurring in humans. 
Candida species are. frequently found in the hospital 
environment - in foods, in the air, on the floor, and on 
other surfaces in hospital wards (Barnett et al., 1983). 
Although the yeasts causing candidosis are found 
throughout the animal kingdom, the most important source 
of Candida in human disease is the human reservoir i.e. 
gut, mouth, and vagina. There are enormous disparities 
in the frequencies of isolation of yeasts from humans. 
Gentles and La Touche (1969) concluded that Ç. albicans 
and a few other yeast species were harmless commensals of 
the mucous membranes and digestive tracts of normal 
individuals.
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2.4 Morphogenesis
2.4.1 Morphological variability
Depending on the growth conditions, C. albicans takes 
on different morphological forms, from a true mycelium to 
budding yeasts. The blastospore is the unicellular form 
of the fungus - distinguished by a specific mode of cell 
division known as budding. The hyphae are long 
microscopic tubes comprising multiple fungal cells, 
separated by septa. The study of morphogenesis in 
dimorphic fungi is crucial in the diagnosis and treatment 
of fungal infections, and in pathogenicity.
2.4.2 Dimorphism and pathogenicity
There are many accounts of experimental studies with 
C. albicans that report an association between mycelium 
formation and infection (Balish and Philips, 1966;
Gresham and Whittle, 1961; Louria and Brayton, 1964). 
These reports are based on the fact that the mycelial 
form is invariably seen in smears or scrapings within 
hours of inoculation of Ç. albicans into experimental 
animals.
Rapid morphological conversion from budding yeasts to 
the mycelial form in tissues suggests pathogenicity of 
this form. Nevertheless, controversy surrounds the 
invasive potential of the two forms; for example, Russell 
and Jones (1973) identified no difference between them. 
When working with rabbits and mice, Evans and Mardon
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(1977) found yeast cells to be more virulent than 
pseudohyphal cells; and further that yeast cells were 
more virulent than hyphal forms because of less effective 
host defence mechanisms against the yeast phase of C. 
albicans (Evans, 1980). These differences were in part 
attributed to differences in the structural integrity of 
the cell wall influencing host defence mechanisms, which 
were more effective against the hyphal than the 
blastospore phase. Savage and Balish (1971) found that 
mycelium deficient variants of C. albicans occurred 
spontaneously in vitro or could be isolated from cases of 
candidosis, thus bringing into question the validity of 
the requirement for the yeast-mycelium conversion.
Martin et (1984) concluded that the pathogenic
potential of C. albicans appears to depend on germ-tube 
formation.
The change from yeast to hyphal form is 
environmentally regulated (Soil, 1986). The molecular 
determinants remain unclear. Production of filaments may 
be a process associated with the adhesion of the invading 
Ç. albicans. and penetration of the host cell.
Conditions such as temperature, pH, and the 
microenvironment of the host may favour hyphal 
development in vitro. Sobel et al^ . ( 1984) found that a 
variant strain of C, albicans, incapable of hyphal 
formation at 37"C, was less likely to colonize the rat 
vagina than the wild-type strain. Thus hyphal production
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by Ç. albicans may be considered an important but not 
essential virulence factor.
3 CELL SURFACE OF CANDIDA ALBICANS
3.1 Cell wall composition
The cell wall of the baker’s yeast Saccharomyces 
cerevisiae has been the subject for most of the studies 
on the structure of yeast cell walls. The cell wall of 
C . albicans has been investigated less intensively. It 
is multilayered in structure (Scherwitz, 1982) and 
composed of glucans (/31,3 and /31,6 polymers of glucose), 
mannoprotein, chitin (a /31,4 polymer of N-acetyl- 
D-glucosamine), protein and lipid (Phaff, 1971). The 
chitin is thought to be located in the bud scar, 
although glucan and mannoprotein are present all over the 
wall.
Evidence suggesting the extracellular location of 
mannose polymers has come from studies with anti-mannan 
antibodies (Ballou, 197 6) and concanavalin A (Tkacz and 
Lampen, 1972). Chattaway et al,. ( 1968) identified 
differences in the quantities of chitin in the cell walls 
of blastospores and hyphae in C. albicans. The /31,3 
linked glucan appears to structure the cell shape. 
Purified /31,3 glucanase can almost completely solubilize 
isolated cell walls (Zlotnik et al., 1984). These latter 
studies indicated that mannoproteins shield the cell wall
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glucan from attack by glucanase. Although removal of 
mannoproteins does not cause cell death, the cell remains 
vulnerable to any basic or positively-charged electrolyte 
in the surroundings. Mannoprotein extraction does not 
destroy cell wall shape and led Zlotnik et al. (1984) to 
infer that mannoprotein is packed on to the glucan layer; 
it is a filling material enmeshed in the glucan 
structural network. Any loosening of this mannoprotein 
layer results in increased porosity of the Candida cell 
wall.
3.2 Chitin
Chitin is a )31,4 polymer of N-acetyl-D-glucosamine. 
Chattaway ^  ad. (1968) found that the amount of chitin 
in the mycelial form of C. albicans was about three times 
higher than in the budding form of the organism. Chitin 
is less evident in the cell walls of yeast than in the 
cell walls of many filamentous fungi, and was first 
identified in Sacch. cerevisiae cell walls by its 
characteristic X-ray diffraction pattern which was 
similar to that of crustacean chitin (Phaff, 1971). The 
physical nature of chitin in the wall is only partially 
understood.
3.3 Mannan/Mannoprotein
Yeast mannan was discovered in 1894 by Salkowski and 
called 'yeast gum' (Phaff, 1971). Chemical
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investigations of yeast mannan have been carried out on 
preparations extracted from intact cells with dilute 
alkali (2% KOH, 100°C) and then precipitated as an 
insoluble copper complex (Arnold, 1983), Peat et al. 
(1961) examined mannan extracted by autoclaving intact 
yeasts at neutral pH. Mannan consists of long chains of 
al,6 linked mannose residues with shorter side chains 
containing «1,2 and «1,3 linkages.
The protein-mannan link is identical to that in many 
other glycoproteins (Nakajima and Ballou, 1974). 
Immunological studies indicate that in Ç. albicans. 
mannoprotein is located on the cell surface (Hasenclever 
and Mitchell, 1964). The general features of its 
structure are similar to those of Sacch. cerevisiae cell 
wall mannoprotein (Ballou, 1976).
Mannoproteins are easily attacked by dilute alkali, 
dithiothreitol and pronase, which probably 
degrade/hydrolyse the protein that holds the polymannose 
chains together. Analysis of these degradation products 
renders a generalized structure for mannoprotein (see 
Figure 1). Two kinds of linkage between carbohydrate and 
protein parts of Sacch. cerevisiae were described by 
Nakajimi and Ballou (1974) and Ballou (1976). Alkali 
treatment cleaves small oligosaccharides from crude 
mannoprotein preparations (/3-elimination) releasing 
fragments linked to serine and threonine in the protein. 
Most of the carbohydrate is attached to asparagine
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Figure 1 Structure of mannan from Saccharomyces 
cerevisiae X 2180
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residues in the protein by di-N-acetylchitobiose links. 
Nakajima and Ballou (197 4) confirmed this linkage between 
mannoprotein to be identical with that found in many 
glycoproteins. A second moiety of mannan consisting of 
«1,2 and «1,3 linked oligosaccharides attach at their 
reducing ends by an 0-glycosidic link to serine or 
threonine. The two C. albicans serotypes A and B 
(Hasenclever and Mitchell, 1964) can be differentiated by 
the extent of branching, length of side chain, and the 
proportion and position of the «1,3 bonds in the side 
chain (Phaff, 1971). Diedrich et (1984) used papain
to release mannopeptides from C. albicans cell walls and 
the material extracted in this way co-migrated on dextran 
gels with mannopeptides from culture filtrates. They 
concluded that these mannopeptides were remnants of 
proteolytic turnover in cell wall polysaccharides.
Less well researched than the carbohydrates of the 
cell wall in Ç. albicans are the levels of phosphorus. 
Higher levels of phosphorus are reported in C. albicans 
mannan than in Sacch. cerevisiae. Stewart and Ballou 
( 1968) reported a mannose; phosphorus ratio of 18:1 in Ç. 
albicans compared to one of 144:1 in Sacch. cerevisiae.
3.4 Glucans
'Glucan' refers to a large group of D-glucose 
polymers that vary in the type and proportion of 
individual glycosidic bonds. Glucans in the yeast cell
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wall are generally /3 D-glucans with 8^1,3 linkages which 
may occasionally be interrupted by (il, 6 sequences (Peat 
et al., 1961). Bacon and Farmer (1968) showed by 
méthylation analysis and periodate oxidation of the 
alkali-extracted glucan, from C. albicans. that it is 
highly branched; 7 3% are /31,6 linkages, the rest being 
/31,3 bonds. It is possible that proportions of (il, 3 and 
/31,6 links may differ in cell walls from yeast and hyphal 
forms (Gopal et , 1984). The physiochemical 
properties of /3-glucan, its insolubility and high degree 
of crystallinity, indicate that its synthesis probably 
occurs in situ i.e. in the cell wall or at the outer 
surface of the plasmalemma (Sentendreu ^  , 1975).
Andaluz et ad. (1986) suggested that the glucan 
molecule is synthesized while bound to an acceptor other 
than glucan, which is subsequently excised, probably 
during the transfer of the glucan moiety to the cell wall 
glucan.
3.5 Plasma membrane
This important organelle has received limited 
attention at the biochemical level. However, plasma 
membrane-enriched fractions have been characterized from 
the yeast and mycelial forms of Ç. albicans. Analysis 
indicated that the major components were protein and 
lipid (Harriot, 1975, a and b). Membranes from the yeast 
form contained 50% protein, 45% lipid, 9% carbohydrate
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and 0.3% nucleic acid. Significant differences in the 
levels of phospholipid free esterified sterols and total 
fatty acids of membranes, were seen between the two 
morphological forms of the organism (Harriot, 1975a). 
Enzyme activity in the plasma membrane of the two forms 
of the organism has also been given little detailed 
attention (Harriot, 1975b). However, mannan synthase may 
reside here along with a magnesium-dependent ATP-ase.
This is likely to be involved in the establishment of 
proton gradients for solute uptake (Blasco and Gidrol, 
1982) .
3.6 Cell wall ultrastructure
The cell wall of C. albicans is important for several 
reasons. Firstly, the cell surface appears to mediate 
the adhesion of parasite to host. Secondly, the cell 
surface plays a role in determining the cell's immunity 
to certain drugs such as polyene antibiotics (Gale et 
al., 1975), and finally it contains antigenic structures 
which are involved in serotyping (Yu et §l1,, 1967 ).
The structure of the cell wall of C. albicans appears 
complex compared to that of Sacch. cerevisiae and by 
comparison our knowledge is limited. Work on the 
ultrastructure of the wall of C. albicans has revealed 
that it is composed of four (Yamaguichi, 1974), five 
(Djaczenko and Cassone, 1972) or eight (Poulain et al., 
1978) distinct layers.
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According to Cassone et al. (1973) the cell wall of 
C. albicans is organized into a multilayered structure 
with amorphous, granular and fibrous components, with 
varying electron densities. Tronchin et al. (1984) 
utilized a periodic acid thiocarbohydrazide-silver 
proteinate technique (PATAg) of staining in conjunction 
with electron microscopy to reveal a fibrillar layer of 
filaments arranged at right angles to the cell surface. 
Djaczenko and Cassone (1972) used transmission electron 
microscopy to visualize five distinct layers and a 
fibrillar floccular layer on the yeast cell surface. 
Takamiya ^  ad. ( 1984) employed post-embedding
immunoferritin tests with ultra-thin sections of Ç. 
albicans to demonstrate mannan antigens on the exterior 
of the cell surface, as well as in the cytoplasm near the 
cytoplasmic membrane, thus indicating that mannan 
antigens are transported from the cytoplasm via 
channel-like organelles in the cell wall to their final 
location in the exterior cell wall layer (see Figure 2).
The ultrastructural features of the host parasite 
relationship in oral candidosis had not been described 
until Montes and Wilborn (1968) showed an electron dense 
material present on the external wall of the cell hyphae 
which had penetrated host epithelial cells. This 
extracellular material was much condensed along a certain 
length of the hyphal tips (Rajasingham and Cawson, 1982). 
Marrie and Costerton (1981) demonstrated that a ruthenium
mannans glucans
mannans glucans 
mannans glucans
mannans glucans
bo o chitins glucans
chitins proteins^ 
polysaccharides
Cell wall structure of C . albicans with channels for 
mannoprotein transportation
Based on Poulain et al. (1978)
and modified by Takamiya et al. ( 1984)
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red positive matrix mediates adhesion of C. albicans 
blastospores to epithelial cells and this finding 
accorded with Mohamed (1975) where the fungus was seen to 
have a thick cell wall, surrounded by an outer floccular 
layer.
3.7 Extracellular polymeric material (EPM)
Ç. albicans excretes polysaccharide-protein complexes 
into the nutrient medium (Masler et ad., 1966) consisting 
of 74-86% mannan, 21-31% glucose, 1-1.5% glucosamine and 
11-14% protein; this material was immunologically active. 
Diedrich et ad. (1984) characterized a low molecular 
weight extracellular material produced by metabolically 
active Ç. albicans. They showed that three strains of Ç. 
albicans produced a low molecular weight extracellular 
substance that could be fractionated into two components 
by ion-exchange chromatography, and further that these 
components were the remains of proteolytic turnover of 
cell wall glycoproteins. Papain treatment of the cells 
also generated this material.
Biological activities have been seen with extra­
cellular polymeric material from C. albicans. Mankowski 
(1968) reported that this material inhibited the growth 
of newborn mice and also had cidal effects on these 
mice.
Masler et (1966) isolated EPM with a molecular
weight of about 200,000 from glucose-containing nutrient
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media after cultivation of slightly, moderately and 
highly virulent strains of Ç. albicans. All the 
complexes were immunologically active against specific 
antisera prepared against moderately virulent strains.
Sikl et (1969) found that glycoprotein from C.
albicans released histamine from most cells and Trnovec 
et al,.(1978) reported that this material was able to 
depress the phagocytic ability of white cells.
Saltarelli and Coppola (1980) used an extracellular 
polymeric substance from Ç. albicans to treat Sarcoma 180 
tumour cells in Swiss female mice. Extracellular 
polymeric material from C. albicans inhibited attachment 
of yeasts to neutrophils (Diamond et al., 1980) and 
adherence to buccal cells (McCourtie and Douglas, 1985). 
Extracellular glycoproteins were part of the outer 
fibrillar layer which was readily released from the cell 
surface (McCourtie and Douglas, 1981). This material is 
presumed to contain the adhesins capable of interacting 
with epithelial cell surface receptors. Extracellular 
polymeric material isolated by prolonged dialysis of 
culture supernatants (Critchley and Douglas, 1987a) was 
similar to that obtained previously (McCourtie and 
Douglas, 1985), comprising about 70% carbohydrate, 10% 
protein and 0.5% phosphorus.
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4 CANDIDOSIS
Candida infections have been reported in virtually 
every tissue of the human body; however the different 
forms fall into two general categories - superficial and 
systemic. Superficial is intended to mean 'on the 
surface' e.g. of the oral mucosa and on the skin and 
nails. Candida infections of organs e.g. kidneys, lungs 
etc. may be considered deep-seated or systemic.
4.1 Factors influencing Candida infections
Since yeast infection, as opposed to yeast carriage 
is a comparatively rare event it follows that in normal 
circumstances an equilibrium between the host and the 
yeast microflora ensures the avirulent, commensal status 
of the latter (Odds, 1988). Gentles and La Touche (1969) 
listed 39 disorders, diseases, disabilities and 
iatrogenic factors that predispose individuals to 
candidosis.
4.1.1 Dietary factors
Gentles and La Touche (1969) listed carbohydrate rich 
diet as a factor predisposing to candidosis. Samaranyake 
and MacFarlane (1985) presented their hypothesis, 
describing how high concentrations of carbohydrate might 
aggravate oral candidosis. The effect of iron deficiency 
on oral candidal infections is difficult to ascertain, 
yet studies indicate that iron deficiency in concert with
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a variety of other dietary factors e.g. vitamin 
deficiency, may be involved in the pathogenesis of oral 
candidosis (Jorrizo, 1982; Samaranayake, 1986).
4.1.2 Mechanical factors
Trauma, local occlusions and maceration of tissues 
predispose the host to candidosis. Local maceration of 
the skin occurs in many common situations. Workers who 
frequently immerse their hands in water are particularly 
prone to candidosis of the nails, nailfolds and finger 
clefts. These forms of candidosis are the only real 
instances of Candida as an agent of occupational disease. 
The same problem is encountered in children who suck 
their thumbs (Odds, 1979). C. albicans is found rarely 
on the skin; however, the probability of its recovery 
from moist areas e.g. groin and toewebs is far higher 
than from the general skin surface (Somerville, 1972). 
Maceration of the skin or membranes so as to give rise to 
increased local humidity may predispose to yeast 
overgrowth and infection (Odds, 1988).
4.1.3 Medical factors
Medical factors increasing host susceptibility to 
Candida albicans include some drugs and various surgical 
techniques. Patients receiving broad spectrum 
antibiotics, or multiple narrow-spectrum antibiotics or 
corticosteriods appear to be more susceptible to yeast 
overgrowth and consequent yeast infection (Odds, 1988).
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These drugs suppress the endogenous microflora or 
suppress the host defence mechanisms against infections. 
Liljemark and Gibbons (1973) investigated the effect of 
antibiotics on gnotobiotic mice and showed that C. 
albicans colonization was inhibited by Streptococcus 
salivarius and Streptococcus miteor. Attachment 
inhibition by indigenous flora may partly explain the 
suppression of Candida colonization.
Immunosuppressive drugs may also create an 
environment favourable for host invasion by C. albicans 
as found after bone marrow transplant (Bandini ^  al.,
1986). In experimental animals, cyclophosphamide 
selectively depletes the immune system - reducing the 
peripheral blood polymorphonuclear leucocytes as well as 
spleen cellularity, creating increased host 
susceptibility to Ç. albicans infection (Bistoni et ad., 
1984).
Oral contraceptives may activate vaginal candidosis. 
Lopez-Martinez et al. (1984) found that the most frequent 
predisposing factors were in decreasing order of 
frequency - pregnancy, the association of pregnancy and 
malnutrition, anaemia and malnutrition. Evidence 
suggesting that the oestrogen contraceptive 'pill' 
predisposes to candidosis has become a matter of 
subsequent controversy. Odds (1979) concluded that oral 
contraceptives containing oestrogen enhance the 
susceptibility of the vagina to yeast overgrowth, which
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in turn leads to symptons of yeast vaginitis.
Of the therapeutic procedures likely to potentiate 
infection, indwelling catheters and intravenous feeding 
are among the most important. Recently an outbreak of 
Candida parapsilosis septicaemia was reported and this 
was associated with contaminated intravenous feeds 
(Solomon et al,, 1984). Marrie and Costerton (1984a) 
used scanning electron microscopy and transmission 
electron microscopy to view iji situ bacterial coloniz­
ation of catheters. Surfaces of catheters are generally 
imperfect; infusites may create a biofilm. Marrie and 
Costerton (1984b) also indicated that bacteria and yeasts 
colonize catheters. These catheters were removed from a 
patient with Ç. albicans peritonitis and yeast cells were 
found to be embedded in the amorphous background.
4.1.4 Natural factors
Natural factors predisposing the host to candidosis 
include other microbial infections, endocrine 
dysfunctions and defects in cell mediated immunity (Odds, 
1988). Candida vulvovaginitis has been described as a 
common presenting sympton of diabetes mellitus (Nagesha 
and Anathakrishana, 1970).
Previous investigators have reported higher than 
normal frequencies of carriage of yeasts from the vagina, 
urine and oropharynx of diabetics (Barlow and Chattaway, 
1969). High blood and tissue glucose levels or low skin 
lactate levels may favour the growth of Candida in
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diabetics. Diabetic women have high glycogen levels so 
that the effect of diabetes on the vagina resembles that 
of pregnancy. There appear to be no differences in in 
vitro phagocytosis of Ç. albicans between diabetic and 
normal leucocytes (Davies and Denning, 1972).
Segal ^  (1984) found that vaginal epithelial
cells from fecund women who were pregnant or diabetic, 
had a greater propensity to bind Ç. albicans than did 
vaginal epithelial cells from non-diabetic controls. 
Maternal vaginal candidosis appears to be the major 
source of neonatal oral thrush (Davidson et ad., 1984). 
During passage of the foetus through the colonized 
vagina, the infant may ingest some of the vagina contents 
(Dennison, 1977). Other factors predisposing to the 
development of oral thrush include prematurity, low birth 
weight, previous antimicrobial therapy, prolonged labour 
with resucitative procedures and contact with nipples and 
bottles contaminated with fungi (Dennison, 1977).
Other factors may also be important in the 
development of oral thrush since only 10-24% of infants 
harbouring C. albicans in their oral cavity develop 
thrush (Lay and Russell, 1977). During the first week of 
life there is an increase in the adherent capacity of 
buccal epithelial cells to C. albicans. It is postulated 
that this increase may have a role in the development of 
oral thrush.
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4.2 Oral candidosis
Epstein et al. (1984) described several categories of 
oral candidosis. Diagnosis depends on the presence of 
the organism in a direct smear, the culture of 
significant numbers of the organism and, indirectly, upon 
the efficacy of the antifungal agents that are 
prescribed.
4.2.1 Acute pseudomembraneous candidosis (oral thrush)
In this, the classically recognized form of 
candidosis, C. albicans invades the epithelial layers of 
the oral mucosa but never appears to penetrate deeper 
than the stratum corneum (Lehner, 1967). The infection 
is usually painless, and is characterized by white 
patches (apthae) that appear as discrete lesions on the 
surface of the buccal mucosa, throat, tongue and gum 
linings. Coalescence results in pseudomembranes.
Lesions may be rubbed off leaving red raw epithelium.
The disease is most prevalent in the very young, the old 
and the terminally ill (Finlay, 1986). A prevalence of 
15% was recorded in debilitated elderly patients: 
therefore the incidence among the elderly population as a 
whole is likely to be lower.
4.2.2 Chronic atrophic candidosis - denture stomatitis
Chronic atrophic candidosis was not mentioned by 
Winner and Hurley (1964) and knowledge of its association 
with Candida arises from more recent studies. Both
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Cawson (1966) and Budtz-Jorgensen (1971) firmly 
established the link between Candida and denture-related 
palatal inflamation.
Denture stomatitis is characterized by chronic 
erythema and oedema of that portion of the upper palate 
which comes into contact with the dentures. Although 
patients may experience slight soreness, the presenting 
complaint is angular cheilitis.
Cawson (1966) and Davenport (1970) found that denture 
stomatitis was four times as prevalent among female as 
male denture wearers. Repeated oral sucrose rinses 
aggravate existing lesions in patients with denture 
stomatitis, and initiate infection in lesion-free denture 
wearers (Olsen and Birkeland, 1976). Denture liners and 
adhesives do not inhibit the growth of C. albicans 
(Williamson, 1968), although antifungal agents may be 
incorporated into denture liners as an alternative 
treatment (Douglas and Walker, 1973).
4.2.3 Chronic hyperplastic candidosis - candidal 
leukoplakia
Chronic hyperplastic candidosis exhibits chronic, 
discrete, localized white lesions of variable size that 
are hard and rough to touch (Odds, 1988). As in the case 
of oral thrush, Candida tissue invasion in leukoplakia is 
restricted to superficial epithelial layers (Mohamed, 
1975). Krogh et aj^ . (1986) suggested that there may be 
phenotypic differences between C. albicans strains
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associated with leukoplakias and normal epithelia in the 
same patient.
4.3 Vaginal candidosis (vaginal thrush)
Hurley (1975) recognised vaginal thrush as the most 
prevalent disease of pregnancy, and recorded an incidence 
of 15% - 16%. With this form of candidosis, sexual 
intercourse often becomes uncomfortable and painful 
(Witkin ^  , 1986).
Kinsman and Collard (1986) indicated that in rat 
vaginas, predisposing factors to C. albicans infections 
included a cornified epithelium and the absence of 
leukocytes - these conditions were present in oestrous. 
Edman et ad. (1986) reported that mild zinc deficiency 
may play a role in susceptibility to recurrent vaginal 
infections. Throughout pregnancy, the main predisposing 
factor may be an indirect effect on the immune system due 
to hormonal changes (Mathur et al., 1978).
h further predisposing factor may be the long-term 
and unjudicious use of broad spectrum antibiotics which 
have a detrimental effect on the normal bacterial flora. 
In the absence of these bacteria, yeast growth and fungal 
pathogenicity is stimulated (Knight and Fletcher, 1971). 
Since systemic fungal disease frequently occurs because 
of a breakdown of the host's immune system (Stenderup and 
Sch^nheyder, 1984), it is possible that vaginal 
candidosis could have a similar predisposing cause
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(Ryley, 1986). However a defective cell mediated immune 
response may not, by itself, always lead to recurrent 
candidal infection (Witkin et al., 1986).
During the sexually active years, the healthy vagina 
is populated by a variety of bacteria, including 
lactobacilli. These produce lactic acid which is largely 
responsible for the acidic nature (pH 4-5) of the 
vagina.
However there is little correlation between pH and 
vaginal candidosis (Ryley, 1986). In order to eliminate 
potential reinfection therefore, the source of Ç. 
albicans must be eliminated. Although in the majority of 
cases, topical treatment with various azole preparations 
or oral treatment with ketoconazole will provide quick 
symptomatic relief, such treatment does nothing to 
correct the initial predisposing factor (Ryley, 1986) and 
oral treatment is preferred.
4.4 Chronic mucocutaneous candidosis
Chronic mucocutaneous candidosis (CMC) is an uncommon 
superficial candidal infection of the skin, nails, and 
oral genital mucosa (Jorrizo, 1982). It is reputedly not 
a single disease entity, but rather a final common 
pathway for multiple predisposing abnormalities of the 
immune system.
CMC often affects children during their first decade 
of life, and, in many cases, before they are two years
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old. Mature onset cases aro rarely seen (Odds, 19 88), 
Patients often show several demonstrable ijmuune defects 
(Lehner et al., 1972).
The first Candida lesion to appear in cases of CMC is 
the typical form of oral thrush. Angular cheilitis and 
lip fissures may develop, and infection may spread to the 
larynx and, rarely, to the oesophagus. Odds (1979) 
tabulated nine principal diseases and disorders 
associated with CMC. Patients with CMC are generally 
refractive to topical antifungals (Jorrizo, 1982). 
Ketoconazole has been successfully used to treat CMC with 
minimal side-effects (Graybill et al,, 1980).
4.5 Systemic candidosis
In contrast to the common Candida infections of 
mucous membranes and skin, candidosis infections of the 
deep organs are rarely seen. Such infections present in 
different ways depending on the site of invasion, the 
effectiveness of the host's immune response and the 
presence of underlying disease (Myerowitz et al., 1977).
Systemic candidosis is difficult to diagnose 
clinically because there is no typical clinical picture 
(De Repentigay and Reiss, 1984). However Burnie and 
Williams (1985) evaluated a commercial latex 
agglutination test, which reliably differentiated between 
colonization of intravenous catheters and systemic 
infection. Although the test failed to detect some cases
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of systemic infection, at a titre of greater than 1:8 it 
is virtually diagnostic of systemic disease and is far 
easier to perform than the radioimmunoassay (Weiner and 
Coates-Stephen, 1979).
Although rare, nosocomal candidosis has recently been 
documented (Isenberg et ad., 1989). An environmental 
reservoir for those Candida species involved in nosocomal 
infections has not yet been established (Burnie et ad., 
1985). In the London outbreak of systemic Ç. albicans 
(Burnie e_k ad., 1985), the strain not only affected 
patients in the intensive care unit, but was also 
isolated from oral swabs taken from four nurses working 
in the unit, and from the hands of one of the nurses. No 
environmental source could be identified. The strain 
exhibited enhanced survival in handwashing experiments 
and was relatively resistant to 'Hibiscrub'
(chlorohexidine). Oral ketoconazole reduced the rate of 
isolation of the outbreak strain from patients.
Collingnon and Sorrell (1983) described systemic 
candidosis in heroin addicts and Hay (1986) provided a 
short review on this. Isenberg et a%. (1989) found that
a single nurse infected eight patients and that following 
her removal from nursing responsibilities, the cluster 
outbreak ended.
4.5.1 Extrahepatic bilary tract candidosis
Although candidosis has been reported in virtually 
every organ, involvement in the extra hepatic bilary
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tract is rare (Irani and Truong, 1986). Clinical and 
laboratory findings are not distinctive enough to suggest 
a specific diagnosis, but right hand upper quadrant pain 
coupled to jaundice could be considered markers. If 
suitable, surgery to remove a fungal ball blocking the 
bile duct, along with antifungal drugs generally provides 
for recovery.
4.5.2 Renal candidosis
In both humans (Barnes et al., 1983) and animals 
(Hasenclever and Mitchell, 1962), the organ most 
susceptible to infection appears to be the kidney. Renal 
candidosis has been diagnosed predominantly in middle 
aged and elderly patients. Its clinical and diagnostic 
features are fever and urinary obstruction.
The mechanism by which Ç. albicans. once localized, 
invades renal parenchyma is as yet undefined (Barnes et 
al., 1983). Lee and King (1983) stated that blood-borne 
C. albicans cells are rapidly cleared from the 
circulation by the liver, lungs, spleen and kidney.
Barnes et al. (1983) suggested that the localization of 
Ç. albicans blastospores within renal vasculature 
occurred primarily by adherence to endothelial surfaces. 
This was substantiated by electron microscopy showing 
numerous fibrils extending from the yeast surface to the 
endothelium.
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4.5.3 Gastrointestinal candidosis
De Maria et aJ. (197 6) suggested that the development 
of systemic candidosis involves gastrointestinal 
colonization followed by mucosal invasion and 
dissemination via the bloodstream. Symptoms include loss 
of appetite, nausea, vomiting and intestinal pain (Odds, 
1988) .
Ç. albicans has been shown to be able to cross the 
human bowel wall (Pope and Cole, 1981) and therefore 
entry of Ç. albicans into the body via the 
gastrointestinal tract (GI tract) is important. Indeed, 
Stone et ad. (1974) suggested that this may be the 
primary invasion mechanism. Krause et ajL. ( 1969 ) 
previously investigated this theory. Two hours after 
ingestion of C. albicans in saline suspension, typical 
symptoms of septicaemia developed - chills, headache and 
high fever. Nystatin administration via oral and 
catheteric routes gave almost immediate remission.
Auguste and Nava (1986) recognised the difficulty in 
diagnosis of this form of infection. A trial of 
clotrimazole has confirmed its efficacy in 
gastrointestinal forms of candidosis and the compound has 
been claimed to prevent the extension of oral thrush into 
the oesophagus (Shechtman et ed,. , 1984)
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4.5.4 Candida endocarditis
The signs of endocarditis are generally fever, 
chills, anorexia, nausea, vomiting and heart failure 
(Odds, 1988). These symptoms and the condition were 
rarely seen before the introduction of antibiotics, 
steroids and cardiac surgery (Chaudhuri, 1970). The 
increased frequency of the disease usually appears in 
three clinical settings - prosthetic valvular insertion, 
intravenous drug abusers, and as a complication of 
prolonged intravenous antibiotic administration, or 
hyperalimentation (Scheld et ^ . , 1983).
Although Marrie et ad. (1984) used scanning electron
microscopy and transmission electron microscopy to 
describe the ultrastructure of C. parapsilosis 
endocarditis, there is no reliable clinical or laboratory 
indicator other than surgically invasive exploration for 
a definitive diagnosis (Odds, 1988). Rapid diagnosis is 
however, the most important factor in the successful 
management of Candida endocarditis. Seelig et ad. (1979) 
proposed vigilance, and prophylactic monitoring of 
patients at risk from the disease should help reduce the 
mortality rate. Rose (1978) recommended that following 
the removal of intravenous catheters, repeated 
blood-cultures may lead to an earlier diagnosis of 
Candida endocarditis.
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4.5.5 Candida endophthalmitis
Graham et al. (1986) presented four cases of Candida 
endopJthalmitis to demonstrate the difficulties of both 
ocular and microbiological diagnosis. The initial 
complaint is of painful photophobia and of particles 
floating in the field of vision. The disease is always 
associated with Candida septicaemia. Once endophthalmitis 
has been diagnosed, antifungal drugs should be given 
although their efficiency is not absolute. The preferred 
regime is probably • fluconazole and ketonazole (Graham 
et al., 1986).
5 ANTIFUNGAL AGENTS
Numerous antifungal agents are active against Candida 
species. The more recent ones can be divided into three 
classes; the polyenes, 5-fluorocytosine and the 
ergosterol biosynthesis inhibitors. These antifungal 
drugs, and their effects have been reviewed by Vanden 
Bossche et al. (1987).
5.1 The polyene macrolide antibiotics: amphotericin B
and nystatin
Nystatin and amphotericin B are characterized by a 
ring of carbon atoms containing both a system of 
conjugated double bonds and a hydrophilic region 
characterized by the number of C atoms in the ring 
(Kerridge and Nicholas, 1986).
67
Nystatin was the first polyene ever to be applied to 
the treatment of candidosis and was first isolated from 
Streptococcus noursei or Strep. albus (Hamilton-Miller, 
1973). It is primarily used to treat Candida infections 
of the skin, intestinal tract and mucous membrane.
Vaginal candidosis usually responds well to nystatin.
At the minimum growth inhibitory concentration, the 
nystatin interacts with sterol-containing plasma 
membranes rendering them permeable (Palacios and Serrano, 
1978). This dissipation of the proton gradient leads to 
the loss of intracellular potassium, sodium and magnesium 
and a decrease in the dry cell mass and intracellular 
amino acid pools.
Amphotericin B is used to treat systemic infections. 
The drug is administered intravenously as it is poorly 
adsorbed from the gastrointestinal tract, and topical 
application does not result in detectable levels of 
amphotericin B in the systemic circulation (Sugar, 1986). 
The maximum dose is 1 mg/kg/day. Because of slow drug 
clearance an alternate day treatment schedule might be 
followed (Graybill and Craven, 1983). Its biological 
action is essentially the same as Nystatin: metabolic 
disruption and cell death are secondary consequences of 
metabolic alterations (Hammond et , 1974). Odds 
(1979) listed several of the side effects, including 
flushing, convulsions, chills and fevers. Antifungal 
resistance is not a recognized problem in patients
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(Kerridge and Nicholas, 1986).
5.2 5-Fluorocytosine
5-Fluorocytosine, the fluorinated pyrimidine, 
inhibits growth of yeasts and many fungi. Since it is 
well adsorbed by the gut it may be given orally, and 
distributes well in the body. It is the only antifungal 
in clinical use where the occurrence of resistance poses 
a serious problem (Kerridge and Nicholas, 1986). 
y The spectrum of 5-fluorocytosine is limited as an 
antifungal. However, activity is best in yeast species, 
including Candida (Vanden Bossche et al., 1987). Polak 
and Grenson (1973) described the mode of action. The 
compound is transported to the yeast cytoplasm via 
cytosine permease, where it is deaminated to 
5-fluorouracil which is then phosphorylated for 
incorporation into cellular RNA; thus protein synthesis 
is disrupted.
5.3 Ergosterol biosynthesis inhibitors
Ergosterol biosynthesis inhibiting antifungals 
constitute the most important group of compounds 
developed for the control of fungal diseases in plants, 
animals and man.
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5.3.1 Azole antifungals
An extensive number of imidazole and triazole 
antifungal agents have been synthesised and developed.
Most of the currently available imidazoles and the 
triazole, terconazole, are mainly for topical treatment.
Ketoconazole was the first azole derivative orally 
active against yeasts, dermatophytes and dimorphic fungi 
(Van Cutsem et ad,, 1987). It is also available for 
topical treatment. Itraconazole has been used for the 
treatment of acute vaginal candidosis. Vanden Bossche et 
al. (1987) reported that this azole has to be given with 
or immediately after a meal; adsorption may be reduced in 
cases of impaired gastric activity, and after evaluation 
in 3000 patients itraconazole is well tolerated. Azoles
act to inhibit the cytochrome P-450 dependent 14
a-demethylation of lanosterol with consequently,
uncoordinated synthesis of chitin, disruption of 
intracellular enzymes and cell membrane disruption 
(Vanden Bossche et al., 1987). Since minute amounts of 
ergosterol are needed to stimulate cell proliferation, 
the depletion of ergosterol, reacted at very low 
concentrations of azole derivatives, will also contribute 
to their antifungal activity.
Clotrimazole was the first substituted imidazole to be 
released as an antifungal drug, and miconazole was the 
second to have been accepted for clinical use.
Miconazole inhibits fungal growth and growth of some Gram
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positive bacteria. The biochemical effects of miconazole 
resemble clotrimazole; topical creams are now in wide 
usage.
Since the introduction of the imidazole antifungals 
in the late sixties and their use in millions of 
patients, only a few isolates of Ç. albicans have shown 
resistance. With ketoconazole, 4 isolates of Ç. albicans 
have been found to be much less sensitive to several 
azole antifungals; two were isolated from American 
patients (Horsburgh and Kirkpatrick, 1983) with chronic 
mucocutaneous candidosis and the other two were isolated 
from British chronic mucocutaneous candidosis patients, 
(Johnson et. ad. , 1984; Ryley et ai., 1984). These 
patients relapsed following prolonged treatment with 
ketoconazole.
5.3.2 Allylamines
The two allylamines, naftifine and terbafine are 
antifungals, of which the former is used topically for 
superficial mycoses and the latter for topical and oral 
treatment (Ryder et ai., 1986).
Naftifine exhibits high activity against Trichophyton 
and against Aspergillus species. Terbinafine is a 
derivative of naftifine with excellent activity against 
dematophytes (Petranyi et ai. , 1984). Both these 
allylamines interfere with ergosterol synthesis as 
squalene epoxidase inhibitors (Vanden Bossche et ai., 
1987). Both compounds have a naphthalene moiety, which
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may indicate that this moiety is involved in binding to 
the squalene epoxidase system.
6 PATHOGENICITY
6.1 Pathogenicity of different Candida species
The pathogenic Candida species can be listed in 
probable order of decreasing virulence; C. albicans, Ç. 
tropicalis. C. stellatoidea (now the same species as Ç. 
albicans), Ç, parapsilosis, C. pseudotropicalis, Ç. 
krusei, Ç. auillermondii (Odds, 1979). C. lusitaniae, C. 
glabrata and C. viswanthii were not mentioned in this 
report. There have been few studies comparing the 
pathogenicity of the various species of Candida under 
well controlled and reproducible experimental conditions. 
Only Ç. albicans, Ç, tropicalis and Ç. viswanthii were 
shown to be pathogenic on intravenous challenge (Bistoni 
et al., 1984), in decreasing order of pathogenicity.
This latter study indicated that strong immunodépression 
(by cyclophosphamide) did not affect the susceptibility 
of mice to Candida species with low or no pathogenicity 
for mice, yet greatly increased susceptibility to Candida 
species with pathogenicity for an unmodified host.
Allen and Beck (1983) reported strain related 
differences in the pathogenicity of C. albicans in the 
rat mucosae.
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Pope and Cole (1982) compared gastrointestinal 
colonization and systemic spread by C. albicans and the 
non-pathogenic Ç. auilliermondii and S. cerevisiae. 
Scanning electron microscopic investigations of the 
gastrointestinal tracts of animals receiving C. 
auilliermondii or cerevisiae were devoid of adherent 
yeasts. Barrett-Bee ^  aul. (1985) compared phospholipase
activity, adherence and pathogenicity in C. albicans, C. 
parapsilosis and cerevisiae. Ç. albicans isolates 
which were highly adherent were the most pathogenic in 
mice and had high phospholipase activities. By contrast, 
Ç. parapsilosis and S. cerevisiae were not very adherent, 
did not kill mice and had lower activities of 
phospholipase.
Wingard et (1979) reported Ç, tropicalis as the
aetiologic agent in 15 of 18 cases of disseminated 
candidosis in patients undergoing treatment for 
haematologic malignamies or receiving bone marrow 
transplants.
Morgan et ad. (1984), reported that in the case of C. 
pseudotropicalis fungaemia in the immunocompromised host, 
the source of infection was the urinary tract. Finally, 
Marrie et (1984) reported Ç. parapsilosis
endocarditis; thus it can be concluded that several 
Candida species are pathogenic to man.
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6.2 Course of infection
During the course of systemic infection, organisms 
become widely disseminated in the blood and may be found 
in most tissues; lesions may be found in kidneys, lungs, 
liver, heart, spleen and other organs: the extent and 
severity depends on the size of the initial inoculum 
(Odds, 1979). The length of infection also depends upon 
the prescribed treatment and its efficacy. In the case 
described by Bandini ^  al. (1986) fever was followed by 
acute renal failure, jaundice, progressive loss of 
consciousness and then death, in the space of two weeks 
after bone marrow transplantation.
6.3 Host responses
A variety of protective mechanisms are active 
intra-orally. Epstein et aj.. (1984) and Smith (1985) 
have both reviewed this subject. When these host defence 
mechanisms act in concert, they represent a formidable 
barrier to candidosis. In the oral cavity there are a 
variety of non-specific host-defence mechanisms. The 
epithelium acts as a physical barrier; epithelium 
turnover contributes to defence. Outwith the oral 
cavity, the stratified squamous epithelium of the skin is 
not usually colonised by C. albicans but is an effective 
barrier to invasion. Regular sloughing off and 
replacement affect loss of attached organisms (Smith,
1985). Saliva functions by its diluting and washing
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effect, and it also contains antimicrobial factors such 
as lysozyme and lactoferrin.
Lysozyme is present in the oral cavity; it originates 
from saliva, gingival crevice fluid and polymorphonuclear 
leukocytes. It can agglutinate and kill Ç. albicans in 
non-ionic solutions and increases the fungicidal activity 
of amphotericin B in culture media (Epstein et aT,,
1984). Salivary glycoproteins may form part of the 
host's non-specific defence mechanism; they may be 
similar to those on the host cell surface preventing 
adhesion to the mucosal epithelium. Lactoferrin has the 
ability to chelate iron from the oral environment and has 
antimicrobial activity at oral concentrations. Its 
acitivity is believed to be due to the binding of iron 
which decreases the amount of available iron required for 
growth (Kirkpatrick et al., 1971). Cell-mediated 
immunity may be active in host resistance to some forms 
of candidosis (Epstein et aj.. , 1984) and has been shown 
to be significant in chronic mucocutaneous candidosis 
(Kirkpatrick et al. , 1971).
In oral microbial interactions, competition and 
inhibition are important in limiting the establishment 
and overall growth of fungi. Bacterial flora may 
restrict, but not eliminate Candida. Endogenous 
bacterial flora may decrease colonization by competing 
for adherence sites on epithelial cells (Marrie and 
Costerton, 1981). Gnotobiotic mice are colonized by C.
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albicans when challenged. This enhanced susceptibility 
is due to reduced inflammatory response, delayed 
cell-mediated immunity, lower levels of immunoglobulin, 
reduced chemotaxis and lack of competition for receptor 
sites.
Alterations in the microbial flora of healthy 
individuals can be associated with systemic illness, 
hormonal changes, use of corticosteriods and antibiotics 
(Rogers and Balish, 1980). Instances of vaginal 
candidosis increase in pregnancy, and may be associated 
with increased glycogen in vaginal secretions (Knight and 
Fletcher, 1971 ) .
The binding of antibodies to antigens in general is 
known to activate the serum complement system, one of 
whose functions is to facilitate phagocytosis, Epstein 
et al. (1984) described anti-Candidal IgA antibodies in 
saliva that could inhibit attachment of C. albicans to 
epithelial cells. They further noted that salivary 
levels of IgA and other anti-Candidal antibodies were 
higher in subjects with candidosis than in non-infected 
controls.
The increasing incidence of vaginal candidosis has 
led to interest in the origin and role of anti-C. 
albicans IgA and IgG in human cervicovaginal secretions. 
Gough et (1984) measured the levels of anti-C.
albicans IgA and IgG in the genital tract of secretions 
of serum of non-pregnant women with vaginal candidosis
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relative to uninfected women. There was however, no 
significant difference between the mean levels of 
specific IgA or IgG in secretions from women from the two 
groups.
6.4 Determinants of virulence
Several virulence factors of Candida albicans have 
been suggested (Table 1).
6.4.1 Toxins
Information about Ç. albicans toxins is both limited 
and contradictory. Hasenclever and Mitchell (1963) 
supported the idea of a Ç. albicans endotoxin but could 
not isolate it. It is clear that no Candida species 
secretes into its culture medium any molecule with a 
biological activity/potency equivalent to a bacterial 
endotoxin (Odds, 1988).
Indirect evidence of toxin existence came from the 
cell-free experiments of Davies and Reeves (1971). 
However, Stanley and Hurley (1967) had already cast doubt 
on the use of cell-free experiments, as when they used 
Candida species with tissue culture, no indirect toxic 
effect was seen. Cutler et (1972) found that only
cell-wall glycoproteins of Ç. albicans had toxic effects. 
However, cell-wall glycoproteins from Ç. albicans may be 
the attachment site for the yeasts to interact with 
epithelial cells. McCourtie and Douglas (1985) found 
that extracellular glycoproteins isolated from culture
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Table 1 Postulated virulence factors of Candida 
albicans
Virulence factor Reference
Adhesion to mucosal surfaces Douglas, 1987
Production of hyphae Odds, 1988
Secretion of hydrolytic enzymes Barrett-Bee ^  al.,
1985
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supernatants of C. albicans inhibited adhesion of yeasts 
to buccal epithelial cells when epithelial cells were 
pretreated with the extracellular glycoprotein. It has 
been shown that Candida hyphae liberate substances which 
inhibit attachment of hyphae to neutrophils (Diamond et 
al. , 1980). Iwata ( 1976) also described a "canditoxin". 
The lack of confirmatory data would bring the existence 
of such a toxin into question.
6.4,2 Filamentation and phenotypic variability
The ability of C. albicans to produce hyphae has long 
been held to account for its relatively high 
pathogenicity (Louria and Brayton, 1964). The effects of 
filamentation within tissues appears to confer on C. 
albicans a heightened mechanical ability to resist 
phagocytosis and penetrate mammalian cells (Saltarelli et 
al.. 1975). However, Cockayne and Odds (1984) suggested 
that hyphal forms of Ç. albicans are more susceptible to 
killing by human polymorphonuclear effectors than are 
yeast forms. This would seem to contradict the commonly 
held belief that hyphal forms of Ç. albicans are endowed 
with a greater invasiveness and resistance to host 
defences than the yeast form.
Several microbial pathogens are known to express 
variable antigenic components, for example, typanosomes. 
Neisseria meningitidis and E. coli. It is therefore 
possible that Candida can do something similar. Anderson 
and Soil (1987) noted that C. albicans switched from
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white to opaque colony types. They thought it unlikely 
that such a carefully organized high frequency switch to 
the opaque phenotype was for any other purpose than 
pathogenesis.
6.4.3 Enzymes
Hydrolytic enzyme activities expressed at the cell 
surface of microbial pathogens are always theoretically 
capable of damage to host cells in vitro. With C. 
albicans there are two main candidates : a proteinase and 
a phospholipase. Acid proteinases are secreted by most 
strains of Ç. albicans/ Ç. tropicalis and Ç. 
parapsilosis; this reflects the sequence of virulence of 
these species in man (Ruchel, 1984; MacDonald, 1984). An 
inducible proteinase secreted by Ç. albicans is likely to 
be a virulence factor of the yeast. Budtz-Jorgensen 
(1971) indicated that clinical isolates of other Candida 
species secreted proteinases, while Staib (1965) reported 
that not all strains of C. albicans release an acid 
proteinase.
The location of Candida proteinase around the fungal 
cells invading host tissue suggests the importance of the 
enzymes in the pathogenesis of Candida infections 
(MacDonald and Odds, 1980).
Tsuboi et al. (1989) suggested that extracellular 
proteinase from Ç. albicans was activated by the 
acidification of the microenvironment close to the 
organism.
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In the buffered milieu of the host, above pH 7.0, 
little acid proteinase activity can be expected. Candida 
acid proteinase can however be traced in the serum of 
mice in the early stages of experimental candidosis; such 
a circulating enzyme may become active in acidic pockets 
of damaged kidney. Muscle tenderness, an early sign of 
disseminated candidosis (Jacobs et al., 1980), may 
reflect an effect of acid proteinases. Evidence that the 
inducible acid proteinase of C. albicans may be one of 
its attributes of virulence comes from MacDonald and Odds 
(1983) and Kwon-Chung et al. (1985). They showed 
significant reductions in mouse lethality of mutant 
strains deficient in secretion of the enzymes. In the 
latter case a proteinase-secreting "revertant" isolated 
from an infected mouse, was shown to have the same
virulence as the parent strain.
Ç. albicans produces phospholipases which may be 
associated with the pathogenicity of the fungus. In 
stationary-phase cells, Pugh and Cawson (1975)
demonstrated the localization of the phospholipase
activities in cells and culture medium by a cytochemical 
method.
Phospholipase A and lysophospholipase activities have 
been located in yeast cells and hyphae of C. albicans 
infecting chick chorioallantoic membranes using 
cytochemical techniques (Pugh and Cawson, 1977). 
Barratt-Bee ^  ai,. ( 1985) measured phospholipase A and
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lysophospholipase activities in culture fluids. They 
showed correlation between phospholipase activity, 
pathogenicity and adherence to epithelial cells. 
Non-pathogenic yeasts and some C. albicans isolates which 
did not adhere, and did not kill mice, had lowered 
phospholipase activity.
7 ADHERENCE OF CANDIDA TO SURFACES 
7.1 Importance of adherence
Colonization of mucosal surfaces by Candida species 
depends on the organisms' ability to adhere. 
Microorganisms are continually lost by the process of 
desquamation or "sloughing off" of surface epithelial 
cells. Organisms must adhere to the newly presented 
surface for effective colonization. This is one of the 
host defences against infection. With Candida species, 
which are opportunistic pathogens, colonization can be 
effected without clinical infection. The crucial role of 
adhesion in the pathogenesis of microbial infections is 
well recognized. Predominantly, reviews have focused on 
bacterial adherence (Wardell et al,. , 1983; Jones and 
Isaacson, 1983; Feingold, 1986). However the subject of 
yeast adherence is now being studied intensively and has 
been reviewed on several occasions (Douglas, 1985; Lee 
and King, 1983; Rotrosen et al., 1986; and Douglas,
1987).
82
Microbial attachment to surfaces is of wide ranging 
interest to physical chemists, engineers, dentists, plant 
pathologists and microbiologists. In recent years there 
has been a growing volume of literature produced on yeast 
adhesion and in particular of C. albicans attachment to 
epithelial surfaces. Non-specific microbial adhesion 
occurs with organisms capable of adhering to many 
different types of surface. Specific adhesion involves 
interactions between complementary molecules on the 
microbial and attached surfaces.
Initial loose docking is followed by permanent 
attachment possibly involving specific bonds between 
complementary molecules (see Figure 3). Using various 
sugars and lectins, inhibition assays have suggested that 
various glycosides act as receptors on mucosal epithelial 
cells (Ofek et al., 1978); and this adhesion is the 
initial step in infection. Considerable progress has 
been made in developing methods of inhibition of 
adherence of pathogens to mucosal surfaces (Beachey,
1981).
The theory of Derjaguin, Landau, Ver and Overbeck 
(DLVO Theory) has been useful in interpreting the 
interaction between two negatively charged bodies (Ho,
1986). The DLVO theory states that as two rigid bodies 
of like charge approach each other, they are subject to 
forces of attraction and repulsion, which are additive 
but which vary with distance (Isaacson, 1983). For
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Figure 3 Adhesion of yeast to epithelial cells.
Adhesion of yeast by specific adhesins (Y ) 
to complementary receptor {|) on the host 
cell membrane
cell membrane glycoproteins
lipid
bilayer
yeasts
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microorganisms to attach to mucosal surfaces, net 
repulsion must be overcome. Ho (1986) summarized the 
factors influencing whether adhesion should take place.
Extracellular surface polymers seem to have a role in 
mediating attachment. Marrie et ad. (1983) saw extensive 
extracellular matrix formation in a very wide range of 
organisms including C. albicans. Ayers et aJL. ( 1979 ) 
were able to correlate the production of extracellular 
polysaccharide by bacteria with their ability to cause 
disease in host inoculation tests.
McCourtie and Douglas (1984) correlated adherence to 
acrylic and buccal epithelial cells with C. albicans cell 
surface composition and virulence. The Ç. albicans 
fibrillar floccular layer may represent something 
analogous to bacterial fimbriae, whose importance in 
adhesion is well documented (Jones and Isaacson, 1983). 
In E, coli the pili or fimbriae appeared to be involved 
in the pathogenesis of infection (Guerina et al., 1983). 
Fimbriae have been reported in a variety of yeast species 
including C. albicans (Gardiner et al., 1982). The 
determination of the nature of the host cell receptors 
has involved the use of sugar analogues to inhibit 
adhesion, or the binding of receptors by lectins.
Lectins of known carbohydrate specificity have been used 
to inhibit adhesion (Critchley and Douglas, 1987b).
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7 .2 Measurement of iji vitro adherence
The first quantative determination of Candida 
adhesion was that of Liljemark and Gibbons (1973). Their 
procedure was modified by Kimura and Pearsall (1978) to 
yield an assay now used in several laboratories to 
determine the adhesion of Candida to epithelial cells.
The final stage of determining the number of adherent 
yeasts is performed either using a visual count (Douglas 
et al. , 1981), a radiolabelling count (King et al., 1980) 
or a Coulter count (Gorman et , 1986). The method 
described by Segal et al. (1982) only determines 
epithelial cells with a minimal number of yeasts 
attached.
7.3 Factors influencing adhesion
A wide variety of factors are thought to be likely 
modulators of the adhesion process and they have been 
categorized (Douglas, 1985; 1987) into three groups: 
yeast factors, host factors and environmental factors 
(see Table 2). A wide range of cells and surfaces to 
which Candida species adhere have been found. These 
include buccal epithelia, vaginal epithelia, corneocytes, 
murine gastrointestinal epithelia, vascular endothelia 
and platelet matrices. Candida species have also been 
found to adhere to foreign bodies within the human body 
such as catheters, contact lenses and dentures. Only a 
few of these will be considered.
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Table 2 Factors influencing adherence of Candida to 
epithelial cells 
(adapted from Douglas, 1985)
Yeast Factors
Concentration and viability 
Phased temperature growth 
Growth medium composition 
Species and strain 
Germ-tube formation
Epithelial Cell Factors 
Cell type
Environmental Factors
Temperature and time of contact 
pH
Bacteria
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7.4 Adherence of Ç. albicans
7.4.1 Adherence of Ç. albicans to buccal epithelial 
cells
The adherence of Ç, albicans and other Candida 
species to buccal cells has been measured by several 
investigators (King et al^ . , 1980; Macura et ad., 1983;
Ray et al., 1984 and Critchley and Douglas, 1985). Ç. 
albicans was found to be the most adherent species, 
whilst Ç. tropicalis and C. stellatoidea (now C. 
albicans) exhibited moderate adherence capabilities and 
C. parapsilosis was only slightly adherent to buccal 
cells. These studies suggest a relationship between the 
ability of different Candida species to adhere to 
epithelial cells and their capacity for colonizing and 
infecting mucosal surfaces. Strains of Ç. albicans from 
active infections showed enhanced adhesion after growth 
in a defined medium containing 500 mM galactose (Douglas 
et al. , 1981). In response to this high sugar 
concentration these strains synthesize surface components 
which are responsible for enhanced adhesion.
Kimura and Pearsall (1980) reported that germinating 
yeasts were more adherent than non-germinating ones. Cox 
(1983) investigated the effect of pH on adherence of 
Candida albicans to buccal cells, and found no 
significant change in adherence between pH 4 to 11. 
Davidson et (1984) claimed that yeasts were more
adherent to buccal cells from adults than those from
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children. This was in contrast to the earlier data of 
Cox (1983) that adults gave adherence values similar to 
those from children; the results of this latter study 
suggested that receptors remain stable and are unaffected 
by age. C. albicans was more adherent to buccal cells 
from children with oral candidosis and oral colonization 
than to buccal cells from uninfected control children 
(Cox, 1983).
7.4.2 Adherence to vaginal epithelial cells
Adherence to vaginal epithelial cells is not markedly 
influenced by pH (King et al., 1980), salts or divalent 
cations, so adherence is unlikely to involve only 
electrostatic or ion-bridging bonds. Lee and King (1983) 
showed that Candida cell fragments contained the 
adherence factor; the integrity of yeast wall 
mannoproteins was important for adhesion.
Germinating yeasts were more adherent to vaginal 
cells than were non-germinating yeasts in jjn vitro 
experiments (Sobel ^  aJL. , 1981). This study also found 
that there was higher adherence to vaginal cells at pH 6 
than at pH 3 to 4 which is nearer the normal vaginal pH. 
Persi et ad. (1985) found that adhesion to vaginal cells 
was affected by the strain of C. albicans used, the side 
of the epithelial cell exposed to the yeast, pH 
conditions and CO^ levels within the assay mixture.
Segal ^  ad. (1984) correlated the hormonal status of 
women and adherence to vaginal cells. They further
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reported that vaginal cells from fecund women who were 
pregnant and/or diabetic had a greater propensity to bind 
C. albicans than did epithelial cells from oral 
contraceptive users and non-pregnant diabetic controls. 
Differences in candidal adhesion between vaginal and 
buccal epithelial cells are significant, as are 
differences between cell donors (Sobel et al., 1981).
7.4.3 Adherence to vascular endothelium
Deep seated infection by C. albicans is usually due 
to widespread dissemination of the organism via the 
bloodstream; to invade the parenchyma of various organs, 
the yeast must attach to vascular endothelium and 
penetrate the vessel wall.
Barnes ^  ad. (1983) demonstrated that adhesion of C.
albicans to renal endothelium is mediated by fibrils on 
the yeast surface. Klotz et al. (1983) investigated 
segments of pig aorta and found that the reason some 
tissues became infected more often than others was that 
the endothelium of some tissues contains more receptors 
than the endothelium of others. The penetration of 
endothelium by yeasts may be attributable to the action 
of exoenzymes of C. albicans. As destruction of the host 
cell progresses, the fungus penetrates deeper into the 
substance of the aorta. Formalin-killed yeasts adhered 
just as well as viable organisms. However, C. albicans 
treated with formalin or papain was incapable of adhering 
to vaginal epithelial cells but could localize in rabbit
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kidneys to the same degree as untreated organisms, 
suggesting the mechanisms of adhesion to vaginal 
epithelial cells and renal endothelium are distinct (Lee 
and King, 1983).
7.4.4 Adherence to fibrin platelet matrices
Studies on the adherence of different Candida species 
to fibrin-platelet matrices formed in vitro (Maisch and 
Calderone, 1980) showed that Ç. albicans and Ç. 
stellatoidae were considerably more adherent than the 
other yeasts tested. Maisch and Calderone later (1981) 
suggested that surface mannan is an important determinant 
in the adherence of Ç. albicans to fibrin-platelet 
matrices formed in vitro on the endocardium of heart 
valves. Experiments in rabbits suggest that humoral 
antibody may protect against C. albicans endocarditis by 
inhibiting yeast adhesion in vivo (Scheld et ^ . , 1983).
7.4.5 Adherence to denture acrylic
McCourtie and Douglas (1981) and McCourtie et al.
(19 85) found that adherence to acrylic in vitro was 
promoted by growing the yeasts to stationary phase in 
high concentrations of certain sugars as the carbon 
source. Adherence of yeasts could be further increased 
by pretreatment of the acrylic with crude mannoprotein 
isolated from culture supernatants (McCourtie and 
Douglas, 1985). Mannoprotein probably enhances adhesion 
by acting as a non-specific polymeric bridge. Divalent
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cations and serum also promote adhesion to acrylic 
(Samaranayake et al., 1980).
7.4.6 Effect of commensal bacteria on adherence of Ç. 
albicans
Liljemark and Gibbons (197 3) investigated the 
mechanism by which bacteria suppress colonization of 
mucosal surfaces by Ç. albicans. They found that twice 
as many yeasts attached to germ-free rat cells than to 
cells from conventional animals, suggesting that 
indigenous flora can interfere with adherence. Adherence 
of Ç. albicans and commensal bacteria to human epithelial 
surfaces has also been studied (King et aJL. , 1980; 
Samaranayake and MacFarlane, 1982). Makrides and 
MacFarlane (1982) showed that although commensal bacteria 
like Escherichia coli and Klebsiella aeroqenes enhanced 
candidal adherence, others such as Streptococcus sanguis 
and Strep. miteor decreased adherence.
Makrides and MacFarlane (1982) investigated the 
mechanism by which E. coli enhances adherence of C. 
albicans to epithelial cells. They indicated that 
increased candidal adherence due to E. coli is mediated 
by fimbriae on bacterial cells and mannose-like receptors 
on surfaces of both Ç. albicans and epithelial cells, 
Sobel et al. (1981) found that preincubation of vaginal 
epithelial cells with two vaginal isolates of 
Lactobacillus species significantly decreased yeast 
adhesion.
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7.5 The yeast adhesin
Most experimental evidence indicates a role for 
mannoprotein in mediating yeast attachment to buccal and 
vaginal cells (Douglas, 1987). For example, Sandin et 
al. ( 1982) reported that preincubation of Ç. albicans
with Concanavalin A, a lectin that binds ot-linked 
D-mannose (or glucose) residues, decreased the adhesion 
to buccal epithelial cells by more than 80%. Adhesion 
can also be inhibited by pretreating Ç,. albicans with 
proteolytic enzymes (Sobel et aJ^ . , 1981) and reducing 
agents (Lee and King, 1983) such as /3-mercaptoethanol and 
dithiothreitol. McCourtie and Douglas (1985) and 
Critchley and Douglas (1987a) inhibited adhesion by 
preincubation of buccal cells with mannoprotein obtained 
from culture supernatants of yeasts grown in a medium 
containing high concentrations of galactose. The 
mannoprotein nature of the adhesin has also been 
demonstrated in experiments with the antibiotic 
tunicamycin (Douglas and McCourtie, 1983). This 
antibiotic functions as an inhibitor of protein 
glycosylation; in yeasts it specifically inhibits 
synthesis of mannoprotein but not that of the other major 
wall components, glucan and chitin (Kuo and Lampen,
1974). Addition of tunicamycin to cultures of Ç. 
albicans in high-galactose medium at the end of 
exponential growth inhibited formation of the fibrillar 
layer. Consequently, the C, albicans showed decreased
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adhesion to buccal cells (> 60%) compared to untreated 
controls. However yeasts grown in low-glucose medium and 
lacking in the fibrillar layer, were unaffected by 
tunicamycin treatment (Douglas and McCourtie, 1983). 
Extracellular material originating, at least partially, 
from a fibrillar layer on the yeast surface is thought to 
contain yeast adhesin as it inhibits adhesion. The 
specificity of this interaction can be demonstrated; 
mannoprotein isolated from one C. albicans (GDH 2023) 
failed to inhibit the adhesion of a second strain, namely 
C . albicans GDH 2346 (McCourtie and Douglas, 1985).
Adhesion of C. albicans to vaginal epithelial cells 
was severely inhibited by pretreating yeasts with a 
variety of proteolytic enzymes or with reducing agents 
such as /3-mercaptoethanol or dithiothreitol (Lee and 
King, 1983). Critchley and Douglas (1987a) found that 
pretreatment of vaginal cells with crude mannoprotein 
from culture supernatants had similar results. Adhesion 
mechanisms in which proteinaceous adhesins interact with 
carbohydrates on animal cell surfaces have already been 
described (Jones and Isaacson, 1983). Involvement of the 
protein portion of the yeast mannoprotein in Candida 
adhesion would be analogous. By contrast, Segal et al. 
(1982) reported that chitin and chitin hydrolysate 
inhibited yeast adhesion to vaginal epithelial cells in 
vitro, yet chitin is thought to be concentrated in the 
inner layers of the yeast cell wall (Cassone et al.,
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1973). Animal experiments by Lehrer al. (1983) also 
showed that N-acetyl-D-glucosamine or an aqueous extract 
of chitin blocked yeast attachment to epithelial surfaces 
in vivo and thus precluded vaginal infection. These 
discrepancies remain unexplained.
Characterization of the mannoprotein adhesin involves 
identifying the fragment of the complex molecule that 
interacts with the epithelial cell. Pretreatment of 
crude adhesin with heat, dithiothreitol or proteolytic 
enzymes (except papain) either partially or completely 
destroys its ability to inhibit adherence. Protein-rich 
fractions obtained by endoglycosidase H digestion and 
fractionation on Concanavalin A columns, and used in 
inhibition assays indicated that the protein-rich 
fraction inhibits adhesion more than the 
carbohydrate-rich fraction. These results suggest that 
the major interaction between yeasts and epithelial cells 
is one involving a protein adhesin (Critchley and 
Douglas, 1987a). This would be analogous with the 
situation in many Gram negative bacteria (Jones and 
Isaacson, 1983 ) .
7.6 The epithelial cell receptor
Sugars used to block yeast adhesion in hapten 
inhibition tests are those present on host cell surfaces 
in glycoproteins and glycolipids (Sharon et aJ., 1981). 
The plasma membrane of all animal cell surfaces consists
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of a lipid bilayer and proteins. The composition and 
organization of the membrane has been reviewed by Ofek et 
al. ( 1985). In isolation these tests can provide 
equivocal results (Douglas, 1987); with Candida, 
mannose-containing components on both cell surfaces may 
participate in adhesion. Furthermore, some sugars may be 
rapidly metabolized during the assay by the microorganism 
under investigation, Ç. albicans, and this may produce 
spurious results. This would partially explain why sugar 
inhibition tests with Ç. albicans have yielded a variety 
of contradictory results. L-fucose (Sobel et ^ ., 1981), 
amino sugars <Segal et al., 1982) and D-mannose (Sandin 
et al. , 1982) have all been reported to be the major 
inhibitor of Candida adhesion and therefore the likely 
receptor determinant. Other investigations have failed 
to identify inhibition with any sugar (Reinhart et al., 
1985), although a full range of sugars known to be 
constituents of epithelial cell membranes was not 
employed. The experiments referred to above would 
indicate that different strains of C, albicans bind to 
different glycoside receptors.
L-fucose is commonly found on the epithelial cell 
membrane of the rabbit gut and has been shown to function 
as a receptor for Vibrio cholerae (Jones and Freter, 
1976). By use of experiments involving Concanavalin A, 
Sandin et (1982) concluded that mannose-containing
moieties on the surface of C. albicans and buccal cells
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would mediate adherence. Critchley and Douglas (1987b) 
utilized a wide range of lectins and sugars and concluded 
that depending on the strain of Ç. albicans, glycosides 
containing L-fucose, N-acetyl-glucosamine, or D-mannose 
may all function as epithelial receptors for the yeast. 
Douglas (1987) tabulated the inhibition of adherence of 
different strains of Ç. albicans to epithelial cells by 
sugars, and concluded that fucose-containing receptors 
may be commonly required for Candida adherence.
Additional mechanisms may also function, since 
introduction of L-fucose into adherence assay mixtures 
only partially inhibits adhesion. Crude mannoprotein 
from C. albicans has been shown to contain "lectin-like" 
proteins capable of binding L-fucose, D-mannose and 
N-acetyl-D-glucosamine. The protein varies from one 
strain to another (Critchley and Douglas, 1987b). Thus 
the relative abundance of these proteins, and in 
particular their stereochemistry, determines the receptor 
specificity of different Ç. albicans strains (Douglas, 
1987).
8 ABO, LEWIS AND RELATED BLOOD GROUP ANTIGENS
8.1 The ABO blood group
The first blood group system to be discovered in man 
was the ABO system by Landsteiner in 1900, cited by Green 
(1989). Clinically, this is the most important system.
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Over six hundred other blood group antigens have been 
described on the red cell membrane. The membrane of the 
red blood cell is formed from a phospholipid bilayer 
containing glycolipids, proteins and glycosphingolipids 
(Gratzer, 1981). Bird (1983) defined blood groups as 
inherited differences in antigens of tissues, 
predominantly used with red cells, but also on platelets, 
tissues and various cell surfaces. The A and B blood 
group antigens are major histocompatibility antigens 
(Joysey ^  ad., 1977 ) and can cause graft and 
transplantation rejection of various organs and tissues. 
A, B and H determinants are found in saliva, and most 
body secretions. In man, various receptor properties 
including specific interactions with antibodies, viruses, 
toxins and pharmacological agents, have been attributed 
to the ABH determinants (Green, 1989).
Figure 4 shows, in a simplified form, the genetic 
pathway for the ABO and Hh systems. The H gene product 
converts a precursor to H substance. This is the 
substrate for the ABO gene-specified transferase to 
catalyse the addition of the blood group sugar (Watkins 
et ^ .  , 1959 ). In hh individuals, often referred to as 
Bombay phenotype, there is no ability to convert the 
original precursor to the H active structure.
Consequently the addition of A and B specific sugars 
(N-acetyl-D-glucosamine and D-galactose) is impossible 
(Green, 1989). Additionally, Rege et (1963)
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Figure 4 Representation of the structures proposed for 
the carbohydrate chains in the precursor 
glycoprotein and the additions to these 
chains controlled by the He, Le, A and B 
genes.
G a l ------------- D-Galactose
GalNAc ----------  N-Acetyl-D-Galactosamine
F u c -------------- L-Fucose
GNAc ------------- N-Acetyl-D-Glucosamine
Genes Structure Formed Chain Specificity
Unidentified 
genes giving 
precursor
GaL/3l,3GNAcpL3Gal/31,3GaLNAc 1
Galj3l,4GNAc/3l,3GaL/3l,3GaLNAc 2 Type XIV
H gene 
(addition of 
L-fucose to 
precursor
Ga L/31,3GNAc/3l,3Ga L/31,3Ga LNAc
I
1* 1 , 2
Fuc
Ga L/31, AGNAcpi, 3Ga 1/31, 3Ga iNAc
I
1* 1 / 2
Fuc
Le gene 
(addition of 
L-fucose to 
precursor)
Gaipl,3GNAcpi,3Galp1,3Ga LNAc
I
1*1/4
Fuc
Ga lp l,AGNAcpi,3Ga Lpl,3Ga LNAc
Le
Type XIV
H and 
Le
genes
Galpl,3GNAcp1,3Galpl,3GaiNAc
I I
1*1 , 2  1«1 , 2  
Fuc Fuc
Galpl,AGNAcpI,3Galpl,3GaiNAc 
1
1* 1/2
Fuc
Le
A gene 
(addition of 
GalNAc to 
H-active chains)
0 gene 
(addition of 
Gal to H-active 
chains)
pl/3
GalNAca1,3Gal or GNAcpi ,3GalpL3GalNAc 1 and 2
I 1/4
1* 1 / 2
Fuc
pi,3
Galor1,3Gal or GNAcpI,3Galpl,3GalNAc 1 and 2
I 1/4
1*1/2
Fuc
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described the structure of H, A and B type 1 and type 2 
chains. On the red cell, all ABH structures are 
synthesized on type 2 chains, up to 80% of these chains 
being bound to protein and some 20% being glycolipids. In 
secretions ABH structures are found as glycoprotein on 
both chain types.
8.2 Se, the secretor gene
An additional gene, ^  is required by the 1-2 fucosyl 
transferase (specified by the H gene) to express itself 
in body secretions. The mechanism is not understood. 
There is evidence (Oriol et al., 1986) that the S_e and H 
genes are two distinct but very closely related 
structural genes each coding for a distinct a-2-L- 
fucosyltransferase, one reacting preferentially with the 
type 1 precursor chain and the other reacting 
preferentially with type 2 precursor chains. The Se and 
se alleles segregate independently of the ABO and Hh 
genes. ^  is dominant, therefore only sese individuals 
are non-secretors.
8.3 The Lewis system
The blood group antigens of the Lewis (Le) system 
differ from those of other systems in that they are not 
synthesized on the red cell but are present in plasma and 
in body secretions such as saliva. The Le-a and Le-b 
antigens are not antithelical i.e. they are not produced
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by two allelic genes at a single locus (Green, 1989). Le 
and _le are inherited independently of the ABO, Hh and 
Sese genes (Race and Sanger, 1975). However they are 
very closely related (Grubb, 1948). Lewis antigens have 
been reported, presumably in the specifically adsorbed 
form, on various epithelial tissues (Lemieux et al.,
1981). Saliva from individuals whose red cell type is 
Le(a+b-) contains Lewis-a substance, but not Le-b 
substance. With the red cell type Le(a-b+), Lewis-b is 
found along with some Lewis-a. Individuals that are 
Le(a-b-) have neither substance, as the presence of Lewis 
substances in the saliva is not dependent on the presence 
of an ^  (secretor) gene. Generally, however, secretors 
of blood group antigens are of Lewis-b type and 
non-secretors are Lewis-a.
8.4 Blood groups and infectious diseases
Correlations between ABO blood group and 
susceptibility to infections have been reported (Mourant 
et al., 1978; Deresinski ^  ad., 1979) and blood group 
determinants like L-fucose have been shown to act as 
microbial receptors (Jones and Freter, 1976). ABO blood 
group antigens are not solely located on erythrocytes but 
are present on the cell surface of many cells including 
mucosal epithelia (Mollicone et ad., 1985). Blackwell et 
al. (1986) suggested that non-secretion of blood group 
substances is associated with increasing susceptibility
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to oral infection with C. albicans. They recently 
reported that non-secretion of ABO blood group antigens 
was associated with susceptibility to superficial fungal 
infections and also diabetes mellitus (Blackwell et al., 
1990). This study only partially agreed with the earlier 
and more convincing data of Burford-Mason et al. (1988) 
which indicated that in healthy subjects, blood group 0 
and non-secretion of blood group antigens were separate 
and cumulative risk factors for oral carriage of C. 
albicans. The study of Blackwell et ad. (1990) concluded
that there was no association between ABO blood group and 
carriage. May et ad. (1989) suggested that the Lewis-a
antigen may be one of the receptors for some yeast 
strains, as the binding of C. albicans to epithelial 
cells from a non-secretor was inhibited by pretreating 
with anti-Lewis-a, but this effect was not observed with 
epithelial cells from a secretor.
9 OBJECTS OF RESEARCH
The mechanism of adherence of Candida albicans to 
mucosal surfaces has yet to be determined. It is known 
that yeast adherence involves specific interactions 
between fungal adhesins and epithelial cell surface 
receptors. Previous data have shown that the fibrillar 
mannoprotein layer, produced when the organism is grown 
in high concentrations of galactose, contains the 
proteinaceous yeast adhesin. The aims of this project
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were
(i) to characterize the adhesin further using 
chromatographic and electrophoretic techniques, and 
to identify by chemical and enzymic dissection of 
the molecule, the minimum structure required for 
adhesion inhibition.
(ii) to characterize the epithelial receptors involved 
in Candida adherence using sugars, lectins, and 
saliva to inhibit adherence.
This information may lead to the development of 
procedures to prevent infection.
M A T E R I A L S A N D M E T H O D S
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1 ORGANISMS
Four species of Candida were used in this study. 
Details of their sites of isolation are given in Table 3. 
Of the thirteen strains of C. albicans, strains 904, 905, 
910 and 911 were isolated from a single patient but were 
shown by biotyping to be different.
The organisms were maintained on slopes of Sabouraud 
dextrose agar and subcultured monthly. Every two months 
cultures were replaced by new ones freshly grown from 
freeze-dried stocks. The identity of each isolate was 
checked using conventional techniques i.e. germ-tube 
formation and sugar assimilation tests.
2 GROWTH CONDITIONS
In all experiments, organisms were exclusively in the 
budding yeast phase.
2.1 For freeze-drying
For freeze-drying, yeasts were grown in yeast 
nitrogen base (Difco) containing 500 mM sucrose. Batches 
of medium (50 ml, in 250 ml Erlenmeyer flasks) were 
inoculated with overnight yeast cultures (5 ml) and 
incubated at 37°C in an orbital shaker operating at 150 
rpm. Cells were harvested after 24 h (MSE bench 
centrifuge: 5 min, 1200 g) and washed in sterile 0.15 M 
phosphate-buffered saline (pH 7.2; PBS). Yeast cells
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Table 3 Origin of Candida isolates used in this study
Species Strain Source Type of infection Site of isolation
C. albicans GDH 2346 Glasgow Dental 
Hospital
Denture stomatitis Oral cavity
GDH 2023 
MRL 3153 Mycological Reference 
Laboratory
GRl 681 Glasgow Royal 
Infi rmary
None Cervical smear
GRI 682
Outbreak The London Hospital Systemic candidosis Oral cavity
C. albicans RDC 902 Royal Dental College, 
Copenhagen
Erythroleukoplakia
1
904 Nodular leukoplakia
1
905 None
906 None
1
910 Nodular leukoplakia
1
911 None
C. glabrata RDC 909 Erythroleukoplakia
C. parapsilosis RDC 912
C. Lusitaniae RDC 936
C. lusitaniae RDC 937 None
All four strains isolated from one patient
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were resuspended in a small volume of 2% (w/v) sterile 
skimmed milk and a drop of suspension was added to a 
sterile glass ampoule. Ampoules were frozen before being 
dried in a centrifugal freeze-drier (Edwards High Vacuum 
Ltd. Sussex).
2.2 For adherence assays and determination of 
cell-surface hydrophobicity
Batches of medium (50 ml, in 250 ml Erlenmeyer 
flasks) containing yeast nitrogen base (YNB) and either 
50 mM glucose, 500 mM sucrose or 500 mM galactose were 
inoculated from stock cultures and incubated overnight at 
37°C on an orbital shaker operating at 150 rpm. The 
overnight culture (5 ml) was used to inoculate the same 
medium (50 ml) containing the same carbon source as 
before. The culture was incubated at 37“C on an orbital 
shaker at 150 rpm for 24 h so that the yeast cells 
reached the stationary phase of growth. Cells were 
harvested by centrifugation (MSE bench centrifuge: 5 min, 
1200 g) and washed twice in 0.15 M PBS (pH 7.2).
2.3 For isolation of extracellular polymeric material
Yeasts were grown in YNB medium containg 500 mM 
galactose as the carbon source. Batches of medium (500 
ml, in 2 1 Erlenmeyer flasks) were inoculated with 50 ml 
of an overnight culture and incubated at 37°C on an 
orbital shaker operating at 150 rpm for 5 d.
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3 ADHERENCE TO HUMAN BUCCAL EPITHELIAL CELLS
3.1 The yeast adherence assay
3.1.1 Collection and preparation of buccal epithelial 
cells
Buccal epithelial cells were collected from the 
appropriate (see Table 4) donor by gently swabbing the 
inside of the cheeks with a sterile swab. The swab was 
agitated in PBS (10 ml) in a universal bottle.
Epithelial cells were harvested by centrifugation (MSE 
bench centrifuge; 5 min, 1200 g) and washed twice in PBS 
to remove loosely-bound microorganisms. After the second 
wash, epithelial cells were standardized using an 
improved Neubauer haemocytometer to a concentration of 1 
X 10^ cells ml  ^ in PBS. Buccal cells were always 
collected between 8.30am and 10.30am to minimize 
variability. Details of the buccal cell donors are shown 
in Table 4. The criteria for all donors are listed in 
Table 5. These criteria were laid down so as to minimize 
variation between donors. Healthy individuals in the age 
range of 22-38 years were used in all but one of the 
assays. All were non-smokers and had had no recent 
antibiotic therapy. Each individual's buccal cells were 
screened for the carriage of Candida prior to their use 
in adherence assays.
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Table 4 ABO and Lewis blood group, and secretor status 
of individual buccal epithelial cell donors
Donor ABO
group
Lewis a/ 
Lewis b 
group
Secretor/ 
non secretor
Sex 
(M or f ;
F.D.T A Lewis a Non secretor M
H.S. A Lewis b Secretor M
A. E. 0 Lewis a Non secretor M
F.F.C. 0 Lewis b Secretor M
E.A. 0 Lewis b Secretor F
J.H.R. A Lewis a Non secretor F
ABO and Lewis blood groups, and secretor status were 
determined as described in Sections 5.1, 5.2 and 5,3 
respectively.
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Table 5 Criteria for buccal cell donors
All healthy individuals
Age 22—38
Non-smokers
No recent antibiotic therapy
No apparent carriage of Candida
Buccal cells collected at the same time of day
Criteria applied to all buccal cell donors except one who 
was more than 60 years old.
110
3.1.2 Preparation of yeast cells
After the second wash of the yeasts in PBS, yeast 
suspensions were standardized using an improved Neubauer
7
haemocytometer to a final yeast concentration of 1 x 10 
cells ml  ^ in PBS. In certain experiments different 
concentrations were used as indicated separately.
3.1.3 Adherence assay
The method used was similar to that described by
Douglas et (1981). Epithelial and yeast cell
suspensions were vortexed using a whirlimixer before
being used in adherence assays. Standardized suspensions
of buccal epithelial cells (1 x 10^ cells ml~^ in PBS;
7 — 10.1 ml) and yeasts (1 x 10 cells ml ; 0.1 ml) were 
mixed in small screw-capped bottles and incubated at 
37°C, with gentle shaking, for 45 min. After incubation, 
3 ml of PBS was added to each bottle to stop any further 
attachment. The epithelial cells were collected on 
polycarbonate filters (12 jum pore size; 25 mm diameter; 
Nuclepore Corp., Pleasanton, CA) and washed with PBS (25 
ml) to remove unattached yeasts. The washed filters were 
placed on labelled slides and air dried. Epithelial 
cells on the filters were fixed with absolute alcohol and 
acetone (1:1) for 5 secs, and stained using the Gram 
procedure. After drying, filters were mounted under 
coverslips using DPX (BDH Chemicals Ltd.). The numbers 
of adherent yeasts on each of 100 epithelial cells were 
counted on every filter. Triplicate filters were
Ill
prepared for each assay. All adherence values quoted 
represent mean figures from 3 independent assays, except 
where indicated when two independent assays were used.
3.2 Use of inhibitors to block in vitro adherence
3.2.1 Extracellular polymeric material (EPM)
5Epithelial cell suspensions (1 ml, containing 1 x 10 
_ 1
cells ml ) were centrifuged in an MSE bench centrifuge 
at 5000 g for 5 min and the supernatants discarded.
Crude EPM samples (10 mg ml ^; 1 ml) were added to the 
cell pellets and the cells were mixed using a 
whirlimixer. Epithelial cells were incubated with the 
EPM solution for 30 min at 37°C in an orbital shaker 
operating at 150 rpm. After this treatment, epithelial 
cells were recovered by centrifugation, resuspended in 
PBS (1 ml) and used in adherence assays.
3.2.2 Lectins
Ulex europaeus lectin (Anti H) (Inverclyde 
Biologicals, Barrhead) was used in saline at a 
concentration (5% v/v) that just gave positive 
agglutination of Group O red blood cells.
Epithelial cells (1 ml, containing 1 x 10^ cells
_ 1
ml ) were harvested in a MSE bench centrifuge at 5000 g 
for 5 min. Cells were suspended in lectin solution (1 
ml) and incubated at 37"C for 30 min on an orbital shaker 
operating at 150 rpm. After incubation, epithelial cells
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were harvested and resuspended in PBS (1 ml). The 
lectin-pretreated epithelial cells were used in adherence 
assays,
3.2.3 Antisera
Various monoclonal antisera raised against different 
blood group antigens were used. Anti-A (kindly supplied 
by Mr J. Keary, Blood Bank, Glasgow Royal Infirmary), 
anti-Lewis a and anti-Lewis b (kindly supplied by Dr R.H. 
Fraser, West of Scotland Blood Transfusion Service, Law 
Hospital, Carluke) sera were all used to pretreat 
epithelial cells. Cells (1 ml, containing 1 x 10^ cells 
ml ^) were harvested using an MSE bench centrifuge at 
5000 g for 5 min. Appropriate antiserum (1 ml) was added 
to the cell pellet and the cells were gently resuspended. 
The suspension was incubated at 37°C for 30 min on an 
orbital shaker operating at 150 rpm. After incubation, 
epithelial cells were harvested and resuspended in PBS (1 
ml). The antiserum-pretreated epithelial cells were then 
used in adherence assays.
3.2.4 Saliva
Saliva from each subject (2 ml) was collected in a 
glass test-tube, boiled for 20 min and then centrifuged 
at 5000 g for 10 min. The supernatant was either stored
frozen at -20°C until tested, or used immediately.
5
Buccal epithelial cells (1 ml, containing 1 x 10 cel:
— 1 7ml ) and yeast cells (1 ml, containing 1 x 10 cells
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ml~^) were harvested using an MSE bench centrifuge at 
5000 g for 5 min. The cell pellets were resuspended in 
saliva (50% in PBS), mixed and incubated at 37°C for 45 
min on an orbital shaker operating at 150 rpm.
3.2.5 Sugars
All sugars, L-fucose, D-mannose, N-acetyl-D- 
glucosamine and N-acetyl-D-galactosamine (all from 
Sigma), and D-galactose (Koch-Light ) were used at a final 
concentration of 25 mg ml"*^  in PBS. Epithelial cells (1 
ml, containing 1 x 10^ cells ml~^) were centrifuged using 
an MSE bench centrifuge at 5000 g for 5 min and the 
supernatant removed. The pellet was resuspended in the 
appropriate sugar solution (1 ml, containing 25 mg 
ml~^ ) .
7 -1Yeast cells (1 ml, containing 1 x 10 cells ml ) 
were centrifuged using an MSE bench centrifuge at 5000 g 
for 5 min. Sugar solution (1 ml) was added to the yeast 
pellet. All cells were thoroughly vortexed using a 
whirlimixer prior to use in adherence assays. Adherence 
assays were performed as described previously, using 
epithelial cells or yeasts suspended in sugar solutions.
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3.3 Isolation and purification of yeast adhesin
3.3.1 Preparation and analysis of extracellular 
polymeric material (EPM)
3.3.1.1 Isolation of EPM from culture supernatants of 
Candida albicans: extracellular polymeric material (EPM) 
was prepared by freeze drying (i) dialysed culture 
supernatants, or (ii) ultrafiltered and dialysed culture 
supernatants. Batches of medium (500 ml in 2 1 
Erlenmeyer flasks) containing yeast nitrogen base (Difco) 
+ 500 mM galactose were inoculated with overnight yeast 
cultures (50 ml) and incubated at 37°C for 5 d in an 
orbital shaker operating at 150 rpm. Yeasts were removed 
by centrifugation and the culture supernatant fluid was 
(i) dialysed at 4“C for one week against five changes (12 
1 each) of distilled water, or (ii) ultrafiltered in an 
Amicon DC5 Hollow Fibre Concentration System using a 5K 
filter and then dialysed at 4"C for 3 d against 5 changes 
(5 1 each) of distilled water. The retentate (crude EPM) 
was freeze dried and weighed.
3.3.1.2 Biochemical analysis of EPM: carbohydrate was
estimated by the method of Dubois et (1956) using
mannose as a standard (see Appendix lA). Protein was 
determined using the method of Lowry et a_l. (1951) with 
bovine serum albumin as a standard (see Appendix IB). 
Phosphorus was estimated according to the method of Chen 
et al. ( 1956) using KH^PO^ as a standard (see Appendix
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1C) .
3.3.2 Isolation of "lectin-like" components from EPM
L-Fucose, D-mannose and N-acetyl-D-glucosamine
(Sigma) were bound to an inert matrix using a procedure
that involved swelling epoxy-activated Sepharose (1 g) in
distilled water for 15 min, and then washing the gel on a
sintered glass filter with more distilled water (100 ml).
Ligand solution (50 mg ml~^ of sugar; 3 ml) was mixed
with the gel suspension and incubated at 37“C for 16 h in
a shaking water bath. Excess sugar was removed by
washing with distilled water (100 ml), 0.1 M sodium
bicarbonate buffer, pH 8.0 (100 ml) and 0.1 M sodium
acetate buffer, pH 4.0 (100 ml). Any remaining reactive
groups were blocked by treatment with 1 M ethanolamine
(5ml) at 45“C for 9 h. The gel was finally washed with
PBS and transferred to a small column (100 x 7 mm). EPM 
—  1(2 00 mg ml in PBS; 1 ml) was applied and the column 
eluted with PBS. The protein contents of the EPM 
solution and the eluate were determined by the Lowry 
method so that the percentage of EPM protein that bound 
to the gel could be calculated. Bound material was 
eluted with a solution of the appropriate sugar (25 mg 
ml ^; 10 ml). The eluate was freeze dried, then 
reconstituted in 1 ml of water and applied to a Sephadex 
G-25 desalting column (Pharmacia; 5 ml). The desalting 
column was equilibrated with PBS and an A^qq profile was
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recorded for 0.5 ml fractions. Fractions constituting 
the protein peak were pooled and used in adhesion 
inhibition assays.
3.3.3 Chemical and enzymic treatments of EPM
In some experiments, crude EPM used to treat 
epithelial cells was processed as described in 3.3.3.1 
and 3.3.3.2. In the others, the treatments described 
were used as pretreatments of EPM before its application 
to Synsorb affinity matrices,
3.3.3.1 Enzyme treatments : N-Glycanase (Genzyme; 250U
ml ^; 0.0024 ml) was used to treat EPM samples (100 mg 
ml  ^ in 0.55 M NagHPO^, pH 8.6; 0.05 ml) for 24 h at 
37"C. The reaction was terminated using 0.1 M sodium 
citrate buffer, pH 4.4 (0.01 ml).
Papain (Sigma) was used at a concentration of 0.1 mg
ml  ^ in 0.01 M potassium phosphate buffer, pH 6.2 (0.016 
ml). EPM (1 mg ml ^; 1 ml) was incubated with this enzyme 
solution at 25°C for 30 min and then 0.05 ml of 
macroglobulin (2 mg ml~^), an enzyme inhibitor, was 
added.
3. 3. 3.2 Alkali treatment: mild alkali treatment
involved dissolving EPM (20 mg ml~^) in NaOH (0.1 M; 1
ml) in a screw capped bottle; the solution was incubated 
at 30°C for 24 h and then neutralized with HCl solution 
(0.1 M; 1 ml) to give a final EPM concentration of 10 mg
117
Table 6 shows the final large scale purification 
protocol for the yeast adhesin. Digests of EPM prepared 
from each stage of the procedure were used as inhibitors 
of yeast adhesin. In some cases EPM was processed 
through merely the first stage in the procedure i.e. 
N-Glycanase degradation; in others EPM was given the full 
treatment protocol.
3.3.4 Isolation of purified adhesin by "Synsorb" 
affinity chromatography
Synsorbs (Chembiomed Ltd, Edmonton, Alberta, Canada) 
are specific affinity adsorbents for the isolation and 
purification or removal of biologically important 
materials. They are composed of synthetic carbohydrate 
structures of known specific composition covalently 
linked to an inert, insoluble matrix (i.e. immobilized 
oligosaccharides). Material adsorbing to the immobilized 
oligosaccharide can be removed in a highly purified form 
and the adsorbent regenerated by the elution of bound 
materials with high or low pH buffers.
Synsorb (0.05 g) of the four types shown in Table 7, 
was suspended in PBS (2 ml) in a Buchner flask and 
degassed using a vacuum pump. The Synsorb slurry was 
washed in a plastic, screw capped tube with 2 ml of PBS 
and allowed to settle. After this, the buffer level over 
the Synsorb was lowered to just above the surface of the 
Synsorb bed and EPM solution (10 mg ml~^, 1 ml) or 
purified EPM digest (1 ml) was applied. The EPM and the
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Table 6 Final purification protocol developed for the 
yeast adhesin
EPM
100 mg ml""^ ; 1 ml in 0.55 M Na^HPO^, pH 8.6 
+
N-Glycanase 250U ml~^; 0.0096 ml 
24 h at 37°C 
Add 0.04 ml 0.1 M sodium citrate buffer, 
pH 4.4, to terminate reaction
N-Glycanase
V
V -1Adjust EPM concentration to 50 mg ml 
with 0.01 M potassium phosphate buffer, 
pH 6.2
+
Papain (0.1 mg ml~^; 0.16 ml)
30 min at 25°C 
Add «2 macroglobulin (2 mg ml” ;^ 0.5 ml)
Papain
V
V
Add 1 ml NaOH (0.1 M)
24 h at 30°C
V
Add 1 ml HCl (0.1 M)
use
in
adherence
assays
Mild alkali
V
Synsorb H-2 
affinity adsorption
Affinity adsorption
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Table 7 Immobilized oligosaccharides bound to silica 
matrix (Synsorbs)
Oligosaccharide Trivial Name
j3Gal(l-3)/3GlcNAc
1 (1- 4 ) -
«Fuc
Lewis--a
aFuc ( 1-2 )ySGal (1-3)/3GlcNAc
1 (1-4) - 
aFuc
Lewis--b
aFuc ( 1-2 )/3Gal( 1-3 )/3GlcNAc H-1
aFuc ( 1-2 ) jSGal ( 1-4 )i3GlcNAc H-2
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Synsorb were gently rotated for 3 h at 4"C. The 
adsorption of EPM solution was halted by the addition of 
1 ml of PBS, and the unbound material eluted using PBS 
until the returned to 0.0. Bound material was then
eluted by the addition of 1 ml aliquots of 1.5% NH^OH in 
sterile saline for 15 min at 4“C until the Agg^ returned 
to 0.0. Bound samples were freeze-dried, reconstituted 
in water and desalted on a Sephadex G-25 (5 ml) desalting 
column, prior to incorporation in adherence assays. The 
adsorbent was re-equilibrated with PBS and then stored at 
4°C in PBS containing 0.02% NaN^ as a bacteriostat.
3.4 Determination of yeast cell surface hydrophobicity
The method of Sweet et aj^ . ( 1987 ), using the volatile 
hydrocarbon xylene was followed. Suspensions of yeasts 
were adjusted to an A^^g of 1.3(±0.1) measured in an SP 
8-100 spectrophotometer (Pye Unicam).
To each of two 15 mm diameter glass test-tubes, 5 ml 
of the test suspension was added representing one sample 
and one control. In addition a sample and control were 
prepared on the suspending medium alone as 
spectrophotometer blanks. To each sample suspension was 
added 1 ml of xylene (Analar). The samples and controls 
were placed in a water bath at 37°C for 10 min to 
equilibrate, then vortexed in turn for 30 sec and 
returned to the water bath for 30 min to allow the 
immiscible xylene and aqueous phases to separate. The
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lower aqueous layers were carefully removed using 
pipettes and transferred to fresh test-tubes. Any 
contaminating xylene that may have been carried over was 
removed by bubbling air through the suspensions for 1 
min. Absorbances were measured as before following 
vortex mixing for 5 sec to disrupt and resuspend any 
aggregates that might have formed. Finally, the 
percentage reduction in absorbance of the test 
suspensions (with xylene) compared with the control 
suspensions (without xylene) was calculated. Each assay 
was performed in triplicate.
4 SDS-PAGE ELECTROPHORESIS
4.1 Gel preparation and electrophoresis
The procedures for preparing stock solutions are 
given in Appendix II. Gel plates were prepared as 
follows. To prevent staining artefacts the plates were 
washed with detergent, thoroughly rinsed with distilled 
water and wiped clean with paper tissues dipped in 
absolute alcohol. Two plates were taped together along 
three sides and baked for 30 min at 80“C to seal the 
tape. Rinsed plastic gloves were worn at all times to 
prevent fingerprints.
The gels were prepared as follows. The separating 
gel solutions containing 12.5% acrylamide, 1.5% Tris-HCl 
(pH 8.9), 0.4% SDS, 0.025% TEMED and 0.8% ammonium
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persulphate, were poured into the gel plates to about 4.0 
cm from the top. Then either saturated butan-l-ol or 
absolute alcohol was used to overlay the separating gel, 
which was left for about 20 min to polymerize. After 
polymerization, the overlay solution was removed and the 
gap between the top of the gel plates and the top of the 
gel was washed thoroughly with distilled water. Stacking 
gel solution containing 4.5% acrylamide, 0.5 M Tris-HCl 
(pH 6.8), 0.4% SDS, 0.02 5% TEMED and 0.0 8% ammonium 
persulphate, was used to fill the gel plates almost to 
the top. Sample combs were introduced into the stacking 
solution and any remaining spaces were filled with the 
stacking gel solution. This was allowed to polymerize 
and the combs were then removed and the gel plates were 
dipped in running buffer to avoid drying out. Gels were 
also prepared with 15% acrylamide in the separating gel. 
Tris-glycine running buffer (pH 8.3) containing 0.1% SDS 
was used to fill the lower electrode tank. The sealing 
tape was removed from the bottom of the gel plates, and 
the plates were inserted into the top electrode tank.
The upper electrode was filled with running buffer. 
Samples of EPM (10 mg ml~^; 20 /j1) treated with 
solubilizing buffer (see Appendix II) were carefully 
pipetted into the sample wells. Gels were run at a 
constant current at 10°C in a Pharmacia GE-24LS tank (20 
mA per gel) for approximately 3.5 h. When the tracking 
dye had reached the end of the gel power was switched
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off. Six marker proteins (Sigma) of molecular weights 
14.2K, 20.IK, 29K, 36K, 45K and 66K were run as 
controls.
4.2 Staining of gel
4.2.1 Coomassie blue stain (Weber and Osborn, 1969)
Gels were carefully removed from the plates and 
immersed in fixing solutions containing Coomassie blue 
stain in acetic acid, for 30 min. Gels were destained by 
several changes of destaining solutions. Gels were 
washed several times in distilled water for 30 min, then 
in 0.03% Na2C02 for 10 min before drying under vacuum in 
a Biorad Model 483 slab dryer. Molecular weights of 
unknown bands could be estimated by interpolation on the 
scale generated by the marker proteins.
4.2.2 Silver staining (Oakley ^  , 1980)
Silver staining was used to detect protein and 
glycoprotein components of EPM. Gels were handled 
wearing plastic gloves, rinsed with water to avoid 
contamination of the gels with protein secreted on the 
surface of the skin, and were agitated at all stages of 
the staining procedure. Gels were prefixed in 10% acetic 
acid, 30% methanol for 30 min. Glutaraldehyde (10%) was 
used as a fixative for 30 min. After fixing, gels were 
rinsed in a large volume of distilled water overnight. 
Gels were then given a final rinse in distilled water for
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20 min. and placed in dithiothreitol (5 pg ml~^) for 30 
min. This solution was then poured off and 0.1% silver 
nitrate, freshly made up, was added without rinsing and 
shaken for a further 30 min. Gels were rinsed rapidly in 
distilled water and then twice in developer, which 
contained 37% formaldehyde (50 jjI) in 100 ml of 3%
NagCOg, before being left to soak in a third volume of 
developer until the desired level of staining had been 
reached. Development was stopped by adding 2.3 M citric 
acid (5 ml) and mixing for 10 min.
5 DETERMINATION OF BLOOD GROUP AND SECRETOR STATUS
ABO and Lewis blood-group was determined for healthy 
buccal cell donors for whom secretor status was also 
established. Subjects were excluded if they had recently 
taken antibiotics. Blood was collected using an Autolet 
Lance to puncture the thumb tip of the donor. The red 
blood cells were then washed twice in saline and blood 
group was determined by agglutination, using standard 
laboratory procedures.
5.1 ABO blood group
The red blood cell suspension was adjusted to 
approximately 4% v/v and two separate drops were added to 
two glass tubes. One drop of either group A or group B 
serum kindly supplied by Mr J. Keary (Blood Bank, Glasgow 
Royal Infirmary) was added to each drop of red blood
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cells. The tubes were observed macroscopically after 5 
min for agglutination. Suitable control experiments were 
performed in parallel to the samples, where sterile 
saline was added instead of serum.
5.2 Lewis blood group
To 40 jul of either anti-Lewis a or anti-Lewis b serum 
in a glass test-tube was added 80 jjI of a 3% (v/v) 
suspension of washed red cells in PBS. This was mixed 
thoroughly and incubated at room temperature for 15 min. 
The tubes were then centrifuged at 1000 g for 15 sec. The 
cell deposit was gently resuspended and observed 
macroscopically for agglutination.
5.3 Secretor status
To study secretor status the method described by 
Burford-Mason ^  (1988 ) was used. Saliva from each
subject (2 ml) was collected in glass test-tubes, boiled 
for 20 min and then centrifuged at 5000 g for 10 min.
The supernatant was either stored frozen at -20°C until 
tested, or used immediately. Secretor status was 
determined by a technique involving inhibition of 
agglutination. Saliva (40 pi) was incubated in 
round-bottomed test-tubes at room temperature for 45 min 
with an equal volume of either anti-A or anti-B 
monoclonal serum (kindly supplied by Mr J Keary, Blood 
Bank, Glasgow Royal Infirmary) or anti-H lectin (Ulex
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europaeus; Inverclyde Biologicals Ltd.). The antisera 
were diluted in PBS before use so that they gave positive 
agglutination when tested against a panel of appropriate 
red cells. (The dilutions were 1:64 for both anti-A and 
anti-B and 1:2 for the anti-H). One drop of either A, B 
or 0 red cells screened for "private" antigens i.e. A, B 
or 0 (Glasgow Royal Infirmary, Department of Haematology) 
and diluted to 3% (v/v) in PBS was added to the tubes.
The tubes were shaken and then incubated at room 
temperature for a further 30 min. Finally the tubes were 
centrifuged at 1000 g for 2 min and samples spread on 
glass slides. Positive agglutination was clearly 
identifiable, the red cells remaining in a pellet. 
Negative agglutination was taken as an indicator that the 
relevant blood group antigen was present in the test 
saliva. Saline controls were included on each plate.
6 F.P.L.C.
Fast high pressure liquid chromatography was kindly 
performed by Dr J.G. Lindsay (Department of Biochemistry, 
University of Glasgow) using a Pharmacia P.E.P. HR5/5 
column. A sample of EPM (100 mg) was digested with 
N-glycanase, papain and mild alkali (see Sections 3.3.3.1 
and 2) and adsorbed on an H-2 Synsorb matrix (see Section 
3.3.4). Bound eluate (protein, 10 mg ml 100 jul) was 
run through the column at a flow rate of 40 ml h~^ using
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trifluoroacetic acid buffer and 0 - 100 mM acetonitrile 
gradient. The sample was detected using ultraviolet 
spectrophometry
7 STATISTICS
Student's t test was used to detect significant 
differences between adherence values and the results are 
presented as p-values. Standard errors of the mean are 
quoted for all adherence assay results.
8 CHEMICALS AND MEDIA
Sabouraud dextrose agar and yeast nitrogen base were 
from Difco. Acrylic was from Pharmacia. Sugars used in 
adherence studies were from Sigma. Glucose, sucrose and 
galactose used in growth media were from BDH Chemicals 
Ltd. Papain was from Sigma. N-Glycanase was from 
Genenzyme Fine Chemicals, Haverhill, Suffolk. Synsorb was 
from Chembiomed, Edmonton, Canada.
R E S U L T S
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1 ADHESION OF CANDIDA ALBICANS AND OTHER CANDIDA 
SPECIES TO EPITHELIAL CELLS
1.1 Effect of time of incubation on adhesion of Candida 
albicans to buccal epithelial cells
The adhesion of Ç. albicans GDH 2346 to buccal 
epithelial cells with respect to time of incubation was 
investigated. Yeasts were grown to stationary phase in 
yeast nitrogen base medium containing 500 mM galactose.
n
In all assays, the yeast concentration was 1 x 10 
organisms ml” ,^ that of the buccal cells was 1 x 10^ 
cells ml ^, and incubation periods of up to 90 min. were 
used. Figure 5 shows that adhesion reached a plateau 
after 45 min. with little increase in attachment after 
this time. In all subsequent assays, therefore, a 45 
min. incubation period was used.
1.2 Adhesion of Candida isolates from leukoplakia 
patients to buccal epithelial cells
Oral leukoplakias, particularly non-homogeneous 
types, are often invaded by yeasts. Taxonomic 
investigations have shown that Candida albicans is by far 
the dominant species in leukoplakia lesions, constituting 
82% of all yeasts identified (Krogh, 1989). Less 
frequently occurring biotypes of C. albicans are often 
found in advanced precancerous leukoplakias, suggesting a 
causal role for these biotypes in the malignant
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Figure 5 Effect of time of incubation on adhesion of 
C. albicans GDH 2346 to buccal epithelial 
cells in vitro.
Bars indicate standard error of the mean.
The buccal cell donor was of blood group A, and a 
non-secretor (F.D.T.).
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transformation. In this part of the investigation the 
adhesive ability of a number of leukoplakia isolates was 
assessed.
Ten Candida isolates from a variety of leukoplakia 
patients attending the outpatients clinic at the Royal 
Dental College, Copenhagen, Denmark were tested in assays 
with buccal epithelial cells. Details of the sites of 
isolation of these organisms are given in Table 3. For 
comparison, the well characterized denture stomatitis 
isolate C. albicans GDH 2346 was also included in this 
study. Initially, all the leukoplakia isolates were 
assumed to be Ç. albicans. However, isolates 909, 912, 
936 and 9 37 failed to produce germ-tubes in serum after 4 
h at 37°C (Table 8). These organisms were subsequently 
identified as Ç. olabrata, Ç. parapsilosis, C. lusitaniae 
and C. lusitaniae respectively by means of carbohydrate 
assimilation assays at the Medical Mycology Unit, 
University of Glasgow.
All isolates were tested for their ability to adhere 
to buccal epithelial cells, following growth to 
stationary phase in medium containing 500 mM galactose or 
50 mM glucose, as infective strains have previously been 
shown to be up to ten times more adhesive after growth in 
high-galactose medium (McCourtie and Douglas, 1984).
Only Ç. albicans 904 adhered to buccal cells in 
comparable numbers to the control strain, Ç. albicans GDH 
2346 (Table 9). However isolates 902, 905, 906, 910 and
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Table 9 Adhesion of different Candida isolates to human buccal epithelial cells after growth to 
stationary phase in yeast nitrogen base containing glucose, galactose or sucrose
Strain number
Carbon
1
source
Mean no. of adherent 
yeasts/100 epithelial 
cells ± SE
Relative
Adhesion
3
P
C. albicans GDH 2346 Glucose 70 ± 10 1.0
Galactose 670 ± 10 9.6 <0.001
902 Glucose 49 ± 10 1.0
Galactose 320 ± 26 6.5 <0.001
904 Glucose 72 ± 18 1.0
Galactose 666 ± 62 9.3 <0.001
905 Glucose 4 ± 2 1.0
Galactose 271 ± 18 67.8 <0.001
906 Glucose 65 ± 9 1.0
Galactose 444 ± 44 6.8 <0.001
910 Glucose 55 ± 11 1,0
Galactose 347 ± 47 6.3 <0.001
911 Glucose 31 ± 3 1.0
Galactose 442 ± 35 14.3 <0.001
C. qlabrata 909 Glucose 213 ± 68 1.0
Sucrose 126 ± 34 0.6 NS
C. parapsilosis 912 Glucose 94 ± 27 1.0
Galactose 31 ± 8 0.3 <0.01
C. lusitaniae 936 Glucose 57 ± 10 1.0
Galactose 136 ± 16 2.4 <0.001
C. lusitaniae 937 Glucose 118 ± 14 1.0
Galactose 119 i 22 1.0 NS
1
The carbon source was either glucose (50 mM), galactose (500 mM) or sucrose (500 mM) as
indicated.
2
Adhesion is calculated relative to that of glucose-grown cells.
Probability values comparing adhesion of galactose- or sucrose-grown yeasts of the same 
strain; NS, not significant.
Results represent mean ± standard error of two independent determinations performed in 
triplicate.
The buccal cell donor was blood group A, and a non-secretor (F.D.T.).
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911 were able to adhere in significantly higher numbers
after growth on 500 mM galactose than after growth in 50
mM glucose. Isolate 905 gave the highest relative
adhesion value, but this was due to the poor ability of
glucose-grown yeasts of this strain to adhere to buccal
cells. Even when very high numbers of yeasts were used 
9 -1(e.g. 1 X 10 ml ) adhesion was poor. Isolate 911 also 
produced a high relative adhesion value of 14.3. In 
contrast, isolates 902, 906 and 910 had relative adhesion 
values of 6.5, 6.8 and 6.3 respectively. Previous work 
has shown that infective (I) strains of Ç. albicans 
modify their cell surface when grown in high 
concentrations of galactose, whereas carrier (C) strains 
do not (McCourtie and Douglas, 1984). Although very 
little is known about the exact origin of the leukoplakia 
isolates, these results indicate that all of the C. 
albicans strains show an ability to modify their cell 
surfaces in response to galactose.
Adhesion of several Candida species to buccal cells 
has been described before (Critchley and Douglas, 1985), 
but this is the first report of assays with C. lusitaniae 
and C. qlabrata. One of the two isolates of C, 
lusitaniae showed no significant enhancement of adhesion 
when grown in high concentrations of galactose.
Similarly, Ç. qlabrata 909 failed to show increased 
adhesion after growth in high-sucrose medium. On the 
other hand, C. parapsilosis 912 was significantly less
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adherent after growth on galactose. However, this 
organism grew rather poorly in high-galactose medium; 
routinely inocula were incubated for 24 h prior to 
subculture for a further 24 h.
2 CRUDE EPM
2.1 Effect of crude EPM on adhesion of Ç. albicans
Adhesion of Ç. albicans to epithelial cells is 
thought to involve lectin-like interactions between yeast 
adhesins and host-cell receptors. Mannoprotein isolated 
from culture supernatants of galactose-grown organisms 
blocks adhesion to buccal or vaginal cells in vitro.
This extracellular material originates, at least in part, 
from a fibrillar surface layer and its ability to inhibit 
adhesion indicates that it contains yeast adhesin. 
Throughout this study, crude EPM was isolated by means of 
ultrafiltration of culture supernatants, followed by a 
short (48 h) period of dialysis. With this method, 
yields of EPM (15-20%) were similar to those obtained by 
acetone precipitation (McCourtie and Douglas, 1985) or by 
prolonged dialysis (Critchley and Douglas, 1987a). EPM 
was produced more rapidly than by the dialysis-only 
method, and was equally effective in inhibiting adhesion 
of Ç. albicans GDH 2346 to buccal epithelial cells. The 
data shown in Table 10 indicate that crude EPM 
preparations obtained by either dialysis method were 
similar in protein content (6.15 and 6.53%) and in their
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Table 10 Effect of crude EPM from Ç. albicans GDH 2346 
on adhesion of strain GDH 2346 to buccal 
epithelial cells^
Method of 
preparation 
of EPM
Adherence 
relative _ 
to control
Protein content 
of EPM 
(% dry weight)
p3
Dialysis only 0.51 6 .15 <0.001
Ultrafiltration 
followed by 
dialysis
0.50 6.53 <0 . 001
Control (no EPM) 1. 00
 ^ Epithelial cells were preincubated with 10 mg ml  ^at
37“C for 30 minutes, then used in adhesion assays with
7 — 1a yeast concentration of 1 x 10 organisms ml
2 Adherence is expressed relative to that of a control 
(PBS-treated buccal cells) for which a value of 896 ± 
54 adherent yeasts per 100 epithelial cells (mean ± 
SEM) was obtained.
3 Probability values relative to the control.
Results represent mean of three independent assays 
performed in triplicate.
The buccal cell donor was blood group A, and a 
non-secretor (F.D.T.).
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ability to inhibit adhesion (50-51%).
2.1.1 Biochemical analysis of crude EPM from five 
different strains
EPM preparations were analysed for carbohydrate, 
protein and phosphorus. The results are shown in Table
11. Carbohydrate was the major component, accounting for 
over 72% of the dry weight. The protein content ranged 
from 7.2% (C. albicans GDH 2346) to 10.5% (C. albicans 
GDH 2023); there were however small batch-to- batch 
variations as seen with the crude EPM used to perform the 
experiment described in Table 10. The phosphorus content 
ranged from 0.41% in C. albicans GDH 2346 to 0.73% in Ç. 
albicans MRL 3153. These analytical results are similar 
to those described by McCourtie and Douglas (1985) and 
Critchley and Douglas (1987a).
SDS PAGE of crude EPM preparations was carried out 
with 15% separating gels. Plate 1 shows a typical result 
obtained with EPM from the Ç. albicans strains indicated. 
Proteins visualized by the silver staining technique 
varied in molecular mass from 13 kDa to 200 kDa, Two of 
the samples run on the gel were from batches of crude EPM 
prepared by prolonged dialysis of C. albicans culture 
supernatant and stored in the freeze-dried state for 
three years; the other six samples were freshly prepared 
using the ultrafiltration technique detailed in Materials 
and Methods 3. 3.1.1. There were no major discernible 
differences in the staining profiles of the samples.
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Table 11 Biochemical analysis of EPM isolated from
culture supernates of C. albicans
Strain No
Carbohydrate 
content 
(% ± SEM)
Protein 
content 
(% ± SEM)
Phosphorus 
content 
(% ± SEM)
GDH 2346 79.2 ± 1.7 7.2 ± 0.3 0.41 ± 0.09
GDH 2023 72.4 ± 0.8 10.5 ± 0.3 0.47 ± 0.04
MRL 315 3 81.3 ± 1.4 7.6 ± 0.1 0.73 ± 0.14
GRI 681 77.0 ± 1.8 9.7 ± 0.4 0.45 ± 0.01
GRI 682 75.2 ± 1.7 8.6 ± 0.4 0.44 ± 0.01
Results represent means of two independent determinations 
performed in triplicate.
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Plate 1 SDS PAGE gel of eight crude EPM samples run on 
a 5% stacking and 15% separating gel
 ^EPM samples prepared by Critchley (1986)
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2.2 "Lectin-like" material isolated from crude EPM by
affinity chromatography
To investigate the presence of lectin-like adhesins 
in C. albicans, crude EPM preparations from three strains 
- GDH 2346, GDH 2023 and GRI 681 - were applied to 
affinity columns which contained three different sugars 
immobilized on epoxy-activated Sepharose. The proportion 
of EPM protein bound to each column was then determined. 
Figure 6 shows that all three preparations contained 
proportions of material with lectin-like binding 
specificities for L-fucose, D-mannose and N-acetyl-D- 
glucosamine. With Ç. albicans GDH 2346, for example, 
22.6% of the total EPM protein bound to immobilized 
L-fucose, whilst 18.0% and 12.3% bound to D-mannose and 
N-acetyl-D-glucosamine respectively. Similarly, although 
rather less EPM protein from strain GRI 681 bound to 
affinity columns, fucose-binding protein was the most 
abundant and N-acetyl-D-glucosamine the least abundant 
type. By contrast, with EPM isolated from Ç. albicans 
GDH 2023, most of the bound protein was associated with 
D-mannose, whilst approximately equal amounts bound to 
L-fucose and N-acetyl-D-glucosamine.
2.2.1 Effect of different "lectin-like" components from 
EPM on adhesion of Ç. albicans
Bound protein, eluted from epoxy-activated Sepharose 
6B columns by means of the appropriate sugar, was
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Figure 6 Percentage of total EPM bound (±SEM) to three 
different immobilized sugars
Bars indicate standard error of the mean.
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concentrated and applied to a Sepharose G-25 desalting 
column. An ^2BQ of the eluate was determined,
and fractions constituting the protein peak were pooled. 
Each fraction was then tested for its ability to inhibit 
adhesion of homologous yeasts (Tables 12 and 13) and the 
Adherence Inhibition Index (All; see Appendix III) 
calculated (Tables 14 and 15).
When purified material from C. albicans GDH 2346 was 
used in adhesion inhibition experiments with strain GDH 
2346, L-fucose-bound protein and N-acetyl-D- 
glucosamine-bound protein were more effective inhibitors 
(on a protein weight basis) than protein bound to the 
D-mannose column (Table 14). By contrast, with Ç. 
albicans GDH 2023 and homologous protein, D-mannose- 
specific protein was the best inhibitor, while L-fucose- 
and N-acetyl-D-glucosamine-bound protein were slightly 
less effective (Table 15). If these results are compared 
with Critchley (1986) it is apparent that there is a 
marked difference in the behaviour of the buccal cells 
from different individuals.
The All values calculated are shown in Tables 14 and 
15. The differing lectins have different effects on the 
two strains. These effects had not been noted previously 
and were unexpected. The protocol was therefore 
repeated, and the results were found to be reproducible 
with respect to the individual buccal cell donor.
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Table 12 Effect of different lectin-like components from 
crude EPM from C. albicans GDH 2 34 6 on the 
adhesion of a homologous yeast strain
Pretreatment of Mean No. of yeasts Percentage
buccal cells per 100 inhibition
EEC's ± SEM
None (PBS control) (1) 951 ± 58 0
(2) 506 ± 23 0
EPM (10 mg ml~^) (1) 424 ± 38 55.4
from strain GDH 2346 (2) 261 ± 13 48.4
L-fucose-bound (1) 404 + 37 57.4
protein (2) 275 ± 19 45.6
D-mannose-bound (1) 687 ± 94 27.8
protein (2) 468 + 19 7.5
N-acetyl-D-glucosamine- (1) 422 ± 31 55.6
bound protein (2) 281 ± 17 44.5
If 2 refer to two separate experiments, the means of 
which are shown, and are from three independent 
determinations performed in triplicate.
Adhesion assays were performed using 1 x 10 yeasts 
ml ^. The buccal cell donor was blood group A, and a
non-secretor (F.D.T.).
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Table 13 Effect of different lectin-like components from 
crude EPM from C. albicans GDH 202 3 on the 
adhesion of a homologous yeast strain
Pretreatment of 
buccal cells
Mean No. of yeasts Percentage
per 100 inhibition
BEC's ± SEM
None (PBS control) (1) 2383 ± 107 0
(2) 1283 ± 43 0
EPM (10 mg ml~^) (1) 1125 ± 76 52 . 8
from strain GDH 2023 (2) 669 ± 34 47 .8
L-fucose-bound (1) 1286 ± 68 46.0
protein (2) 738 ± 20 42.5
D-mannose-bound (1) 1139 ± 67 52.2
protein (2) 881 ± 20 31. 3
N-acetyl-D-glucosamine- (1) 1222 ± 82 48.7
bound protein (2) 764 ± 38 40.5
1, 2 refer to two separate experiments, the means of 
which are shown, and are from three independent 
determinations performed in triplicate.
n
Adhesion assays were performed using 1 x 10 yeasts 
ml~^ .
The buccal cell donor was blood group A, and a
non-secretor (F.D.T.).
145
Table 14 Adhesion Inhibition Index values for
lectin-like material isolated from the EPM of
C. albicans GDH 2346 by affinity
chromatography
Sugar coupled 
to Sepharose gel
Adhesion Inhibition Index 
1st Assay 2nd Assay
L-fucose 30.5 28.7
D-mannose 8.7 11.3
N-acetyl-D-glucosamine 31.1 24.1
Table 15 Adhesion Inhibition Index values for
lectin-like material isolated from the EPM of
C. albicans GDH 2023 by affinity
chromatography
Sugar coupled 
to Sepharose gel
Adhesion Inhibition Index 
1st Assay 2nd Assay
L-fucose 19.2 17.2
D-mannose 22.7 21.2
N-acetyl-D-glucosamine 16.1 11.7
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2.2.2 Effect of different sugars on the adherence of C. 
albicans to buccal epithelial cells
With C. albicans GDH 2023, the sugars L-fucose, 
D-mannose and N-acetyl-D-glucosamine, when incorporated 
in adhesion assays at 25 mg ml~^, possessed the ability 
to inhibit adherence to buccal cells by 39%, 43% and 35% 
respectively (Table 16). On the other hand, with C. 
albicans GDH 2346, which had previously shown a different 
pattern of adhesion (Tables 14 and 15), the dual effect 
of L-fucose and N-acetyl-D-glucosamine was tested; the 
inhibition of adherence was significantly (P < 0.001) 
increased relative to the effect of the two sugars when 
assayed independently, with adherence being only 69% 
relative to the control (Table 17).
2.2.3 Effect of Ç. albicans "lectin-like" proteins on 
the adhesion of heterologous strains
Possible inhibition by the different lectin-like EPM 
components on heterologous strains of Ç. albicans was 
investigated. Partially purified fractions of EPM from 
C. albicans GDH 2023 had no significant effect on the 
adhesion of Ç. albicans GDH 2346 (Table 18). This was in 
agreement with previous results (McCourtie and Douglas, 
1985; Critchley and Douglas, 1987b) which showed that 
crude EPM from Ç. albicans GDH 2023 had no effect on the 
adhesion of strain GDH 2346, thus indicating the 
specificity of yeast adhesin. In contrast L-fucose and 
N-acetyl-D-glucosamine-specific lectins isolated from
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Table 16 Effect of different sugars on adhesion of C.
albicans GDH 2023 to buccal epithelial cells
Sugar present 
in assay 
mixture
Mean no. of adherent 
yeasts/100 epithelial 
cells ± SEM
% 1 
Adherence
None
(PBS control)
1088 ± 22 100 -
L-fucose 699 ± 25 61 <0.001
D-mannose 623 ± 37 57 <0.001
N-acetyl-D-
glucosamine
709 ± 62 65 <0.001
 ^ Adherence relative to that of yeasts suspended in
PBS.
2
Probability values relative to adhesion of PBS 
control.
Results represent means of three independent 
determinations performed in triplicate.
7
Adherence assays were performed using 1 x 10 yeasts
The buccal cell donor was blood group A, and a
non-secretor (F.D.T.)
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Table 17 Effect of different sugars on adhesion of Ç.
albicans GDH 2346 to buccal epithelial cells
Sugar present 
in assay 
mixture
Mean no. of adherent 
yeasts/100 epithelial 
cells ± SEM
% 1 
Adherence p'
None
(PBS control)
480 ± 28 ' 100 -
L-fucose 385 ± 22 80 <0 . 001
N-acetyl-D-
glucosamine
382 ± 45 80 <0.001
L-fucose/N-acetyl- 333 ± 29 
D-glucosamine
69 <0.001
 ^ Adherence relative to that of yeasts suspended in
PBS.
2
Probability values relative to adhesion of PBS 
control.
Results represent means of three independent 
determinations performed in triplicate.
n
Adherence assays were performed using 1 x 10 yeasts 
ml“  ^.
The buccal cell donor was blood group A, and a
non-secretor (F.D.T.)
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Table 18 Effect of EPM protein from C, albicans GDH 2023 
on the adhesion of Ç. albicans GDH 2346 to 
buccal cells
Pretreatment 
of buccal 
cells
Mean no. of 
yeasts per 100 
EEC’s ± SEM
Percentage 
Inhibition 
(and . 
significance )
Adhesion
Inhibition
Index
None
(PBS control)
472 ± 12
EPM (10 mg ml 471 ± 17
from Ç, albicans 
GDH 2023)
L-fucose-bound
protein
445 ± 21
0 (NS)
5.7(NS) 2.3
D-mannose-bound 448 ± 13 
protein
5.1(NS) 3.4
N-acetyl-D- 
glucosamine- 
bound protein
437 ± 12 7,4(NS) 2.1
NS, not significant;
2
Adhesion inhibition index for protein relative to 
effect of crude EPM from Ç. albicans GDH 2346 on the 
adhesion of strain GDH 2346 to buccal cells.
Results represent means of three independent 
determinations performed in triplicate.
The buccal cell donor was blood group A, and a
non-secretor (F.D.T.)
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Ç. albicans GDH 2346 inhibited adhesion of C. albicans 
GDH 2023, whereas the D-mannose-specific lectin had no 
effect (Table 19).
3 PURIFICATION OF THE YEAST ADHESIN
3.1 Effect of chemical and enzymic pretreatments on 
the ability of crude EPM to inhibit adhesion of Ç.
albicans GDH 2346 to buccal epithelial cells
3.1.1 Pretreatment with mild alkali
Mild alkali has previously been reported to enhance 
the ability of EPM to inhibit adhesion of Ç. albicans GDH 
2346 to buccal epithelial cells (Critchley and Douglas, 
1987b). However the optimal conditions for pretreatment 
have never been investigated. Mild alkali has been shown 
to eliminate from yeast mannoprotein the base-labile 
oligosaccharides linked through serine and threonine 
residues to the protein part of the molecule (Ballou, 
1976), In the present study, the effect of pretreatments 
with different concentrations of NaOH on the ability of 
crude EPM to inhibit adherence of Ç. albicans GDH 2346 to 
buccal epithelial cells was compared with that of 
pretreatment with PBS.
The results (Figure 7) indicate that pretreatment 
with NaOH at a concentration of 0.1 M (the concentration 
previously used by Critchley and Douglas, 1987b) produces 
maximal inhibition of adhesion. This concentration was
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Table 19 Effect of EPM protein from C. albicans GDH 2346 
on the adhesion of Ç, albicans GDH 2023 to 
buccal cells
Pretreatment Mean no. of 
of buccal yeasts per 100 
cells BEG'S ± SEM
Percentage 
Inhibition 
( and  ^
significance )
2
Adhesion
Inhibition
Index
None 1236 ± 60 0 (NS)
(PBS control)
EPM (10 mg ml~^ 904 ± 18 27 (*)
from C. albicans
GDH 2346)
L-fucose-bound 849 ± 68 31 (*) 20.1
protein
D-mannose-bound 1295 ± 25 0 (NS) 0
protein
N-acetyl-D- 901 ± 33 27 (*) 15 .1
glucosamine-
bound protein
 ^ NS, not significant; * P < 0.001 
2 Adhesion inhibition index for protein relative to 
effect of crude EPM from Ç. albicans GDH 2023 on the 
adhesion of strain GDH 2023 to buccal cells.
Results represent means of three independent 
determinations performed in triplicate.
The buccal cell donor was blood group A, and a
non-secretor (F.D.T.)
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Figure 7 Effect of pretreatment with different
concentrations of NaOH on the ability of 
crude EPM to inhibit the adhesion of C. 
albicans GDH 2346 to buccal epithelial cells
Bars indicate standard error of the mean
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used in all subsequent experiments. Higher alkali 
concentrations produced less inhibition and it is 
possible that there was some hydrolysis of the protein 
portion of the mannoprotein under these conditions.
3.1.2 Pretreatment with papain
Previous work (Critchley and Douglas, 1987b) has 
shown that partial degradation of EPM from C. albicans 
GDH 2346 by papain digestion, followed by mild alkali 
treatment, increases the effectiveness of EPM as an 
inhibitor of adhesion. This increased inhibition was 
attributed to the production of peptide fragments which 
bound more easily to epithelial cell receptors. In the 
present study the effects of combined papain/mild alkali 
pretreatment of EPM were further investigated. The 
results confirmed the increased inhibition described by 
Critchley and Douglas (1987b); this is shown in Table 20 
which contains results from experiments with buccal cells 
from a secretor of blood group antigens. The effect is 
independent of secretor status as shown in Table 21, 
where the buccal cells were from a donor who was a 
non-secretor of blood group antigens.
Papain/mild alkali pretreatment of EPM from C. 
albicans GDH 2023 similarly enhanced the effectiveness of 
this material as an inhibitor (Table 22). Such 
pretreatment increased EPM inhibition of adhesion of the 
homologous yeast strain from 44% to 64%. Overall, these 
results with EPM preparations from two strains indicate
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Table 20 Effect of papain/mild alkali on the ability of 
EPM from Ç. albicans GDH 2346 to inhibit 
adherence of the homologous yeast strain to 
buccal epithelial cells from a secretor
Pretreatment 
of EPM
Mean no. of adherent 
yeasts/100 epithelial 
cells ± SEM
Percentage 
inhibition 
of adherence1
Control 
(No EPM)
768 ± 16 0 -
None
(Crude EPM)
377 ± 22 51 <0.001
Mild alkali 357 ± 18 5 6 <0.001
Papain; 
mild alkali
229 ± 9 74 <0 . 001
Inhibition relative to PBS control.
2 Probability values relative to the control.
Buccal epithelial cells were incubated at 37“C for 30 
min. in a solution (10 mg ml~^) of EPM pretreated as 
indicated. Control buccal cell preparations were 
incubated under the same conditions in PBS.
The buccal cell donor was blood group A, secretor 
(H.S. ) .
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Table 21 Effect of papain/mild alkali on the ability of 
EPM from Ç. albicans GDH 2346 to inhibit 
adherence of the homologous yeast strain to 
buccal epithelial cells from a non-secretor
Pretreatment 
of EPM
Mean no. of adherent 
yeasts/100 epithelial 
cells ± SEM
2Percentage p 
inhibition  ^
of adherence
Control 
(No EPM)
849 ± 48 0
None
(Crude EPM)
463 ± 22 47 <0.001
Papain : 
mild alkali
275 ± 17 69 <0.001
Inhibition relative to PBS control.
2
Probability values relative to the control.
Buccal epithelial cells were incubated at 37"C for 30 
min. in a solution (10 mg ml ^) of EPM pretreated as 
indicated. Control buccal cell preparations were 
incubated under the same conditions in PBS.
The buccal cell donor was blood group A, non-secretor 
(F.D.T.),
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Table 22 Effect of papain/mild alkali on the ability of 
EPM from C. albicans GDH 2023 to inhibit 
adherence of the homologous yeast strain to 
buccal epithelial cells from a non-secretor
Pretreatment 
of EPM
Mean no. of adherent Percentage p'
yeasts/100 epithelial inhibition ^
cells ± SEM of adherence
Control 
(No EPM)
None
(Crude EPM)
Papain: 
mild alkali
1502 ± 86
848 ± 41
684 ± 41
44
64
< 0.001
< 0.001
Inhibition relative to PBS control.
2
Probability values relative to the control.
Buccal epithelial cells were incubated at 37“C for 30 
min. in a solution (10 mg ml~^) of EPM pretreated as 
indicated. Control buccal cell preparations were 
incubated under the same conditions in PBS.
The buccal cell donor was blood group A, non-secretor 
(F.D.T.).
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that this degradation protocol produces fragments that 
are more effective inhibitors of adhesion. The 
specificity of the treatments involved was confirmed in 
suitable control experiments (Table 23).
3.2 Affinity adsorption of EPM protein from C.
albicans 
3.2.1 Affinity adsorption of EPM protein using 
epoxyactivated Sepharose
A simple protocol was developed using epoxyactivated 
Sepharose 6B-beads. EPM solution was incubated with 
Sepharose, to which had been bound either L-fucose, 
D-mannose or N-acetyl-D-glucosamine. Bound protein was 
eluted using the appropriate sugar. This batch technique 
for binding EPM protein gave a similar pattern of results 
(Figure 8) to those obtained earlier (Figure 6) where 
columns were used.
3.2.2 Binding of EPM protein and carbohydrate to Synsorb 
matrices
Following the observation that mixtures of glycosides 
appeared to be significantly better inhibitors of 
adhesion than single glycosides, immobilized 
oligosaccharides were used to further purify the yeast 
adhesin. Crude EPM was bound and eluted from four 
different blood-group oligosaccharides immobilized on a 
silica matrix (Synsorb). Biochemical analyses were 
performed on the eluates. EPM preparations from three
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Table 23 Specificity of chemical and enzymic treatments
on the ability of crude EPM to inhibit adhesion
of C. albicans GDH 2346 to buccal epithelial
cells
Pretreatment Mean no. of
of EPM adherent yeasts/100 
buccal cells ± SEM
Relative^
Adhesion
None 345 ± 10 50 <0.001
Mild alkali 306 ± 34 44 <0.001
Papain + 
mild alkali
243 ± 17 35 <0.001
Acid + - 
alkali (t^ )
351 ± 11 49 <0.001
Papain + 
a^macroglobulin
„38B ± 25
(to)
56 <0.001
3
a^i^ac^oglobulin 337 ± 29 51 <0.001
Control (No EPM) 693 ± 37 100 -
 ^ Mild alkali (NaOH, 0.1 M) and mild acid (HCl, 0.1 M)
were mixed prior to the addition of crude EPM (10 mg
2 Papain and «g^acroglobulin were 
addition of crude EPM (10 mg ml~^).
mixed prior to the
agMacroglobulin was dissolved in PBS, prior to the 
addition of crude EPM (10 mg ml” )^.
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Table 23 (continued)
 ^ Adhesion is expressed as a percentage of that of
control. Prior to adhesion assays, the buccal cells 
were incubated at 37"C for 30 min. in a solution (10 
mg ml ) of crude EPM. Control buccal cell 
preparations were incubated under the same conditions 
in PBS. Adhesion assays were performed twice in 
triplicate, with a yeast cell concentration of 1 x 10 
m l - 1 '
5 Probability values relative to the adhesion of PBS 
control.
The buccal cell donor was of blood group A, non-secretor
(F.D.T.).
The donors of the buccal cells in all of these
experiments were of blood group A.
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Figure 8 Percentage of total EPM protein bound to 
three different immobilized sugars as 
measured by batch affinity adsorption
Bars indicate standard error of the mean
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different strains of Ç. albicans were used.
The results (Tables 24, 25, 26) indicated that 
significant amounts of EPM bound to the oligosaccharides, 
EPM protein from C. albicans GDH 2346 bound in lowest 
amounts to the H-1 oligosaccharide (5.1%), whilst the 
binding to the Lewis-a, Lewis-b and H-2 oligosaccharides 
was 14.4%, 12.2% and 13.4% respectively (Table 24), With 
C. albicans GDH 2023 there was the greatest binding to 
the H-2 oligosaccharide (24.8%) and least to the Lewis-b 
oligosaccharide (4.5%) (Table 25). On the other hand, 
the EPM protein from strain GRI 681 showed some 
predilection for the Lewis-b oligosaccharide (Table 26). 
These results are summarized in Figure 9,
3.3 Efficiency of partially purified adhesin in 
the inhibition of yeast adhesion
3.3.1 The use of partially purified adhesin from Ç. 
albicans GDH 2346 to inhibit adhesion
To determine which of the bound fractions showed the 
greatest inhibition of adherence relative to crude EPM, a 
series of inhibition assays was performed; in each assay 
C. albicans GDH 2346 was used with a buccal cell donor of 
blood group A (a non-secretor). The results of these 
experiments are shown in Tables 27, 28, 29 and 30. The 
All values are summarized in Table 31, from which it can 
be seen that H-2 bound material had the highest All of 
62.2, and Lewis-b bound material had the lowest All of
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Table 24 Biochemical analysis of EPM from Ç. albicans
GDH 2 34 6 bound to Synsorb
Immobilized 
Oligosaccharide 
(Trivial Name)
Percentage of crude EPM' 
(±SEM) bound as
Protein Carbohydrate
/3Gal(l-3)/3GlcNAc 
(1-4) 
aFuc
(Lewis a)
aFuc ( 1-2 )/3Gal ( 1-3 )/3GlcNAc
(1-4) 
aFuc
(Lewis b)
14.410.4 20 . 111.0
12 . 210.2 16.010.5
aFuc ( 1-2 )/3Gal ( 1-3 )/3GlcNAc 5.110.1 7 . 910 .1
(H 1)
aFuc( 1-2 )j3Gal ( 1-4 )/3GlcNAc 
(H 2)
13.410.2 8.310.1
Results represent means of two independent 
determinations performed in triplicate.
Samples of EPM (50 mg ml ^; 0.2 ml) were applied to 0.16 
ml of the immobilized oligosaccharide matrix and tumbled 
end-over-end at 4°C for 3 h. The matrix was eluted with 
PBS to remove non-specifically bound material. Bound 
material was then eluted with a 1.5% solution of NH^OH in 
sterile saline.
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Table 25 Biochemical analysis of EPM from C. albicans
GDH 2023 bound to Synsorb
Immobilized 
Oligosaccharide 
(Trivial Name)
Percentage of crude EPM' 
(±SEM) bound as
Protein Carbohydrate
PGal(l-3)/3GlcNAc 
(1-4) 
aFuc
(Lewis a)
aFuc ( 1-2 )/3Gal ( 1-3 ) jGGlcNAc
(1-4) 
aFuc
(Lewis b)
aFuc( 1-2 )/3Gal ( l-3)^GlcNAc 
(H 1)
18.710.2 8.510.3
4.510.2 5.510.1
10.410.1 12.410.2
aFuc ( 1-2 )/3Gal ( 1-4 ) jGGlcNAc 
(H 2)
24.810.4 11.710.2
Results represent means of two independent 
determinations performed in triplicate.
Samples of EPM (50 mg ml~^; 0.2 ml) were applied to 0.16 
ml of the immobilized oligosaccharide matrix and tumbled 
end-over-end at 4 ° C for 3 h. The matrix was eluted with 
PBS to remove non-specifically bound material. Bound 
material was then eluted with a 1.5% solution of NH^OH in 
sterile saline.
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Table 26 Biochemical analysis of EPM from Ç. albicans
GRI 681 bound to Synsorb
Immobilized 
Oligosaccharide 
(Trivial Name)
Percentage of crude EPM' 
(±SEM) bound as
Protein Carbohydrate
(Lewis a)
)3Gal(l-3)/3GlcNAc 
(1-4) 
aFuc
8 .6±0.2 18,4+0.4
aFuc (1-2 ) jGGal (1-3) /3GlcNAc
(1-4) 13.7+0.2 27.410.6
aFuc
(Lewis b)
aFuc ( 1-2 )/3Gal ( 1-3 )/3GlcNAc 6 .110 .1 13. 010 . 2
(H 1)
aFuc ( 1-2 )/3Gal ( 1-4 )pclcNAc 
(H 2)
8.510.1 12.610.3
Results represent means of two independent 
determinations performed in triplicate.
Samples of EPM (50 mg ml ^; 0.2 ml) were applied to 0,16 
ml of the immobilized oligosaccharide matrix and tumbled 
end-over-end at 4 ° C for 3 h. The matrix was eluted with 
PBS to remove non-specifically bound material. Bound 
material was then eluted with a 1.5% solution of NH^OH in 
sterile saline.
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Figure 9 Percentage of total EPM protein bound to four 
different immobilized oligosaccharides
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Table 27 Synsorb Lewis-a for adhesin purification:
inhibition of adhesion of C. albicans GDH 2346 
to buccal epithelial cells by EPM fractions
Pretreatment 
of EPM
Mean no. of 
adherent yeasts/ 
100 epithelial 
cells ± SEM
Percentage
inhibition
of
adherence
AII^
Lewis-a bound^ 372 ± 33 52 46.7
Lewis-a eluted^ 608 ± 33 22 2 . 0
None 411 ± 22 48 1.0
PBS Control (No EPM) 783 ± 14 0 -
Samples of EPM from strain GDH 2346 (100 mg ml 1 0.2
ml) were applied to 0.16 ml of the immobilized 
oligosaccharide matrix and tumbled end-over-end at 4“C 
for 3 h. The matrix was eluted with PBS to remove 
non-specifically bound material. Bound material was 
eluted with a 1.5% solution of NH^OH in sterile saline. 
Both eluted and bound fractions were lyophilized and 
reconstituted in distilled water and desalted on a 
Sephadex G-25 desalting column (Pharmacia). Appropriate 
material was then incubated with buccal epithelial cells 
(37*C for 30 min) before their use in adhesion assays.
2 Adhesion inhibition index (All) calculated relative to
untreated EPM. The buccal cell donor was blood group A
and a non-secretor (F.D.T.).
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Table 28 Synsorb Lewis-b for adhesin purification:
inhibition of adhesion of C. albicans GDH 2346 
to buccal epithelial cells by EPM fractions
Pretreatment 
of EPM
Mean no. of 
adherent yeasts/ 
100 epithelial 
cells ± SEM
Percentage
inhibition
of
adherence
2
All
Lewis-b bound^ 214 ± 17 71 17.7
Lewis-b eluted^ 476 ± 28 35 3.7
None 388 ± 11 47 1.0
PBS Control (No EPM) 754 ± 35 0 -
 ^ Samples of EPM from strain GDH 2346 (100 mg ml~^; 0.2 
ml) were applied to 0.16 ml of the immobilized 
oligosaccharide matrix and tumbled end-over-end at 4°C 
for 3 h. The matrix was eluted with PBS to remove 
non-specifically bound material. Bound material was 
eluted with a 1.5% solution of NH^OH in sterile saline. 
Both eluted and bound fractions were lyophilized and 
reconstituted in distilled water and desalted on a 
Sephadex G-25 desalting column (Pharmacia). Appropriate 
material was then incubated with buccal epithelial cells 
(37°C for 30 min) before their use in adhesion assays.
Adhesion inhibition index (All) calculated relative to
untreated EPM. The buccal cell donor was blood group A
and a non-secretor (F.D.T.).
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Table 29 Synsorb H-1 for adhesin purification;
inhibition of adhesion of C. albicans GDH 2346 
to buccal epithelial cells by EPM fractions
Pretreatment 
of EPM
Mean no. of 
adherent yeasts/ 
100 epithelial 
cells ± SEM
Percentage
inhibition
of
adherence
2All
H-1 bound^ 276 ± 33 63 51.3
H-1 eluted^ 483 ± 26 26 2.3
None 377 ± 33 49 1.0
PBS Control (No EPM) 737 ± 29 0 -
 ^ Samples of EPM from strain GDH 2346 (100 mg ml” ;^ 0.2 
ml) were applied to 0.16 ml of the immobilized 
oligosaccharide matrix and tumbled end-over-end at 4"C 
for 3 h. The matrix was eluted with PBS to remove 
non-specifically bound material. Bound material was 
eluted with a 1,5% solution of NH^OH in sterile saline. 
Both eluted and bound fractions were lyophilized and 
reconstituted in distilled water and desalted on a 
Sephadex G-25 desalting column (Pharmacia). Appropriate 
material was then incubated with buccal epithelial cells 
(37"C for 30 min) before their use in adhesion assays.
Adhesion inhibition index (All) calculated relative to
untreated EPM. The buccal cell donor was blood group A
and a non-secretor (F.D.T.).
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Table 30 Synsorb H-2 for adhesin purification:
inhibition of adhesion of Ç. albicans GDH 2346 
to buccal epithelial cells by EPM fractions
Pretreatment 
of EPM
Mean no. of 
adherent yeasts/ 
100 epithelial 
cells ± SEM
Percentage
inhibition
of
adherence
All
H-2 bound^ 435 ± 26 41 62.2
H-2 eluted^ 547 ± 27 25 1.7
None 400 ± 16 45 1.0
PBS Control (No EPM) 733 ± 17 0 -
 ^ Samples of EPM from strain GDH 2346 (100 mg ml ^; 0.2 
ml) were applied to 0.16 ml of the immobilized 
oligosaccharide matrix and tumbled end-over-end at 4°C 
for 3 h. The matrix was eluted with PBS to remove 
non-specifically bound material. Bound material was 
eluted with a 1.5% solution of NH^OH in sterile saline. 
Both eluted and bound fractions were lyophilized and 
reconstituted in distilled water and desalted on a 
Sephadex G-25 desalting column (Pharmacia), Appropriate 
material was then incubated with buccal epithelial cells 
(37°C for 30 min) before their use in adhesion assays.
2 Adhesion inhibition index (All) calculated relative to
untreated EPM. The buccal cell donor was blood group A
and a non-secretor (F.D.T.).
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Table 31 Purification of the yeast adhesin by affinity 
adsorption: adhesion inhibition index values 
for C. albicans GDH 2346
Synsorb Adhesion Inhibition Index 
(based on protein content)
Lewis—a 46.7
Lewis-b 17.7
H-1 51. 3
H-2 62 . 2
Table 32 Purification of the yeast adhesin by affinity
adsorption; adhesion inhibition index values
for C. albicans GDH 2023
Synsorb Adhesion Inhibition Index 
(based on protein content)
Lewis-b 30.4
H-2 53.0
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17.7. Lewis-a and H-1 bound protein had All values of 
46.7 and 51.3 respectively.
3.3.2 The use of partially purified material from C . 
albicans GDH 2023 to inhibit adhesion
To further investigate the effectiveness of Lewis-b 
and H-2 bound material as inhibitors of adherence, 
experiments were performed in which bound EPM protein 
from C. albicans GDH 2023 was used to inhibit the 
adhesion of Ç. albicans GDH 2023 to buccal epithelial 
cells, again from a donor of blood group A (a non- 
secretor) . The results are summarized in Table 32 and 
given in detail in Tables 33 and 34. Lewis-b bound 
material had an All of 30.4, but H-2 bound material had 
an All 53.0. This latter value is the highest All value 
yet recorded for an EPM fraction from Ç. albicans GDH 
2023.
3.3.3 Effect of purified EPM protein from C. albicans on 
the adhesion of a heterologous yeast
Critchley and Douglas (1987b) showed that EPM from Ç. 
albicans GDH 2346 inhibited the adhesion of C, albicans 
GDH 2023 to buccal epithelial cells. The fact that the 
reverse did not hold was taken to indicate the specific 
nature of the adhesion (McCourtie and Douglas, 1985). As 
yet however, no reports have been published on the use of 
purified material in these inhibition tests. In 
addition, the method of purification involving
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Table 33 Synsorb Lewis-b adhesin purification:
inhibition of adhesion of Ç. albicans GDH 2023 
to buccal epithelial cells by EPM fractions
Pretreatment 
of EPM
Mean no. of 
adherent yeasts/ 
100 epithelial 
cells ± SEM
Percentage
inhibition
of
adherence
2All
1
Lewis-b bound 700 ± 41 46 30.4
Lewis-b eluted^ 1167 ± 64 23 2 . 6
None 881 ± 57 42 1.0
PBS Control (No EPM) 1524 ± 54 0 -
1  —  1Samples of EPM from strain GDH 2023 (100 mg ml ; 0.2
ml) were applied to 0,16 ml of the immobilized
oligosaccharide matrix and tumbled end-over-end at 4°C
for 3 h. The matrix was eluted with PBS to remove
non-specifically bound material. Bound material was
eluted with a 1.5% solution of NH^OH in sterile saline.
Both eluted and bound fractions were lyophilized and
reconstituted in distilled water and desalted on a
Sephadex G-25 desalting column (Pharmacia). Appropriate
material was then incubated with buccal epithelial cells
(37“C for 30 min) before their use in adhesion assays.
2
Adhesion inhibition index (All) calculated relative to
untreated EPM. The buccal cell donor was blood group A
and a non-secretor (F.D.T.).
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Table 34 Synsorb H-2 for adhesin purification:
inhibition of adhesion of C. albicans GDH 2023 
to buccal epithelial cells by EPM fractions
Mean no. of Percentage ^
Pretreatment adherent yeasts/ inhibition All
of EPM 100 epithelial of
cells ± SEM adherence
H-2 bound material^ 1118 ± 52 28 53.0
H-2 eluted material^ 1179 ± 30 24 2.7
None 858 i 15 45 1.0
PBS Control (No EPM) 1548 ± 49 0 -
 ^ Samples of EPM from strain GDH 2023 (100 mg ml~^; 0,2 
ml) were applied to 0.16 ml of the immobilized 
oligosaccharide matrix and tumbled end-over-end at 4°C 
for 3 h. The matrix was eluted with PBS to remove 
non-specifically bound material. Bound material was 
eluted with a 1.5% solution of NH^OH in sterile saline. 
Both eluted and bound fractions were lyophilized and 
reconstituted in distilled water and desalted on a 
Sephadex G-25 desalting column (Pharmacia). Appropriate 
material was then incubated with buccal epithelial cells 
(37°C for 30 min) before their use in adhesion assays.
Adhesion inhibition index (All) calculated relative to
untreated EPM. The buccal cell donor was blood group A
and a non-secretor (F.D.T.).
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chromatography on Concanavalin-A Sepharose and DEAE 
Cellulose (Critchley and Douglas, 1987a) was not as 
efective as the technique described in Section 3,2, since 
the All value determined for material purified from the 
H-2 matrix exceeded 62, in contrast to the Concanavalin- 
A/DEAE Cellulose protein which had an All of just over 
30.
In subsequent experiments, the results of which are 
shown in Table 35 and Table 36, purified material was 
used to inhibit heterologous yeast adhesion. Purified 
material from Ç, albicans GDH 2346 was able to inhibit 
the adhesion of Ç, albicans GDH 2023 (Table 35). The All 
of 57.8 was comparable with that of purified EPM from C. 
albicans GDH 2023, in the inhibition of adhesion of C. 
albicans GDH 2023 (Table 34).
By contrast to the work of Critchley and Douglas 
(1987b), where only crude material was used, purified 
material from C. albicans GDH 2023 was able to inhibit 
adhesion of C. albicans GDH 2346 to buccal cells (Table 
36). This result was unexpected, as although EPM from Ç. 
albicans GDH 2346 may inhibit the adhesion of C. albicans 
GDH 2023, the reverse is not true. EPM from C. albicans 
GDH 2023 cannot inhibit the adhesion of Ç. albicans GDH 
2346. This has been taken by McCourtie and Douglas 
(1985) and Critchley and Douglas (1987b) as showing the 
specificity of yeast adhesion. Here the results show a 
purified fraction of the EPM from Ç. albicans GDH 2023
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Table 35 Effect of EPM protein from Ç. albicans GDH
2346, purified by Synsorb H-2 batch affinity
adsorption , on the adhesion of C. albicans GDH
2023
Method used Mean no. of 
to pretreat adherent yeasts/ 
epithelial 100 epithelial 
cells cells ± SEM
Percentage
inhibition
of
adherence
2
All
H-2 bound material 652 ± 37 41 57.8
H-2 eluted material 963 ± 41 12 0.6
Untreated EPM 857 ± 20 22 1.0
PBS 1097 ± 35 0 -
Untreated EPM from 
GDH 2023 against Ç. 
albicans GDH 2023 
adhesion
582 ± 20 47 -
1 ~  1Samples of EPM (100 mg ml ; 0.2 ml) were applied to
0.16 ml of the immobilized oligosaccharide matrix, and
tumbled end-over-end at 4“C for 3 h. The matrix was
eluted with PBS to remove non-specifically bound
material. Bound material was eluted with a 1.5% solution
of NH^OH in sterile saline. Both eluted and bound
fractions were lyophilized and reconstituted in distilled
water and desalted on a Sephadex G-25 desalting column
(Pharmacia). Appropriate material was then incorporated
into the adherence assay,
2 Adhesion inhibition index (All) calculated relative to 
the untreated EPM.
The buccal cell donor was of blood group A, and a non-
secretor (F.D.T.).
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Table 36 Effect of EPM protein from Ç. albicans GDH
2023, purified by Synsorb H-2 batch affinity 
adsorption, on the adhesion of Ç. albicans GDH 
2346
Method used Mean no. of 
to pretreat adherent yeasts/ 
epithelial 100 epithelial 
cells cells ± SEM
Percentage
inhibition
of
adherence
2
All
H-2 bound material 519 ± 26 27 31.0
H-2 eluted material 695 ± 22 2 0.0
Untreated EPM 705 ± 19 0 -
PBS 706 ± 26 0 -
Untreated EPM from 
GDH 2346 against C. 
albicans GDH 2346 
adhesion
387 ± 26 45
1 —  1Samples of EPM (100 mg ml ; 0.2 ml) were applied to
0.16 ml of the immobilized oligosaccharide matrix, and
tumbled end-over-end at 4°C for 3 h. The matrix was
eluted with PBS to remove non-specifically bound
material. Bound material was eluted with a 1.5% solution
of NH.OH in sterile saline. Both eluted and bound
fractions were lyophilized and reconstituted in distilled
water and desalted on a Sephadex G-25 desalting column
(Pharmacia). Appropriate material was then incorporated
into the adherence assay.
2 Adhesion inhibition index (All) calculated relative to 
the untreated EPM.
The buccal cell donor was of blood group A, and a non-
secretor (F.D.T.).
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inhibiting the adhesion of C. albicans GDH 2346. No 
adequate explanation for these results has yet emerged.
3.4 Development of a purification protocol for the
yeast adhesin
3.4.1 Purification of the yeast adhesin by chemical and 
enzymic degradation prior to Synsorb H-2 batch 
affinity adsorption
Previous experiments (Section 3.1.2) indicated that 
papain digestion, followed by mild alkali treatment of 
EPM from Ç. albicans GDH 2346 produced a more effective 
inhibitor of yeast adhesion than crude EPM. Similarly, 
partially purified proteinaceous material from an H-2 
matrix was shown in Section 3.3.1 (and Table 30) to be a 
better inhibitor of adhesion than was crude EPM.
Thus, a combination of these treatments was performed 
prior to affinity adsorption. From Table 37 it can be 
seen that the resultant protein fraction had an All of 
greater than 114, and inhibited adhesion by 79%. This 
was the highest level of inhibition reported to date from 
this laboratory. In a subsequent dose response 
experiment, progressively increasing concentrations of 
proteinaceous material treated with papain, mild alkali 
and then bound to and eluted from the H-2 matrix, were 
used to pretreat the buccal cells. The results (Table 
38) showed that the maximum level of inhibition achieved 
was approximately 65%.
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Table 37 Purification of the yeast adhesin of Ç. albicans GDH 2346, by papain, mild alkali 
pretreatment prior to Synsorb H-2 batch affinity adsorption
Pretreatment 
of EPM
Mean no. of 
adherent yeasts/ 
100 epithelial 
cells ± SEM
Percentage
inhibition
of
adherence
AII^
1
None (H-2 bound) 213 ± 16 72 55.7
1
None (H-2 eluted) 735 ± 23 4 0.3
None 401 ± 23 48 1.0
Papain; mi Id alkali 278 ± 14 64 -
Papain; mild alkali^ 
(H-2 bound)
158 ± 8 79 114.6
2
Papain; mild alkali 
(H-2 eluted)
566 ± 31 26 2.6
PBS Control (No EPM) 765 ± 14 0 -
1 -1
Samples of EPM (100 mg ml ; 0.2 ml) were applied to 0.16 ml of the immobilized
oligosaccharide matrix, and tumbled end-over-end at 4°C for 3 h. The matrix was eluted with PBS
to remove non-specifically bound material. Bound material was eluted with a 1.5% solution of
NH^OH in sterile saline. Both eluted and bound fractions were lyophilized and reconstituted in
distilled water and desalted on a Sephadex G-25 desalting column (Pharmacia). Appropriate
material was then incorporated into the adherence assay.
2
EPM was pretreated with papain, followed by mild alkali prior to application to the H-2 
matrix.
Adhesion inhibition index (All) calculated relative to the untreated EPM.
The buccal cell donor was of blood group A, and a non-secretor (F.D.T.).
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Table 38 Purification of the yeast adhesin from EPM of Ç. albicans GDH 2346, by papain, mild 
alkali pretreatment prior to Synsorb H-2 batch affinity adsorption: effect of 
increasing protein concentration
Pretreatment Mean no. of adherent Percentage
of yeasts/100 epithelial inhibition ^
EPM cells ± SEM of adherence
Papain; mild alkali
-1
H-2 bound (fvg ml )
0.77 721 ± 27 1
1.54 641 ± 36 12
3.08 494 ± 20 32
6.15 394 ± 25 46
12.3 253 ± 14 65
Papain; mild alkali 260 ± 26 64
-1
Crude EPM (10 mg ml ) 396 ± 15 46
PBS Control (No EPM) 765 ± 14 0
1
Inhibition relative to the PBS control.
EPM was pretreated with papain, followed by mild alkali, prior to application to the H-2 matrix. 
-1
Samples (10 mg ml ; 1.0 ml) were applied to 0.16 ml of the immobilized oligosaccharide matrix,
and tumbled end-over-end at 4'C for 2 h. The matrix was eluted with PBS to remove non-
specif ically bound material. Bound material was eluted with a 1.5% solution of NH OH in sterile
4
saline. The bound fraction was lyophilized and reconstituted in distilled water and desalted on 
a Sephadex G-25 desalting column (Pharmacia), and assayed for protein (Lowry method). Appropriate 
material was then incorporated into the adherence assay.
The buccal cell donor was of blood group A, and a non-secretor (F.D.T,).
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Experiments described by Tarantino et al, (1985) have 
showed that N-glycanase, purified from Streptomyces 
griseus, has the capacity to degrade glycoproteins into 
their constituent carbohydrate and protein components by 
cleaving the N-glycoside linkage between N-acetyl-D- 
glucosamine and the protein. This occurs without 
disrupting the integrity of the proteinaceous portion of 
the molecule. Since EPM from C. albicans is known to 
consist mainly of mannoprotein, the effect of N-glycanase 
on EPM from Ç. albicans was investigated. After 
N-glycanase digestion, the EPM hydrolysate was applied to 
the H-2 affinity matrix, eluted and used in adhesion 
assays.
The results of such an experiment are shown in Table 
39; from this, and by comparison with Table 37, it can be 
seen that the All of greater than 135 was the highest 
value recorded to date. Despite these treatments, 
elimination of all the carbohydrate from the EPM had not 
yet been achieved.
To this end N-glycanase followed by mild alkali 
treatment of the EPM was used. Although this had the 
desired effect of reducing the carbohydrate content of 
the bound fraction, some carbohydrate still remained 
(Table 40), The All was fractionally greater (144.1) 
than that recorded previously (Table 39).
In a final attempt to remove all traces of the 
carbohydrate, two different pretreatments were tested.
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Table 39 Purification of the yeast adhesin from EPM of Ç. albicans GDH 2346, by Synsorb H-2 
batch affinity adsorption; effect of N-glycanase pretreatment on the adherence of Ç. 
albicans GDH 2346 to buccal epithelial cells
Pretreatment 
of buccal 
epithelial 
cells
Mean no. of 
adherent yeasts/ 
100 epithelial 
cells ± SEM
Percentage
inhibition
2
adherence
AII^
1
H-2 bound 346 ± 22 74 135.8
1
H-2 unbound 1142 ± 53 16 3.9
-1
Crude EPM (lOmgml ) 736 ± 51 46 1.0
PBS Control (No EPM) 1356 ± 35 0 -
1 -1
Samples (100 mg ml ; 0.05 ml) were pretreated with N-glycanase for 24 h and then applied to 
0.16 ml of the immobilized oligosaccharide matrix, and tumbled end-over-end at 4°C for 3 h. The 
matrix was eluted with PBS to remove non-specifically bound material. Bound material was eluted 
with a 1.5% solution of NH^OH in sterile saline. Both fractions were lyophilized and 
reconstituted in distilled water, desalted on a Sephadex G-25 desalting column (Pharmacia), and 
assayed for protein (Lowry method). Appropriate material was then incorporated into the 
adherence assay.
Inhibition relative to PBS control.
3
Adhesion inhibition index (All) calculated relative to the untreated EPM.
The buccal cell donor was of blood group A and a non- secretor (F.D.T.).
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Table 40 Purification of the yeast adhesin from EPM of C. albicans GDH 2346, by Synsorb H-2 
batch affinity adsorption; effect of N-glycanase, mild alkali pretreatment on the 
adherence of Ç, albicans GDH 2346 to buccal epithelial cells
Pretreatment 
of buccal 
epithelial 
cells
Mean no. of 
adherent yeasts/ 
100 epithelial 
cells ± SEM
Percentage
inhibition
2
adherence
AII^
1
H-2 bound 267 ± 20 77 144.1
1
H-2 unbound 947 t 48 18 5.9
-1
Crude EPM (lOmgml ) 638 ± 34 45 1.0
PBS Control (No EPM) 1150 ± 51 0 -
1 -1
Samples (100 mg ml ; 0,05 ml) were pretreated with N-glycanase for 16 h and then mild alkali
(0.1 M NaOH). They were than applied to 0.16 ml of the immobilized oligosaccharide matrix, and
tumbled end-over-end at 4'C for 3 h. The matrix was eluted with PBS to remove non- specifically
bound material. Bound material was eluted with a 1.5% solution of NH OH in sterile saline. Both
4
fractions were lyophilized and reconstituted in distilled water, desalted on a Sephadex G-25
desalting column (Pharmacia), and assayed for protein (Lowry method). Appropriate material was
then incorporated into the adherence assay.
2
Inhibition relative to PBS control.
Adhesion inhibition index (All) calculated relative to the untreated EPM.
The buccal cell donor was of blood group A and a non-secretor (F.D.T.).
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In one method EPM was treated with either N-glycanase 
then papain, whilst in the second, N-glycanase/papain 
treatment was followed by a 24 h degradation with mild 
alkali. The results of these experiments are shown in 
Table 41. N-glycanase/papain/mild alkali treatment 
resulted in a fraction that was over 200 times more 
effective than was crude EPM.
A summary of these results, together with the 
corresponding biochemical analyses are shown in Table 42. 
This table indicates that as the protein: carbohydrate 
ratio decreased, the effectiveness of the H-2 bound 
fraction as an inhibitor of adhesion was increased. This 
provided further evidence for the proteinaceous nature of 
the adhesin.
3.4.2 The number of yeast adhesin receptors on the 
buccal epithelial cell surface
The number of yeast receptors on the buccal cell 
surface is of some interest. To investigate this, the 
effect of an increasing concentration of purified adhesin 
on the inhibition of adhesion of Ç. albicans GDH 2346 to 
buccal epithelial cells was examined. A dose response 
experiment was conducted with purified material adjusted 
to a known protein concentration (Table 43). The maximum 
inhibition observed was 78%. This suggests that either 
insufficient adhesin was used, or that more than one 
yeast receptor operates.
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Table 41 Purification of the yeast adhesin from EPM of 
Ç. albicans GDH 2346, by Synsorb H-2 batch 
affinity adsorption; effect of N-glycanase, 
papain and mild alkali pretreatment on the 
adherence of C. albicans GDH 2346 to buccal
epithelial cells
Pretreatment 
of buccal 
epithelial 
cells
Mean no. of 
adherent yeasts/ 
100 epithelial 
cells ± SEM
Percentage
inhibition
of g 
adherence
4All
1
H-2 bound 189 ± 29 80 220.5
1H-2 unbound 707 ± 29 , 27 2.0
H-2 bound^ 267 ± 28 72 130.8
2
H-2 unbound 711 ± 36 28 8.5
Crude EPM (lOmgml ^) 508 ± 15 47 1.0
PBS Control (No EPM) 965 ± 23 0 -
Samples (100 mg ml ; 0.05 ml) were pretreated with
N-glycanase for 24 h, then papain (30 min) and then mild
alkali (0.1 M NaOH) for 24 h.
2 —  1Samples (100 mg ml ; 0.05 ml) were pretreated with
N-glycanase for 24 h and then papain (30 min).
Samples were applied to 0,16 ml of the immobilized
oligosaccharide matrix, and tumbled end-over-end at 4 °C
for 3 h. The matrix was eluted with PBS to remove non-
specif ically bound material. Bound material was eluted
with a 1.5% solution of NH^OH in sterile saline. All
fractions were lyophilized and reconstituted in distilled
water desalted on a Sephadex G-25 desalting column
(Pharmacia), and assayed for protein (Lowry method).
3 Inhibition relative to PBS control.
 ^ Adhesion inhibition index (All) calculated relative to 
the untreated EPM.
The buccal cell donor was of blood group A, and a non
secretor (F.D.T.).
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Table 42 Purification of the yeast adhesin from EPH of C. albicans GDH 2346, by Synsorb H-2 
batch affinity adsorption; effect of decreasing protein:carbohydrate ratio
Biochemical
-1
content (/jg ml ) Protein:
protein carbohydrate
All
carbohydrate
-1 2
1:11Crude EPM (10 mg ml ) 720 7920 1
H-2 bound 12.5 20.2 55.7 1: 1.62
Papain, mild alkali treated 
H-2 bound
EPM: 6.84 7.85 114.6 1: 1.15
N-glycanase treated EPM: 
H-2 bound
10.54 9.24 135.8 1: 0.88
N-glycanase, mild alkali 
treated EPM: H-2 bound
10.70 4.18 144.1 1: 0.39
N-glycanase, papain 
treated EPM: H-2 bound
10.20 N 130.6 1: 0
N-glycanase, papain, 
mild alkali treated EPM: 
H-2 bound
6.72 N 220.5 1: 0
Adherence inhibition index ( A I D  calculated relative to untreated EPM. 
The buccal cell donor was of blood group A, and a non-secretor (F.D.T.).
N - Not detectable.
Different crude EPM preparations were used during the purification of the yeast adhesin
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Table 43 Purification of the yeast adhesin from EPM of
Ç. albicans GDH 2346, by N-glycanase, papain
and mild alkali pretreatment prior to Synsorb
H-2 batch affinity adsorption: effect of 
increasing protein concentration
Pretreatment 
of buccal 
epithelial 
cells
Mean no, of adherent 
yeasts/100 epithelial 
cells ± SEM
Percentage 
inhibition _ 
of adherence
N-glycanase, papain, mild
alkali, H-2 bound (pg ml ^)^
1.25 725 ± 19 4
2.50 625 ± 28 17
5.00 280 ± 27 63
7.50 209 ± 19 72
10.00 195 ± 17 78
Crude EPM (10 mg ml'l) 412 ± 15 46
PBS Control (No EPM) 752 ± 28 0
Samples (100 mg ml ; 0.05 ml) were pretreated with 
N-glycanase for 24 h, then papain (30 min) and then mild 
alkali (0.1 M NaOH). All samples were applied to 0.16 ml 
of the immobilized oligosaccharide matrix, and tumbled 
end-over-end at 4°C for 3 h. The matrix was eluted with 
PBS to remove non-specifically bound material. Bound 
material was eluted with a 1.5% solution of NH.OH in 
sterile saline. All fractions were lyophilized and 
reconstituted in distilled water, and assayed for protein 
(Lowry method), and the protein concentration was 
adjusted.
2 Inhibition relative to the PBS control.
The buccal cell donor was of blood group A, and a non-
secretor (F.D.T.),
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3.4.3 Use of purified adhesin to inhibit adhesion of Ç. 
albicans GDH 2346 to buccal epithelial cells
3.4.3.1 Effect of different growth conditions for C. 
albicans GDH 2346; throughout the experiments
described in Sections 2 and 3, buccal cells from one 
donor and yeasts (C. albicans GDH 2346) grown in the same 
medium (YNB + 500 mM galactose) were used in inhibition 
assays. Here the growth conditions were modified to 
determine if there was any discernible effect. The 
results shown in Table 44 relate to C. albicans GDH 2346 
grown in YNB + 50 mM glucose. As described in Section 
1.2, yeasts with this carbon source are approximately ten 
times less adherent to buccal cells than are the same 
organisms grown with 500 mM galactose as the carbon
source. For this reason, a higher concentration of 1 x
8 — 1 10 organisms ml was used. Despite this, the purified
yeast adhesin was unable to inhibit adhesion completely
with inhibition levelling off at approximately 75% (Table
44) .
3.4.3.2 Effect of different buccal epithelial cell 
donors : in all previous experiments describing
inhibition by purified adhesin, a single buccal cell 
donor - a non-secretor of blood group A antigens in body 
fluids - was used. In a final purification experiment 
(Table 45) a different buccal cell donor - a secretor of 
blood group A antigens - was investigated. Although very
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Table 44 Effect of increasing concentrations of protein, 
treated with N-glycanase, papain and mild 
alkali prior to Synsorb H-2 batch affinity 
adsorption on the adhesion of Ç. albicans GDH 
2346 grown with 50 mM glucose as the carbon 
source
Concentration Mean no. of adherent 
of purified yeasts/100 epithelial 
adhesin cells ± SEM
Percentage 
inhibition  ^
of adherence
N-glycanase, papain, mild
alkali, H-2 : — 1 1 bound (pg ml )
0.9375 384 ± 21 1
1. 875 361 ± 18 7
3.75 281 ± 37 27
7.50 151 ± 19 61
15.00 97 ± 9 75
Crude EPM (1Omgml"^) 326 ± 22 16
PBS Control (No EPM) 387 ± 14 0
Inhibition relative to PBS control.
Assays were performed three times in triplicate, using 
1 X 10® yeasts ml~^.
Assays were performed using 24 h cultures of Candida 
albicans GDH 2346 grown in Yeast Nitrogen Base (Difco) 
medium containing 50 mM Glucose as the carbon source. 
The buccal cell donor was of blood group A, and a non- 
secretor (F.D.T.).
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Table 45 Effect of different pretreatments on the
adherence of C. albicans GDH 2346 to buccal 
epithelial cells from a donor who was a 
secretor of blood group A antigens
Pretreatment Mean no. of 
of buccal adherent yeasts/ 
epithelial 100 epithelial 
cells cells ± SEM
Percentage
inhibition
of 2
adherence
3
All
PBS Control (No EPM) 768 ± 16 0 -
Crude EPM (lOmgml"^) 377 ± 22 51 1. 0
H-2 unbound^ 632 ± 45 18 11.8
H-2 bound^ 245 ± 32 69 273.3
1 —  1Samples (100 mg ml ; 0.2 ml) were applied to 0.16 ml
of the immobilized oligosaccharide matrix, and tumbled
end-over-end at 4°C for 3 h. The matrix was eluted with
PBS to remove non-specifically bound material. Bound
material was eluted with a 1.5% solution of NH.OH in
sterile saline. Both fractions were lyophilized and
reconstituted in distilled water, desalted on a Sephadex
G-25 desalting column (Pharmacia), and assayed for
protein (Lowry method). Appropriate material was then
incorporated into the adherence assay.
2
Inhibition relative to PBS control.
3 Adhesion inhibition index calculated relative to the 
untreated EPM.
The buccal cell donor was of blood group A, and a non-
secretor (H.S.).
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little purification of adhesin had been employed (i.e. 
only H-2 affinity adsorption, but no chemical and enzymic 
dissection), the resultant All of over 270 was the 
highest described throughout this study. This indicated 
that there was a significant difference between the 
effectiveness of the adhesin with respect to two donors 
of the same blood group but differing secretor status.
3.5 Purification protocol for the yeast adhesin
The final purification protocol developed in this 
study is outlined in Table 46. As was shown in Table 42, 
N-Glycanase, papain, mild alkali-treated EPM was totally 
devoid of carbohydrate and had the highest All value 
(>220) recorded to date, i.e. being 220 times more 
effective than crude EPM as an inhibitor of yeast
3.6 Analysis of the purified yeast adhesin
Exhaustive attempts were made to demonstrate the 
purified adhesin as one or more bands on SDS-PAGE gels, 
but no success was achieved. However using F.P.L.C. it 
was possible to confirm the presence of the yeast adhesin 
and a trace from a reverse phase hydrophobicity column is 
shown in Figure 10.
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Table 46 Purification protocol for the yeast adhesin
EPM
V
N-Glycanase 
Papain 
Mild alkali
V
Synsorb affinity adsorption
V
Purified yeast adhesin
V
Use in adhesion assay
Details of this protocol are supplied in Materials and 
Methods.
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Figure 10 F.P.L.C. trace of purified yeast adhesin, on 
PEP HR5/5 reverse phase hydrophobicity 
column
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4 BUCCAL CELL RECEPTORS FOR CANDIDA ALBICANS 
4.1 Effect of blood group and secretor status on yeast 
adhesion to human buccal epithelial cells
In the present study, the effect of the buccal cell 
donor's blood group and secretor status on the adhesion 
of Ç. albicans to buccal cells in vitro was investigated. 
Initially, adhesion of C. albicans GDH 2346 to buccal 
epithelial cells from donors of two different blood 
groups, A and O, was compared (Table 47). There was no 
significant difference between adhesion to group-A and 
group-0 cells either for secretors or for non-secretors. 
However within each blood group, adhesion to cells from 
secretors was significantly lower than that to cells from 
non-secretors (P < 0.02 for group A; and P < 0.05 for 
group O), With group-0 donors, for example 751 ± 31 
yeasts (mean ± SE) adhered to 100 secretor cells as 
compared with 864 ± 41 yeasts which adhered to 100 
non-secretor cells.
4.2 Effect of saliva and antiserum on yeast adherence
4.2.1 Effect of saliva on yeast adherence
Unstimulated whole saliva was collected, boiled for 
twenty minutes, clarified by centrifugation, and then 
added to adhesion assay mixtures. Table 48 shows the 
results of an experiment where the effect of saliva on 
yeast adherence to buccal cells from a donor of blood
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Table 47 Adherence of Candida albicans GDH 2346 to
buccal epithelial cells from donors of blood 
groups A and O: effect of secretor status
Blood
group
Secretor
status
Mean no. of adherent 
yeasts/100 BECs ± SEM
pi
0 Secretor 751 ± 31
0 Non-secretor 864 ± 41 <0 .05
A Secretor 739 ± 25
A Non-secretor 813 ± 15 <0 . 02
 ^ Probability values relative to the secretor cells,
7Adherence assays were performed using 1 x 10 yeast cells
ml'l.
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Table 48 Effect of saliva on the adherence of C.
albicans GDH 2346 to buccal epithelial cells 
from a donor of blood group A (non-secretor)
Saliva
treatment
Mean no. of adherent 
yeasts/100 epithelial 
cells ± SEM
%
Adherence^
p2
None
(PBS Control)
813 ± 15 100
Non-secretor
saliva
759 ± 13 93 <0 .01
Secretor
saliva
749 ± 15 92 <0.01
 ^ Adherence relative to that of controls resuspended in 
PBS.
2
Probability values relative to the adhesion of PBS 
control.
Saliva was collected from healthy male donors (blood 
group A, F.D.T., H.S.), of known secretor status.
Results represent means of three independent 
determinations performed in triplicate.
The buccal cell donor was of blood group A, non-secretor
(F.D.T.).
196
group A, non-secretor, was examined. Saliva from both a 
secretor and non-secretor (group A) had a significant 
inhibitory effect on yeast adhesion, with adherence being 
92% and 93% (P < 0.01) relative to the control 
respectively. By contrast, Table 49 shows the results 
for a group A donor who was a secretor of blood-group 
antigens; neither saliva sample had a significant effect 
on yeast adhesion.
Group O individuals have been demonstrated to be more
susceptible to carriage of Candida (Burford-Mason et al.,
1988). Table 50 shows the effect of saliva on adherence 
of Ç. albicans GDH 2346 to buccal cells from a group O 
donor (secretor). Although secretor saliva had no 
effect, saliva from a non-secretor had a highly 
significant effect, enhancing adhesion by 22% (P <
0.001). With cells from a non-secretor, self saliva 
again had no effect but secretor saliva inhibited
adherence by 21% (Table 51; P < 0.001).
These results suggest that the Lewis-b antigen in 
secretor saliva somehow blocks adhesion to non-secretor 
cells, by binding to the yeast or epithelial cell.
However the Lewis-a antigen present in non-secretor 
saliva may enhance adhesion by acting as a bridge to link 
yeast and buccal cells. Non-secretor cells would already 
possess bound Lewis-a antigen. If this were to be 
blocked using the appropriate antiserum, yeast adhesion 
should be inhibited. This possibility was examined for
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Table 49 Effect of saliva on the adherence of C.
albicans GDH 2346 to buccal epithelial cells
from a donor of blood group A (secretor)
Saliva
treatment
Mean no. of adherent 
yeasts/100 epithelial 
cells ± SEM
%
Adherence^
p2
None
(PBS Control)
739 ± 25 100
Secretor
saliva
749 ± 27 101 NS
Non-secretor
saliva
778 ± 20 105 NS
 ^ Adherence relative to that of controls resuspended in 
PBS.
2
Probability values relative to the adhesion of PBS 
control; NS, not significant.
Saliva was collected from healthy male donors (blood 
group A, F.D.T., H.S.), of known secretor status.
Results represent means of three independent 
determinations performed in triplicate.
The buccal cell donor was of blood group A, secretor 
(H.S.).
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Table 50 Effect of saliva on the adherence of Ç.
albicans GDH 2346 to buccal epithelial cells
from a donor of blood group 0 (secretor)
Saliva
treatment
Mean no. of 
yeasts/100 
cells
adherent 
epithelial 
± SEM
%
Adherence^
p2
None
(PBS Control)
751 ± 31 100
Secretor
saliva
744 ± 30 99 NS
Non-secretor
saliva
915 ± 22 122 <0.001
 ^ Adherence relative to that of controls resuspended in 
PBS.
2
Probability values relative to the adhesion of PBS 
control; NS, not significant.
Saliva was collected from healthy male donors (blood 
group 0; F.F.C., A.E.), of known secretor status.
Results represent means of three independent 
determinations performed in triplicate.
The buccal cell donor was blood group O, secretor
(F.F.C.).
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Table 51 Effect of saliva on the adherence of Ç.
albicans GDH 2346 to buccal epithelial cells 
from a donor of blood group 0 (non-secretor)
Saliva
treatment
Mean no. of 
yeasts/100 
cells
adherent 
epithelial 
± SEM
%
Adherence^
p2
None
(PBS Control)
864 ± 41 100
Non-secretor
saliva
838 ± 26 97 NS
Secretor
saliva
685 ± 29 79 <0.001
 ^ Adherence relative to that of controls resuspended in 
PBS.
2
Probability values relative to the adhesion of PBS 
control; NS, not significant.
Saliva was collected from healthy male donors (blood 
group 0; F.F.C., A.E.).
Results represent means of three independent 
determinations performed in triplicate.
The buccal cell donor was of blood group O, non-secretor 
(A.E.).
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donors of blood groups A (Table 52) and O (Table 53), 
both secretors and non-secretors. For each blood group a 
consistent pattern of results was recorded. Pretreatment 
of non-secretor buccal cells with anti-Lewis a antiserum 
had a significant (P < 0.001) inhibitory effect on 
adhesion. By contrast none of the other pretreatments 
produced statistically significant differences.
4.2.2 Effect of monoclonal antiserum and lectin specific 
for blood group antigens on yeast adherence
In further experiments anti-A monoclonal antiserum 
and anti-H lectin (Ulex europaeus) were used to pretreat 
buccal cells prior to their use in adhesion assays.
For group A donors, there was no statistically 
significant effect with anti-A monoclonal antiserum and 
the secretor cells (Table 54). By contrast, anti-A 
monoclonal antiserum enhanced yeast adhesion to buccal 
cells of the non-secretor. Similarly for group O donors 
(Table 55) anti-H lectin enhanced yeast adhesion by 14% 
to the non-secretor, but had no significant effect with 
the secretor. These results suggest that the monoclonal 
antibodies, although specific for the A antigen, are 
probably similar to lectins (e.g. Concanavalin A) in 
being able to bind to more than one site.
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Table 52 Effect of anti-Lewis a and anti-Lewis b
antiserum on the adherence of Ç. albicans GDH 
2346 to buccal epithelial cells from donors of 
blood group A, but differing secretor status
Pretreatment 
of buccal 
cells
Mean no. of adherent 
yeasts/100 epithelial 
cells ± SEM
%
3
Adherence
p4
Non-secretor^
None
(PBS Control)
890 ± 26 100
Anti-Lewis a 675 ± 26 76 <0 .001
Anti-Lewis b 825 ± 38 92 NS
2Secretor
None
(PBS Control)
793 ± 41 100
Anti-Lewis a 816 ± 19 103 NS
Anti-Lewis b 837 ± 22 106 NS
 ^ The buccal 
secretor (F.D.
cell donor was of blood 
T. ) .
group A, non-
The buccal cell donor was of blood group A, secretor 
(H.S.)•
Adherence relative to that of yeasts pretreated with 
PBS.
 ^ Probability values relative to the adhesion of PBS 
control; NS, not significant.
Results represent means of three independent
determinations performed in triplicate.
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Table 53 Effect of anti-Lewis a and anti-Lewis b
antiserum on the adherence of C. albicans GDH 
2346 to buccal epithelial cells from donors of 
blood group 0, but differing secretor status
Pretreatment 
of buccal 
cells
Mean no. of adherent 
yeasts/100 epithelial 
cells ± SEM
%
3
Adherence
p4
Non-secretor^
None
(PBS Control)
877 ± 23 100
Anti-Lewis a 536 ± 12 61 <0.001
Anti-Lewis b 813 ± 22 93 NS
2
Secretor
None
(PBS Control)
771 ± 24 100
Anti-Lewis a 747 ± 14 97 NS
Anti-Lewis b 742 ± 17 96 NS
 ^ The buccal cell donor was of blood group 0, 
non-secretor (A.E.).
2
The buccal cell donor was of blood group O, secretor 
(E.A.),
 ^ Adherence relative to that of yeasts pretreated with 
PBS.
 ^ Probability values relative to the adhesion of PBS 
control; NS, not significant.
Results represent means of three independent
determinations performed in triplicate.
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Table 54 Effect of antiserum on the adherence of C.
albicans GDH 2346 to buccal epithelial cells 
from donors of blood group A, but differing 
secretor status
Antiserum 
pretreatment 
of buccal 
cells
Mean no. of adherent 
yeasts/100 epithelial 
cells ± SEM
%
3
Adherence
Non-secretor^
None
(PBS Control)
779 ± 41 100
Anti-A 908 ± 36 117 <0,01
2Secretor
None
(PBS Control)
732 ± 43 100
Anti-A 713 ± 53 97 NS
 ^ The buccal cell donor was of blood group A, 
non-secretor (F.D.T.).
2
The buccal cell donor was of blood group A, secretor 
(H.S.).
3 Adherence relative to that of yeasts pretreated with 
PBS.
 ^ Probability value relative to the adhesion of PBS 
control; NS, not significant.
Appropriately diluted (1:64) monoclonal anti-A was used 
to pretreat BECs for 30 min prior to incorporation in 
adherence assays.
Results represent means of three independent
determinations performed in triplicate.
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Table 55 Effect of anti-H lectin (Ulex europaeus) on the 
adherence of C. albicans GDH 2346 to buccal 
epithelial cells, from donors of blood group 0 
but differing secretor status
Lectin 
pretreatment 
of buccal 
cells
Mean no. of adherent 
yeasts/100 epithelial 
cells ± SEM
%
3
Adherence
Non-secretor^
None
(PBS Control)
851 ± 29 100
Anti-H 976 ± 49 114 <0.01
2
Secretor
None
(PBS Control)
854 ± 39 100
Anti-H 916 ± 45 107 NS
 ^ The buccal cell donor was of blood group 0, 
non-secretor (A.E.).
2
The buccal cell donor was of blood group O, secretor 
(F.F.C.).
Adherence relative to that of yeasts pretreated with 
PBS .
 ^ Probability value relative to the adhesion of PBS 
control; NS, not significant.
Appropriately diluted (1:2) lectin was used to pretreat 
BECs for 30 min prior to incorporation in adherence 
assays.
Results represent means of three independent
determinations performed in triplicate.
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4.2.3 Effect of antiserum concentration on yeast 
adherence
The effect of decreasing concentrations of anti-Lewis 
a monoclonal on yeast adhesion was investigated with 
non-secretors of two blood groups, A (Table 56) and O 
(Table 57), For each blood group, undiluted antiserum 
had the most inhibitory effect and 1:2 diluted antiserum 
had the least effect. In addition there was a 
significant difference between undiluted and 1:2 diluted 
antiserum. Thus, although undiluted anti-Lewis a 
antiserum inhibited yeast adhesion to buccal cells from a 
group O donor by 34% and adherence to a group A donor by 
33%, antiserum diluted 1:2 in PBS inhibited adhesion by 
only 28% and 21% respectively.
These data suggest that the Lewis-a receptor is not 
the major epithelial receptor, and that there is likely 
to be an alternative mechanism of Candida adhesion, 
otherwise a higher level of adhesion inhibition would 
have been achieved using undiluted antiserum,
4.2.4 Effect of washing buccal cells prior to 
pretreatment with anti-Lewis a antiserum
Blackwell (1989) proposed that the Lewis-a antigen 
bound to the buccal cell surface and thus enabled a 
bridging link to be formed when the yeast cell bound to 
the buccal cell/antigen complex. This could imply that 
successive washes would remove the antigen, and this 
possibility was examined. The results for such
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Table 56 Effect of anti-Lewis a antiserum on the
adherence of C. albicans GDH 2346 to buccal 
epithelial cells from a donor of blood group A 
(non-secretor)
Pretreatment 
of buccal 
cells
Mean no. of 
yeasts/100 
cells
adherent 
epithelial 
± SEM
%
Adherence^
p2
None
(PBS Control)
791 ± 25 100
Anti-Lewis a 
(undiluted)
527 ± 20 67 <0.001
Anti-Lewis a 
(1:1 dilution)
601 ± 23 76 <0.001
Anti-Lewis a 
(1:2 dilution)
632 ± 26 79 <0.001
 ^ Adherence relative to that of yeasts pretreated with
PBS .
2 Probability values relative to the adhesion of PBS 
control.
The buccal cell donor was of blood group A, non-secretor 
(F.D.T.).
Results represent means of three independent 
determinations performed in triplicate.
7 ~ 1Adherence assays were performed using 1x10 yeasts ml
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Table 57 Effect of anti-Lewis a antiserum on the
adherence of C. albicans GDH 2346 to buccal 
epithelial cells from a donor of blood group O 
(non-secretor)
Pretreatment 
of buccal 
cells
Mean no. of 
yeasts/100 
cells
adherent 
epithelial 
± SEM
%
Adherence^
P^
None
(PBS Control)
856 ± 12 100
Anti-Lewis a 
(undiluted)
563 ± 17 66 <0 . 001
Anti-Lewis a 
(1:1 dilution)
601 ± 20 70 <0.001
Anti-Lewis a 
(1:2 dilution)
614 ± 10 72 <0.001
1
Adherence relative to that of yeasts pretreated with 
PBS.
9
Probability values relative to the adhesion of PBS 
control.
The buccal cell donor was of blood group O, non-secretor 
(A.E.).
Results represent means of three independent 
determinations performed in triplicate.
7 — 1Adherence assays were performed using 1x10 yeasts ml
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experiments are shown for non-secretors in Tables 58 
(group O) and 59 (group A). The results suggest that the 
first wash removed some Lewis-a binding sites from the 
buccal cell surface. As it is known that the Lewis 
antigen is to be found in the saliva of secretors 
(Lewis-b) and non-secretors (Lewis-a), unwashed cells 
would not have any superficial, non-specifically bound 
saliva removed. Thus in this instance with Lewis-a 
bound, adherence to unwashed cells would be higher than 
may have been expected.
Throughout this study, the data presented on 
adherence and blood grouping relate only to Ç. albicans 
GDH 2346. However a different strain, C. albicans GDH 
2023, is known to have a significantly different 
mechanism of binding to epithelial cells (Critchley and 
Douglas, 1987b). In the following experiments anti-Lewis 
antiserum was used to pretreat group A and group 0 
non-secretor buccal cells. By comparing the results for 
a group O non-secretor (Table 60) and a group A 
non-secretor (Table 61) it can be seen that the pattern 
of results was similar to that presented for Ç. albicans 
GDH 2346, in that although anti-Lewis b had no effect on 
yeast adherence, anti-Lewis a antiserum significantly 
inhibited adherence (P < 0.001).
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Table 58 The effect of washing buccal cells prior to
their pretreatment with anti-Lewis a antiserum: 
adherence of C. albicans GDH 2346 to buccal 
cells from a donor of blood group O (non- 
secretor)
Pretreatment 
of buccal 
cells
Mean no. of 
yeasts/100 
cells
adherent 
epithelial 
± SEM
%
2Adherence
p3
None - 
(PBS Control)
8 64 ± 20 100
Anti-Lewis a 
(0 wash)
500 ± 25 57 <0.001
Anti-Lewis a 
(1 wash)
649 ± 22 75 <0.001
Anti-Lewis a 
(2 wash)
628 ± 26 73 <0.001
 ^ Buccal cells received 2 washes but were pretreated
with PBS only.
2 Adherence relative to that of yeasts pretreated with 
PBS.
 ^ Probability values relative to the adhesion of PBS 
control.
Buccal cell donor was a non-secretor of blood group 
antigens (A.E.).
Results represent means of three independent 
determinations performed in triplicate.
Adherence assays were performed using 1x10^ yeasts ml ^
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Table 59 The effect of washing buccal cells prior to
their pretreatment with anti-Lewis a antiserum:
adherence of Ç. albicans GDH 2346 to buccal
cells from a donor of blood group A (non-
secretor)
Pretreatment 
of buccal 
cells
Mean no. of 
yeasts/100 
cells
adherent 
epithelial 
± SEM
%
2
Adherence
p3
None . 
(PBS Control)
745 ± 22 100
Anti-Lewis a 
(0 wash)
465 ± 14 62 <0.001
Anti-Lewis a 
(1 wash)
567 ± 18 76 <0.001
Anti-Lewis a 
(2 washes)
607 ± 8 81 <0.001
 ^ Buccal cells received 2 washes but were pretreated 
with PBS only.
2 Adherence relative to that of yeasts pretreated with 
PBS.
Q
Probability relative to that of yeasts pretreated with 
PBS.
Buccal cell donor was of blood group A, non-secretor 
(F.D.T.).
Results represent means of three independent 
determinations performed in triplicate.
7 — 1Adherence assays were performed using 1x10 yeasts ml
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Table 60 Effect of anti-Lewis antiserum on the adherence 
of C. albicans GDH 2023 to buccal epithelial 
cells from a donor of blood group O (non- 
secretor )
Pretreatment 
of buccal 
cells
Mean no. of 
yeasts/100 
cells
adherent 
epithelial 
± SEM 1Adherence
None
(PBS Control)
1239 ± 16 100
Anti-Lewis a 949 ± 32 77 <0.001
Anti-Lewis b 1212 ± 18 9 8 NS
 ^ Adherence relative to that of yeasts pretreated with
PBS.
2 Probability value relative to the adhesion of PBS 
control; NS, not significant.
The buccal cell donor was of blood group O, non-secretor 
(A.E.).
Antiserum was diluted in sterile PBS (1:2 dilution) prior 
to use in pretreating buccal cells.
Results represent means of three independent 
determinations performed in triplicate.
7 — 1Adherence assays were performed using 1x10 yeasts ml
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Table 61 Effect of anti-Lewis antiserum on the adherence 
of Ç. albicans GDH 2023 to buccal epithelial 
cells from a donor of blood group A (non- 
secretor )
Pretreatment 
of buccal 
cells
Mean no. of adherent 
yeasts/100 epithelial 
cells ± SEM 1Adherence
None 1133 ± 20 100
(PBS Control)
Anti-Lewis a 870 ± 35 77 <0.001
Anti-Lewis b 1154 ± 13 102 NS
 ^ Adherence relative to that of yeasts pretreated with
PBS.
2
Probability value relative to the adhesion of PBS 
control; NS, not significant.
The buccal cell donor was of blood group A, non-secretor 
(F.D.T.).
Antiserum was diluted in sterile PBS (1:2 dilution) prior 
to use in pretreating buccal cells.
Results represent means of three independent 
determinations performed in triplicate.
7 —1Adherence assays were performed using 1x10 yeasts ml
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4.3 Effect of sugars on yeast adhesion to buccal
epithelial cells
4.3.1 Effect of sugars on the adhesion of Ç. albicans 
GDH 2346 to buccal epithelial cells
Sugar inhibition tests, as have already been
described in Section 2.2.2, are widely used in work on
Candida adhesion mechanisms (Douglas, 1987). The effects
of different sugars on yeast adhesion to buccal cells
from donors of two different blood groups, were examined.
Table 62 shows that for a donor of blood group A (non-
_ 1
secretor), L-fucose (25 mg ml ) and N-acetyl-D- 
glucosamine gave similar degrees of inhibition (23% and 
22% repectively) but that D-galactose was less effective 
(15% inhibition).
These results were comparable with those obtained 
both for a female donor of blood group A, non-secretor 
(Table 63: 26%, 20% and 13% for L-fucose, N-acetyl-D- 
glucosamine and D-galactose respectively), and those 
results for a donor of blood group A but a secretor of 
blood group antigens (Table 64: 26% inhibition with 
L-fucose and 24% inhibition with N-acetyl-D- 
glucosamine).
By contrast, for all three donors, a mixture of two 
or more of these sugars gave significantly better 
inhibition than single sugars. However, as previously 
shown in Section 2.2.2 (Table 17), this was not a 
cumulative effect. Although only tested once, a mixture
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Table 62 Effect of different sugars on the adherence of 
C. albicans GDH 2346 to buccal epithelial cells 
from a male donor of blood group A 
(non-secretor)
Sugar Mean no. of adherent 
present in yeasts/100 epithelial 
mixture cells ± SEM
%
Adherence^
p2
None
(PBS Control)
524 ± 16 100
L-fucose  ^
(50 mg ml )
311 ± 17 59 <0.001
L-fucose - 
(25 mg ml )
402 ± 16 77 <0.001
D-galactose , 
(25 mg ml )
444 ± 18 85 <0.001
N-acetyl-D-glucos- 
amine .
(25 mg ml )
410 ± 20 78 <0.001
L-fucose:D-galactose: 
N-acetyl-D-glucos­
amine; 2 :1:1_^
(25 mg ml )
211 ± 13 40 <0.001
 ^Adherence relative to that of yeasts suspended in PBS.
2
Probability values relative to the adhesion of PBS
control.
Results represent means of three independent 
determinations performed in triplicate.
7 — 1Adherence assays were performed using 1x10 yeasts ml
The buccal cell donor was male, blood group A,
non-secretor (F.D.T.).
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Table 63 Effect of different sugars on the adherence of 
Ç. albicans GDH 2346 to buccal epithelial cells 
from a female donor of blood group A (non- 
secretor)
Sugar 
present in 
mixture
Mean no. of adherent 
yeasts/100 epithelial 
cells ± SEM
%
Adherence^
p2
None
(PBS Control)
709 ± 41 100
L-fucose 527 ± 30 74 <0 . 001
N-acetyl-D-
glucosamine
572 ± 37 80 <0.02
L-fucose:N-acetyl- 
D-glucosamine; 1:1
433 ± 32 61 <0.001
D-galactose 622 ± 34 87 NS
 ^ Adherence relative to that of yeasts suspended in
PBS.
o
Probability values relative to the adhesion of PBS 
control: NS, not significant.
All the sugars used were incorporated in the assay 
mixtures at a concentration of 25 mg ml ^.
Results represent means of three independent 
determinations performed in triplicate.
7 ~1Adherence assays were performed using 1x10 yeasts ml
The buccal cell donor was female, blood group A,
non-secretor (N.R.).
216
Table 64 Effect of different sugars on the adherence of 
Ç, albicans GDH 2346 to buccal epithelial cells 
from a male donor of blood group A (secretor)
Sugar 
present in 
mixture
Mean no. of adherent 
yeasts/100 epithelial 
cells ± SEM
%
1
Adherence
p2
None
(PBS Control)
786 ± 23 100
L-fucose 583 ± 36 74 <0.001
N-acetyl-D-
glucosamine
596 ± 41 76 <0.001
L-fucose:N-acetyl- 
D-glucosamine; 1:1
521 ± 24 6 6 <0 .001
 ^ Adherence relative to that of yeasts suspended in
PBS.
2 Probability values relative to the adhesion of PBS 
control.
All the sugars used were incorporated in the assay 
mixtures at a concentration of 25 mg ml ^.
Results represent means of three independent 
determinations performed in triplicate.
V ~ 1Adherence assays were performed using 1x10 yeasts ml
The buccal cell donor was male, blood group A, secretor
(H.S.).
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of all three sugars, L-fucose:D-galactose:N-acetyl~D~ 
glucosamine (2:1:1), chosen to mimic the relative ratios 
of the sugars present in the Lewis-b antigen and found in 
the saliva of secretors, produced a percentage inhibition 
of 60% relative to the control. This exceeded the figure 
obtained with 50 mg ml~^ of L-fucose alone and was the 
highest sugar inhibition reported from this laboratory to 
date.
In a final series of experiments with group A donors, 
the immunodominant sugar, N-acetyl-D-galactosamine, was 
used. The results (Table 65) showed that this was the 
most inhibitory single sugar allowing only 58-59% 
adhesion. This inhibition was also greater than the 
L-fucose/N-acetyl-D-glucosamine mixture, but not greater 
than the complete mixture of all three sugars. Such 
results might be expected if the blood group A antigen, 
in which N-acetyl-D-galactosamine is the immunodominant 
sugar, could act as an epithelial receptor for Ç. 
albicans.
4.3.2 Effect of different sugars on the adherence of Ç. 
albicans to buccal epithelial cells from donors 
of blood group O
The effect of donor blood group on sugar inhibition 
tests with Ç. albicans GDH 2346 was investigated using a 
donor of blood group O who was a secretor. From Table 66 
it can be seen that whilst N-acetyl-D-glucosamine 
produced no significant effect, L-fucose and D-galactose
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Table 65 Effect of N-acetyl-D-galactosamine on the
adherence of C, albicans GDH 2346 to buccal 
epithelial cells from donors of blood group A, 
but differing secretor status.
Sugar 
present in 
mixture
Mean no. of adherent 
yeasts/100 epithelial 
cells ± SEM
%
3
Adherence
p"
Non-secretor^
None
(PBS Control)
764 ± 30 100
N-acetyl-D-
galactosamine
452 ± 23 59 <0.001
2Secretor
None
(PBS Control)
686 ± 24 100
N-acetyl-D-
galactosamine
400 ± 25 58 <0.001
 ^ The buccal cell donor was of blood group A, non- 
secretor (F.D.T.),
2
The buccal cell donor was of blood group A, secretor 
(H.S.).
3 Adherence relative to that of yeasts suspended in 
PBS.
 ^ Probability values relative to the adhesion of PBS 
control.
The sugar used was incorporated in the assay mixtures at 
a concentration of 25 mg ml ^.
Results represent means of three independent 
determinations performed in triplicate.
7 — 1Adherence assays were performed using 1x10 yeasts ml
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Table 66 Effect of different sugars on the adherence of 
Ç. albicans GDH 2346 to buccal epithelial cells
from a donor of blood group 0
Sugar 
present in 
mixture
Mean no. of adherent 
yeasts/100 epithelial 
cells ± SEM
%
Adherence^
p2
None
(PBS Control)
786 ± 42 100
L-fucose 596 ± 28 76 <0.001
N-acetyl-D-
glucosamine
751 ± 35 96 NS
D-galactose 488 ± 47 62 <0 . 001
 ^ Adherence relative to that of yeasts suspended in
PBS.
2 Probability values relative to the adhesion of PBS 
control; NS, not significant.
All the sugars used were incorporated in the assay 
mixtures at a concentration of 25 mg ml ^.
Results represent means of three independent 
determinations performed in triplicate.
Y  ^
Adherence assays were performed using 1x10 yeasts ml
The buccal cell donor was of blood group O, secretor
(F.F.C.).
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showed a highly significant ability to inhibit adherence, 
by 24% and 38% respectively. By contrast, all three 
sugars investigated were able significantly to inhibit 
the adherence of C. albicans GDH 2023 (Table 67) by 20% 
(L-fucose), 28% N-acetyl-D-glucosamine and 31%
(D-galactose).
5 CELL SURFACE HYDROPHOBICITY OF CANDIDA ALBICANS
GDH 2346
The cell surface hydrophobicity of Ç. albicans GDH 
2346 was investigated using the method described by Sweet
A o
et al. ( 1987 ). Table 68 shows that there was/_signifleant 
change in cell surface hydrophobicity when cells were 
grown on different carbon sources, relative to control 
cells grown in yeast nitrogen but containing 50 mM 
glucose. This was consistent with several other studies 
performed in this laboratory, and considered supportive 
evidence that the adhesion of Ç. albicans is a specific 
effect.
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Table 67 Effect of different sugars on the adherence of 
Ç. albicans GDH 2023 to buccal epithelial cells 
from a donor of blood group 0
Sugar 
present in 
mixture
Mean no. of adherent 
yeasts/100 epithelial 
cells ± SEM
%
Adherence^
p2
None
(PBS Control)
895 ± 43 100
L-fucose 719 ± 43 80 <0.001
N-acetyl-D-
glucosamine
644 ± 31 72 <0.001
D-galactose 617 ± 59 69 <0.001
 ^ Adherence relative to that of yeasts suspended in
PBS.
2
Probability values relative to the adhesion of PBS 
control.
All the sugars used were incorporated in the assay 
mixtures at a concentration of 25 mg ml ^.
Results represent means of three independent 
determinations performed in triplicate.
7Adherence assays were performed using 1 x 10 yeasts 
m l ~ ^ .
The buccal cell donor was of blood group O, secretor
(F.F.C.).
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Table 68 Hydrophobicity of Ç. albicans GDH 2346, grown 
on different carbon sources
Growth in 
yeast nitrogen 
base containing
Percentage 
drop in . 
&600 (iSEM)
p2
Glucose, 5 0 mM 0 . 0 -
Glucose, 5 00 mM 1 . 3 ± 0.9 NS
Sucrose, 500 mM 2 . 6 ± 1.8 NS
Galactose, 5 00 mM 4.2 ± 2.9 NS
 ^ Values are means of three independent determinations 
performed in triplicate.
2
Probability values relative to the 50 mM glucose-grown 
control; NS, not significant.
D I S C U S S I O N
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1 ADHERENCE OF CANDIDA TO BUCCAL EPITHELIAL CELLS
1.1 Measurement of adherence
A variety of methods have been described for 
determining the number of yeasts adhering to buccal 
epithelial cells. These fall into three distinct 
categories: light microscopy, where a visual count is 
employed; radiolabelling; and a Coulter count method. Of 
these, the visual count is the one most frequently 
adopted, and indeed this technique was used exclusively 
throughout this study. A quantitative visual 
determination of Candida adhesion in vivo was first 
reported by Liljemark and Gibbons (1973) who measured the 
adherence of C. albicans to buccal cells from rats. This 
method was subsequently modified by Kimura and Pearsall 
(1978) and again by Douglas et (1981). Briefly the
procedure involves mixing standardized epithelial and 
yeast cell suspensions at 37°C, filtering the mixtures 
and counting stained, adherent yeasts on the filters by 
light microscopy. In the present study, yeasts were 
grown to stationary phase prior to their incorporation in 
the assay.
To prevent any counting bias, filters were coded and 
read 'blind'. For every sample that was filtered and 
fixed, 100 epithelial cells were counted. Although the 
method is tedious, adhesion to individual cells can be 
monitored if necessary, as can yeast-to-yeast adherence.
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In most assays described in this study Ç. albicans 
was grown in yeast nitrogen base containing 500 mM 
galactose. This high concentration of carbohydrate has 
been shown (Douglas et aj^ . , 1981) to make individual 
yeasts more adhesive. Because of the high sugar 
concentration it would not be feasible to grow yeasts on 
labelled galactose and then use a radiometric assay, like 
that described by King et al. (1980) where [^^C] glucose 
was the carbon source.
Most adherence assays in this investigation were
7 — 1performed with 1 x 10 yeast cells ml . This was used
in preference to the yeast concentration of 1 x 10 cells
ml  ^ employed by Douglas ^  ad. (1981) since adherence
values with the latter concentration were very high and
n
counting was difficult. A concentration of 1 x 10 yeast 
cells ml  ^was considered here to be more reliable and 
also more convenient.
In the initial studies (Results, 1) buccal epithelial 
cells (1 X  10^ ml ^) were obtained from a single donor 
who was a healthy adult male (blood group A, non-secretor 
of blood group antigens); the donor's cells showed no 
obvious or visible daily changes. Cells were collected 
at the same time of day, generally between 8.30 am and 
10.30 am. Buccal cells were sampled where possible on 
Thursday, Friday and then on the following Monday, 
allowing the buccal mucosa time for some regeneration 
over the weekend. The buccal cells investigated here
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were exfoliated, and collected by gentle swabbing of the 
inside of the cheek. Variation in adherence occurs with 
different donors and this will be discussed in detail 
later. This variation is widely documented (King et ad., 
1980; Kearns et ad., 1983). When light microscopy is 
used to measure adhesion, the distribution of yeasts over 
the buccal cell surface can be seen. Certain epithelial 
cells have higher numbers of yeasts attached to them than 
others. This presumably arises because some cells have 
more yeast receptors than others.
Initially, adherence of Ç. albicans to buccal cells 
was measured following periods of incubation ranging from 
15 to 90 min. This was to determine the most suitable 
duration for the assay. The results indicated that there 
was no detectable increase in adhesion after 45 min. of 
incubation, and so this incubation period was used 
throughout the study.
1.2 Adherence of different Candida species
The adherence of Candida isolates obtained from 
outpatients at a clinic at the Royal Dental College, 
Copenhagen was investigated using the standard assay. 
Initially all the isolates were thought to be C. 
albicans, and as part of the routine experimental 
procedure, were tested for germ-tube formation in 
foetal-calf serum, and for growth on glucose, sucrose and 
galactose. As a result of these tests four of the ten
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isolates were found to be species of Candida other than 
C. albicans. Two were identified as C. lusitaniae whilst 
the other two were found to be Ç, glabrata and C. 
parapsilosis. Four strains were described as being from 
one patient. This is contrary to the common finding 
(Odds, 1988) that only one strain can be isolated from a 
single host, in this case the mouth of a leukoplakia 
sufferer. Since any organisms on the mucosal surface may 
circulate in the oral milieu it seems unlikely that some 
strains originate solely from the normal mucosa, and 
others from nodular mucosa. It would seem more likely 
that there is a higher concentration at the infected site 
but that organisms circulate freely in the oral cavity, 
unless very rigidly bound.
The results of the assays were generally similar to 
those of Douglas et (1981), McCourtie and Douglas
(1984), and Critchley and Douglas (1985) which indicated 
that strains from active infection show enhanced 
adherence after growth in a medium with a high galactose 
content. However, strain 906 showed enhanced adhesion 
and was from normal mucosa. Strains 905 and 911 may have 
originated from leukoplakia infections but were isolated 
from normal mucosa.
Kearns et al. (1983) did not observe any differences 
in adherence between yeasts isolated from active 
infections and yeasts isolated from asymptomatic 
carriers. This is in direct contrast to the results of
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Douglas et al. (1981) and Critchley and Douglas (1985),
where various isolates adhered similarly after growth in 
glucose but differences were revealed following growth on 
500 mM galactose. In the latter studies, strains from 
carriers showed much smaller increases in adherence after 
growth in a high galactose medium. These differences 
between the two laboratories may have resulted from the 
use of malt agar or Lee's medium by Kearns et al. (1983). 
Whilst infective strains grown in Lee’s medium did adhere 
to buccal cells, such strains grown in the high sugar 
medium synthesized more adhesins and thus bound in higher 
numbers.
Since precise details of the site of isolation of the 
leukoplakia strains are not available, and it is not 
known whether some of the patients ever developed 
Candida-associated infections, only limited conclusions 
may be drawn from the present study. With C. albicans 
GDH 2346, yeasts grown in a medium containing 500 mM 
galactose were over 9 times more adherent to buccal cells 
than 50 mM glucose-grown organisms. Under the same 
conditions C. albicans RDC 902, 904, 905, 910 and 911 all 
showed significant increases in relative adhesion. All of 
these isolates were from patients that had oral 
infections. The results therefore support those of 
McCourtie and Douglas (1984) who concluded that there is 
a relationship between the ability of different Candida 
albicans strains to adhere to epithelial cells, their
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capacity for cell-surface modification, and their 
virulence.
The results also indicate that Ç, lusitaniae has 
only a limited capacity to modify its cell surface and is 
thus less likely to be a major causal agent of Candida 
infections.
2 EXTRACELLULAR POLYMERIC MATERIAL (EPM) AND ITS EFFECT
ON YEAST ADHESION
McCourtie and Douglas (1981) have shown that growth 
of Ç. albicans in high concentrations of galactose 
results in the production of an additional layer of 
fibrils on the cell surface. These adhesion enhancing 
fibrils are sloughed off into the surrounding medium 
during prolonged incubation of the yeast at 37°C. In the 
present study, cultures of C. albicans were grown for 5 d 
at 37“C to generate yields of EPM of approximately 15%; 
this figure is roughly in line with yields obtained by 
McCourtie and Douglas (1985) and Critchley and Douglas 
(1987a). Fibrils have also been described by Gardiner ^  
al. ( 1982), while Pugh and Cawson ( 1978) noted a mucus 
layer on the Candida cell surface. Biochemical analysis 
of EPM isolated from culture supernatates indicated that 
the carbohydrate : protein ratio ranged from 10.7:1 in Ç. 
albicans MRL 3153 to 6.9:1 with Ç. albicans GDH 2 023. 
These results confirm previous data from this laboratory. 
McCourtie and Douglas (1985) found that EPM contained a
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large quantity of mannose and they suggested that it 
consisted mainly of mannoprotein.
A variety of techniques have been employed in the 
isolation of EPM. McCourtie and Douglas (1985) described 
EPM that was isolated by precipitation of culture 
supernatants with acetone. The method described by 
Critchley and Douglas (1987a) involved the extensive 
dialysis of culture supernates to remove low 
molecular-weight components; the retentate was 
freeze-dried. The latter method was preferred as there 
was no possibility of dénaturation or aggregation that 
could have occurred during acetone precipitation. In the 
present study the procedure was modified to include an 
ultrafiltration step. This ultrafiltration speeded up 
the EPM production process by several days. EPM prepared 
in this way was found to be as effective in inhibiting 
adherence of Ç. albicans GDH 2346 to buccal cells as were 
the methods described above.
Previous attempts in this laboratory to resolve EPM 
by SDS-polyacrylamide gel electrophoresis have always 
proved unsuccessful (Critchley, 1986). No bands were 
detected when gels were stained with Coomassie blue R250 
or silver stain. This was considered to be caused by the 
low (5 mg ml” ;^ 25 pi) levels of glycoprotein applied to 
the gel, probably beyond detectable limits. However 
silver staining is normally useful down to nanogram 
level. In the present study SDS gels were run using EPM
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from several C. albicans strains and several distinctive 
bands were visualized using both silver stain and 
Coomassie blue R250. Samples of EPM, prepared several 
years prior to the gel experiments described here, were 
applied to the gel and found to run identically with 
freshly prepared EPM; indeed this was a suitable means of 
verifying the similar nature of EPM samples prepared in 
this laboratory. One possible explanation for this 
inconsistency may be that previous workers did not use a 
high enough concentration of acrylamide in the separating 
gel; alternatively, the fixing protocol may have been in 
some way flawed and the protein bands lost during the 
washing phase of the experiment.
The results of affinity chromatography indicated that 
EPM protein possesses the ability to interact with 
immobilized sugars. These preliminary experiments were 
done to investigate whether EPM from C. albicans had any 
'lectin-like' binding properties. Fractions with sugar- 
binding specificities were isolated by applying crude EPM 
preparations to Sepharose affinity columns containing a 
coupled sugar. The sugars coupled to the Sepharose gels 
were chosen because they are known to be present on the 
surface of host cells. Possibly the protein component of 
EPM binds in a 'lectin-like' way to glycoside receptors 
on the host cell surface. EPM from strains GDH 2346 and 
GRI 681 had similar sugar specificities and bound to 
L-fucose, D-mannose and N-acetyl-D-glucosamine at
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decreasing levels of magnitude. EPM from Ç. albicans GDH 
2023 showed a different order of sugar specificities and 
bound in preference to D-mannose and in approximately 
equal quantities to N-acetyl-D-glucosamine and L-fucose. 
The results described here are in broad agreement with 
those presented by Critchley and Douglas (1987a). Indeed 
these results further confirmed that the EPM samples used 
in these and previous experiments were similar.
Further experiments were conducted using bound 
protein fractions as inhibitors of adhesion against the 
homologous yeast strain. The use of adherence inhibition 
indices represents an attempt to relate adhesion 
inhibition to the protein content of each fraction and 
hence determine its relative efficiency at inhibiting 
adhesion. Results were compared with those of Critchley 
(1986) and, for both C. albicans GDH 2346 and GDH 2023, 
there were marked differences between the two studies.
The entire protocol was repeated to ensure 
reproducibility; as the results were consistent (Tables 
14 and 15) it was concluded that the differences must be 
due to the buccal cell donor. All other criteria had 
been standardized, namely the EPM, the sugar binding 
capacity of the EPM, and the adherence assay.
Evidence suggesting that epithelial cell-surface 
sugars function as attachment sites for some bacteria has 
come from experiments in which adherence was inhibited 
with monosaccharides, lectins, sugar oxidants and
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glycosides. In the present study, sugars which may 
function as epithelial cell receptors were utilized to 
inhibit adherence to see if there was consistency with 
the results provided by the lectin-inhibition assays.
The results provided in Tables 16 and 17 indicate that 
for Ç. albicans GDH 2346, L-fucose- and N-acetyl-D- 
glucosamine-containing receptors on the epithelial cell 
surface play a major role in adherence, whereas for C. 
albicans GDH 2023, D-mannose-containing receptors appear 
to be predominant.
This first observation, with respect to Ç. albicans 
GDH 2346 has some similarities to previously published 
data. L-fucose has not been detected on the surface of 
Ç. albicans and this eliminates the possibility of it 
acting as an adhesion analogue. Jones and Freter (1976) 
reported that L-fucose and other fucosides, may act as 
receptors for Vibrio cholerae in isolated brush-border 
membranes. Cinco et al. (1984) used L-fucose to inhibit 
adherence of Campylobacter species to epithelial cells.
It is interesting to note that in these latter 
experiments, inhibition was enhanced by increasing sugar 
concentration in the assay up to 50 mg ml ^. After this 
no further inhibition was seen, and this would suggest 
that another receptor may have been operating in 
conjunction with L-fucose.
With regard to the present study, and previously 
discussed results (Critchley, 1986) there were
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inconsistencies. The possibility of experimental error 
was considered small; the most obvious difference was 
between buccal cell preparations. Blood-group and 
secretor status of the donors were considered the most 
likely areas of difference as previous data (Critchley, 
1986) had been generated with a donor of blood group B, 
who was a secretor of blood group antigens. Effects 
caused by using buccal cells from donors of different 
blood group and secretor status will be discussed later. 
At this stage in the investigation the results indicated 
firstly that different individuals with different buccal 
cells generate different lectin-inhibition assay results, 
and secondly that different buccal cells give different 
results in sugar inhibition tests.
The effect of Ç. albicans lectin-like proteins on the 
adhesion of heterologous strains was investigated. The 
specificity of yeast adhesion has been demonstrated 
(Critchley and Douglas, 1987b) in that although EPM from 
Ç. albicans GDH 2346 inhibits adhesion of C. albicans GDH 
2023, the reverse is not true. Here partially purified 
fractions from C. albicans GDH 2023, like the crude EPM, 
had no significant effect on the adhesion of C. albicans 
GDH 2346. By contrast, the L-fucose- and N-acetyl-D- 
glucosamine-specific lectins isolated from C, albicans 
GDH 2346 inhibited adhesion of Ç. albicans GDH 2023, 
whereas the D-mannose-specific lectin had no effect. 
Although these results appear to support the conclusion
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that C. albicans GDH 2346 does have some predilection for 
L-fucose and N-acetyl-D-glucosamine residues found on the 
epithelial cell surface, a more detailed investigation of 
buccal cell donors was obviously required.
3 PURIFICATION OF THE YEAST ADHESIN
3.1 Chemical nature of the yeast adhesin
Ç. albicans has been reported to adhere in comparable 
numbers to different epithelial cell types (Botta, 1981); 
however it is not necessarily true that the binding 
mechanism is the same between C. albicans and all 
epithelial cells. In the present study, an attempt was 
made to define the binding mechanism(s) of C. albicans to 
buccal epithelial cells to which much of the literature 
relates.
Investigations carried out by other workers have 
focused on the use of blocking agents, enzymes or 
antibiotics, as this approach has been widely used in 
studying bacterial adhesion. To date, most experimental 
evidence supports a role for yeast mannoprotein in the 
attachment of yeasts to buccal cells. Surface mannan is 
important in mediating adherence of C. albicans to 
fibrin-platelet clots formed in vitro (Maisch and 
Calderone, 1981). Ray et (1984) concluded that cell
wall mannan participated in the adhesion complex, yet 
found only minor inhibition of adherence using mannan.
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This inconsistency may have been due to the fact that the 
mannan used was derived from Saccharomyces cerevisiae and
not from C. albicans. As is demonstrated here, EPM 
mannoprotein from C. albicans inhibits yeast adhesion to 
buccal cells.
The adhesin mediating attachment of C. albicans is a 
component of the EPM produced by the yeast after growth 
in a medium containing high concentrations of certain 
sugars, most notably galactose (McCourtie and Douglas, 
1985a). Several investigators have shown that yeast 
adhesins may be released into the culture medium 
(McCourtie and Douglas, 1985; Tronchin et a%., 1984; 
Diamond et , 1980). Sentendreu and Northcote (1968) 
demonstrated that exposure to dilute alkali causes 
^-elimination of manno-oligosaccharides attached to 
serine and threonine residues in yeast mannoproteins. In
this study EPM preparations were subjected to varying 
degrees of alkaline hydrolysis. The results indicated 
that the most suitable concentration of mild alkali was 
0.1 M NaOH. This finding ensured that in subsequent 
experiments deglycosylation of the EPM via ^-elimination 
was performed with maximum efficacy, without hydrolysing 
the protein portion of the mannoprotein.
Evidence for the importance of protein in the yeast 
adhesin was derived from experiments examining the effect 
of EPM samples treated with papain, on the adherence of 
Ç. albicans to buccal cells. Critchley and Douglas
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(1987a) showed that trypsin, chymotrypsin and pronase all 
reduced the ability of EPM to inhibit adherence. This 
suggested that these enzyme treatments degrade the 
adhesin or interfere with the stereochemistry of the 
interaction with buccal cells thus destroying the 
blocking effect of EPM on adhesion. Incubation of EPM 
with papain, on the other hand, enhanced its ability to 
inhibit adhesion of Ç. albicans to buccal cells, while a 
combination of papain followed by mild alkali resulted in 
notably increased inhibition. Here, the effect of 
papain/mild alkali was reproducible for two donors of the 
same blood group, but different secretor status. The 
importance of secretor status, with respect to yeast 
adhesion will be discussed fully in the next section. 
However the papain/mild alkali effect was not confined to 
Ç. albicans GDH 2346 but was also obtained with strain 
GDH 2023; this would imply that for two very different Ç, 
albicans strains, the method of attachment is via a 
proteinaceous adhesin. It was suggested that papain/mild 
alkali treatment releases peptide fragments capable of 
binding to epithelial cell receptors more efficiently 
than untreated EPM (Critchley and Douglas, 1987a). Such 
fragments may be related to the small mannoprotein 
reported by Lee and King (1983) to be released by 
treating C. albicans with papain. This mannoprotein 
inhibited yeast adhesin to vaginal epithelial cells.
Small glycopeptides are not unknown. Diedrich et al.
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(1984) showed that low molecular weight glycoprotein 
could be isolated from the culture medium of C. albicans ; 
indeed, Diamond et al. (1980) isolated peptides from Ç. 
albicans hyphae which had been subjected to ultra violet 
light and found that they impaired neutrophil function.
As will become evident, this part of the study 
related to development of a protocol for the purification 
of the yeast adhesin. Thus it was essential to ensure 
the specificity of the enzymic and chemical treatments to 
which EPM was subjected prior to its use in the adhesion 
assay; to this end a series of control experiments was 
performed. In every case, increased inhibition by 
papain/mild alkali-treated EPM was attributable to the 
degradation of EPM and not to other components of the 
incubation mixture, for example the macroglobulin 
which inhibited papain acivity.
3.2 Purification of the yeast adhesin by affinity
adsorption
Experiments carried out in this study (Results 2) 
indicated that it was possible to purify lectin-like 
adhesins from the crude EPM of Ç. albicans using affinity 
chromatography. Single sugars were immobilized on 
epoxy-activated Sepharose beads; these beads were packed 
into a column and crude EPM solution was passed over the 
beads. Purified bound material was then used in 
adherence assays. With the Synsorb adsorbents (which are
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expensive), only small quantities of material were 
available and a column technique was impracticable. To 
test the efficacy of a batch, or tumble method of 
affinity adsorption, EPM was incubated with epoxy­
activated Sepharose linked to immobilized sugars. Bound 
EPM was eluted using the appropriate sugar and the 
results indicated that the tumble technique produced data 
of a similar pattern to those from column 
chromatography.
Synsorb affinity adsorbents have blood group 
oligosaccharides bound to an inert silica matrix and have 
been used to purify highly specific lectins and antisera. 
These Synsorb matrices were therefore used to purify the 
protein from crude EPM solutions derived from three 
strains of Ç. albicans, namely GDH 2346, GDH 2023 and GRI 
681. The relative binding specificities of the crude EPM 
solutions showed no obvious pattern between strains, 
although the EPM from C. albicans GDH 2023 and GRI 681 
did show some predilection for the H-2 and Lewis-b 
matrices, respectively. The four oligosaccharides 
employed were all thought to be of relevance in the 
adhesion of C. albicans to buccal cells. Lewis-a and 
Lewis-b antigens are found in the saliva of non-secretors 
and secretors, respectively, of blood group antigens.
Thus these antigens are to be found in the in vivo 
adhesion milieu. H-1 and H-2 antigens are precursors of 
the A and B antigens of the ABO blood group system. They
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have structures similar to those of the Lewis-a and 
Lewis-b antigens (Figure 4). All these antigens are 
fucose-containing oligosaccharides; L-fucose has been 
implicated as a receptor for Ç. albicans GDH 2346 
(Critchley and Douglas, 1987b).
3.2.1 Efficiency of partially purified adhesin from Ç.
albicans GDH 2346 and GDH 2023 to inhibit adhesion 
of the homologous yeast strain
Adhesion inhibition tests were used to monitor 
purification of EPM components which could be used to 
block yeast adhesion to buccal epithelial cells.
Purified material from the Synsorb H-2 matrix inhibited 
yeast adhesion to buccal cells 62 times more efficiently 
(on a protein weight basis) than did crude EPM. It was 
unclear whether more than one type of adhesin was present 
in this fraction. Experiments described by Critchley and 
Douglas (1987b) indicate that Ç. albicans GDH 2346 does 
possess more than one adhesin for buccal cells.
Adhesion inhibition tests were also used to monitor 
the purification of the yeast adhesin from Ç, albicans 
GDH 2023. As the main emphasis of this study was to 
purify the adhesin from strain GDH 2346, only two 
purified fractions were tested. Affinity binding to the 
H-2 matrix appeared to purify the adhesin from Ç, 
albicans GDH 2023 more than 50-fold.
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3.2.2 Efficiency of partially purified adhesin from Ç.
albicans GDH 2346 and GDH 2023 to inhibit adhesion 
of the heterologous yeast strain
Strain-related differences in adherence of C. 
albicans have been reported throughout this study; with 
this in mind, the effect of purified EPM protein from Ç. 
albicans on the adhesion of a heterologous yeast was 
investigated. Ç. albicans GDH 2023 has been reported to 
show a different pattern of response to EPM preparations 
from various other Ç. albicans strains. Adhesion of Ç. 
albicans GDH 2023 is substantially inhibited only by the 
homologous EPM and to a lesser extent, by that of strain 
GDH 2346 (Critchley and Douglas, 1987b). Moreover, crude 
EPM from this yeast failed to give significant inhibition 
of adhesion with any other C. albicans strain tested.
This is consistent with the results shown in Tables 18 
and 19 and would point to a different adhesion mechanism 
for this strain. Consequently the results of experiments 
described here (Table 36) in which purified EPM protein 
from C. albicans GDH 2023 was able to partially inhibit 
the adhesion of Ç. albicans GDH 2346 were unexpected and 
difficult to explain. However these data would also 
suggest that there is more than one binding mechanism for 
the yeast to the buccal cell surface.
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3.3 Purification protocol for the yeast adhesin
The development of a protocol for purification of the 
yeast adhesin involved using information from experiments 
described in Results 3.1.2 and 3.3.1. In these assays, 
optimal conditions for mild alkaline hydrolysis, papain 
digestion and Synsorb H-2 adsorption were established. 
When a combination of papain/mild alkali/H-2 adsorption 
was tested, an All value of 114 was calculated (Table 
37). This was taken as evidence of an improved 
purification protocol. Since adhesion inhibition was 
79%, it was worth considering if higher concentrations of 
the purified material would increase inhibition to 100%. 
The data presented in Table 38 show that this is not the 
case; indeed the maximum inhibition achieved in this 
assay was only 65%. Such day-to-day differences in the 
response of buccal cells are not uncommon. The results 
imply that there is not just one Candida binding 
mechanism per strain but at least two. However, the bound, 
fraction did still contain some carbohydrate, and in an 
effort to further purify the adhesin, more degradation 
experiments were performed. In this case an additional 
deglycosylation step was introduced.
The experiments of Tarantino et ad. (1985) have been
referred to in Results 3.4.1. N-Glycanase, purified from 
Streptomvces griseus, has the capacity to degrade 
glycoproteins into their constituent carbohydrate and 
protein components, without disrupting proteinaceous
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integrity. N-Glycanase digestion was performed firstly 
before H-2 adsorption, secondly before mild alkali 
treatment then H-2 adsorption, and thirdly before 
papain/mild alkali treatment then H-2 adsorption.
Gradually the data presented in Table 42 were 
accumulated. During the course of the protocol shown in 
Table 42, the protein ; carbohydrate ratio decreased, and 
the effectiveness of the H-2 bound fraction as an 
inhibitor of adhesion increased. After N-Glycanase, 
papain, mild alkali treatment and Synsorb H-2 adsorption 
there was no detectable carbohydrate and the All was 
220. As was attempted at previous stages, a dose 
response experiment was performed. Again maximum 
inhibition was not 100% but 78%; thus more than one yeast 
receptor probably operates.
Two additional experiments yielded interesting data. 
Firstly, C. albicans GDH 2346 was grown in YNB + 50mM 
glucose as an alternative to high galactose medium.
Again the purified yeast adhesin was unable to inhibit 
adhesion completely, with the dose-response curve 
levelling off at approximately 75% inhibition. Secondly, 
an alternative buccal cell donor was used. The new donor 
was of identical blood group (A), but of different 
secretor status. Although only a very low concentration 
of partially purified adhesin was used, and the crude EPM 
was subjected merely to H-2 affinity adsorption rather 
than the complete purification protocol, an All of over
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270 was obtained (Table 45). This would suggest 
significant differences in the ability of such material 
to inhibit adhesion to buccal cells from donors of 
differing secretor status, as the corresponding All value 
for a non-secretor was 55.7 (Table 42).
The final purification protocol is outlined in Table 
46. Exhaustive attempts were made using SDS-PAGE 
techniques to visualize the adhesin without success. 
Various reasons for this failure could be suggested. It 
seems unlikely that the protein peptide was small enough 
to run off the end of the gel i.e. ahead of the tracking 
dye. However, it is possible that insufficient protein 
was applied to the gel, or that the gel was inadequately 
fixed. To verify the existence of the purified adhesin 
F.P.L.C. was utilized. A suitable trace was obtained 
using a A^qq detector.
4 THE BUCCAL CELL RECEPTOR
Adhesion of Candida to epithelial cells is the first 
stage in the colonization of mucosal surfaces by this 
organism. Although the mechanism of adhesion is not 
fully established, there is now considerable evidence for 
the involvement of glycosides as epithelial receptors for 
the yeast (Critchley and Douglas, 1987b; Douglas, 1989).
A number of studies have demonstrated that in vitro/ C. 
albicans adheres more readily to exfoliated buccal or 
vaginal epithelial cells from some donors than from
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others (King ^  ad., 1980; Sobel et ad., 1981), 
suggesting that some incWLduals may be more susceptible to 
colonization by the yeast. Recently, Burford-Mason ^  
al. ( 1988) reported that oral carriage of Ç. albicans in 
healthy subjects could be correlated with two host 
factors, namely blood group O and non-secretion of blood 
group antigens, with the trend towards carriage being 
greatest in group O non-secretors. In the present study 
the effect of donor blood group and secretor status on 
adhesion of Ç, albicans to buccal epithelial cells in 
vitro, was investigated.
4.1 Effect of blood group and secretor status on yeast 
adhesion to human buccal epithelial cells
Correlations between ABO blood group or secretor 
status and vulnerability to disease have been documented 
for a number of bacterial infections (Mourant et , 
1978). With C. albicans, blood group O and non-secretion 
of blood-group antigens have been identified as possible 
risk factors for oral carriage of the yeast in healthy 
subjects (Burford-Mason et al., 1988). The results of 
the present study shown in Table 47, indicate that 
Candida adhesion to the oral mucosa - the first step in 
the colonization process - is affected by the secretor 
status of the host. However, in this small sample of 
four buccal cell donors, there was no evidence that yeast 
adhesion was dependent on the ABO blood group.
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4.2 Effect of saliva and antiserum on yeast adherence
The possible importance of secretor status was first 
suggested by Blackwell et aj^ . ( 1986) who briefly reported 
that Candida adhesion to buccal cells could be inhibited 
by secretor saliva but enhanced by non-secretor saliva. 
The results shown in this study both confirm and 
contradict these findings and also provide additional 
evidence that the Lewis-a antigen which is adsorbed on 
the surface of the buccal cells in non-secretors could 
function as a receptor for the yeast. This conclusion 
would be consistent with previous work from this 
laboratory (Critchley and Douglas, 1987b) which indicated 
that C. albicans GDH 2346 produces surface mannoproteins 
with a lectin-like affinity for L-fucose residues, and 
that fucose-containing glycosides are likely to be major 
epithelial cell receptors for this yeast strain. It 
would also be consistent with the protocol described here 
for the purification of the yeast adhesin; this involves 
binding an EPM digest to a Synsorb-H-2 affinity matrix 
containing a terminal a-fucosyl residue and assaying the 
adhesion inhibition index relative to the crude EPM. The 
Lewis-a antigen also contains a terminal L-fucose 
residue. Fucose is the immunodominant sugar of the 
H-antigen of blood group 0 and it is possible that 
cell-bound H antigen could similarly function as a 
receptor although its presence in secretor saliva may 
effectively block adhesion. The results presented here
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do not suggest an analagous role for the Lewis-b antigen 
since treatment of buccal cells with anti-Lewis b 
antiserum had no effect on adhesion (Tables 52 and 53), 
The effects of monoclonal antiserum specific for 
blood group A and anti-H lectin fUlex europaeus), on 
yeast adherence suggest that these treatments bind 
specifically to the appropriate antigens. However, such 
experiments can lead to confusing results; Concanavalin A 
and lentil lectin both significantly enhanced the 
adherence of strain GDH 2346 to buccal epithelial cells 
(Critchley and Douglas, 1987b). This may have been due 
to the pH value (7.2) used in the assay, as Concanavalin 
A has been shown by Bittiger and Schnebli (197 6) to exist 
as a pseudo-tetrahedral molecule at this pH, with four 
saccharide binding sites, one on each subunit. Yeast 
cell envelopes are abundant in mannoprotein which is 
composed of a-D-mannopyransyl residues. The mannan 
backbone consists of a(l-6) linkages with side chains 
varying in length from 1 to 3 monomers joined by a(l-2) 
and a(l-3) linkages which are recognized by Concanavalin 
A (Goldstein et al., 1965). In the present study no 
aggregation of buccal epithelial cells occurred when they 
were pretreated with anti-A monoclonal or anti-H lectin 
(Ulex europaeus).
The effect of the antiserum concentration on yeast 
adherence was investigated. Buccal cell donors of 
differing blood group were selected for these
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experiments, although they had the same secretor status.
By varying the concentration of the anti-Lewis a 
antiserum it was concluded that the Lewis-a antigen is 
not the major epithelial receptor, and that another 
mechanism must operate. Further experiments are 
described here that show the effect of washing on buccal 
cells. Blackwell (1989) proposed that the Lewis-a 
antigen bound to the buccal cell surface and thus a 
bridging link was formed when the yeast bound to the 
buccal cell/antigen complex. Successive washes should 
remove the antigen. The results of the present study 
indicate that the first wash removes some Lewis-a binding 
sites from the buccal cell surface, but not all, and this 
trend may or may not continue with progressive washes.
In contrast to the experiments discussed above, some 
assays were performed with C, albicans GDH 2023, a strain 
known to be significantly different in binding mechanism 
(Critchley and Douglas, 1987b). These assays involved 
pretreating group A and group O, non-secretor buccal 
cells with anti-Lewis a and anti-Lewis b antisera. For 
non-secretors, anti-Lewis a antiserum inhibited adhesion 
of C. albicans GDH 2023 for both group A and group O 
buccal cell donors, i.e. secretor sta tus influenced 
yeast adhesion, but changing the C. albicans strain had 
no effect, as the results were similar to those seen with 
C. albicans GDH 2346.
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4.3 Evidence from sugar inhibition tests for the role of
glycosides as epithelial cell receptors
In vitro sugar inhibition tests have been widely used
with both bacteria and yeasts to predict the nature of
epithelial cell receptors. The sugars used to block 
adhesion here are thought to be present on host cell 
surfaces in glycoproteins or glycolipids (Sharon et al., 
1981) .
C. albicans GDH 2346 was inhibited by L-fucose; this 
sugar has not been detected on the cell surface of C. 
albicans which rules out the possibility of it acting as 
an adhesin analogue (Table 62). Jones and Freter (1976) 
recognized that L-fucose and other fucosides may function 
as receptors for V. cholerae. Cinco et al. (1984) 
described the adherence of Campylobacter species as being 
mediated by L-fucose. In the latter study, inhibition of 
Campylobacter adherence by L-fucose was concentration- 
dependent up to 50 mg ml” ,^ with no further inhibition 
above this point. This suggests that another receptor 
may be present in addition to L-fucose. Here, results 
from the dose response experiments using purified yeast 
adhesin (Tables 42 and 43) would suggest a similar 
situation with Candida adherence.
The results of these sugar inhibition tests were 
comparable with those obtained both for a female donor of 
blood group A, non-secretor and for another male donor of 
blood group A but a secretor of blood group antigens.
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Thus, although the blood group of the buccal cell donor 
influences the results of sugar inhibition tests (Tables 
62 and 66), neither the sex nor the secretor status of 
the donor affects the results of these assays (Tables 62 
to 64).
Sobel et al. (1981) noted that L-fucose inhibited the 
adherence of a clinical isolate of Ç. albicans to vaginal 
cells. Sanden et al. (1982) on the other hand found that 
methyl-oc-D-mannoside inhibited adherence, whereas Segal 
et al. (1982) reported that amino sugars inhibited yeast 
adhesion to epithelial cells. In E coli, nine adhesins 
have been described which are proteins and interact in a 
lectin-like fashion with glycoside receptors on the host 
cell surface (Jones and Isaacson, 1983). Different Ç. 
albicans strains may also have different protein adhesins 
which are specific for different sugars.
Segal et al. (1982) claimed that inhibition with 
N-acetyl-D-glucosamine was due to its role as an adhesin 
analogue rather than a receptor analogue. They described 
chitin, a soluble derivative and N-acetyl-D-glucosamine 
as inhibitors of adherence when incorporated in assay 
mixtures. Chitin, which it was suggested mediated 
adhesion, is located in the bud scars of yeasts. Poulain 
et al. (1978), in their scheme for cell wall 
architecture, showed chitin not to be on the cell surface 
but located several layers beneath in an alkali-insoluble 
matrix with glucan. The inhibitory effect of
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N-acetyl-D-glucosamine on the adherence of Ç. albicans 
observed by Segal et (1982) may therefore be due to
the sugar acting as a receptor analogue, as chitin is not 
easily accessible for interacting with the epithelial 
cell receptor.
For all three donors described in Tables 62 (see also 
Table 17), 63 and 64 a mixture of the sugars L-fucose and 
N-acetyl-D-glucosamine gave significantly better 
inhibition than single sugars. This was not a cumulative 
effect; however it would suggest that the receptor for 
yeast adhesion is a complex of two or more sugars.
Indeed when a mixture of L-fucose, D-galactose and 
N-acetyl-D-glucosamine was tested as an inhibitor, the 
percentage inhibition was the highest reported for any 
sugar solution from this laboratory to date. This 
combination of sugars was chosen at a stage in the 
investigation when evidence was accumulating to suggest 
that secretor status influenced the adhesion of yeast to 
buccal epithelial cells. These three sugars combine to 
form the Lewis blood group oligosaccharide and as 
virtually all humans are either Lewis a- or Lewis b- 
positive it was not surprising that this combination was 
so effective. In the final assays using group A donors 
N-acetyl-D-galactosamine gave greater inhibition of yeast 
adhesion than either L-fucose, N-acetyl-D-glucosamine or 
a mixture of these two sugars. Such a result might be 
expected if the blood group A antigen, in which N-acetyl-
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D-galactosamine is the immunodominant sugar, could act as 
an epithelial cell receptor for Ç, albicans.
The effect of different sugars on the adherence of C. 
albicans to buccal epithelial cells from a donor of blood 
group O was investigated. In contrast to experiments 
with A donors, N-acetyl-D-glucosamine produced no 
significant inhibition, but L-fucose and D-galactose 
significantly inhibited adherence. This suggested that 
for individuals with different blood groups, different 
receptors function. This would again be consistent with 
previously published data if the blood group determinant 
on buccal cell surfaces was the receptor for C. albicans, 
as L-fucose is the immunodominant sugar for the 
H-antigen. Finally the effect of different sugars on the 
adherence of Ç. albicans GDH 2023 to buccal cells from a 
donor of blood group O was investigated and in contrast 
to strain GDH 2346, N-acetyl-D-glucosamine was found to 
significantly inhibit adhesion. This was consistent with 
the data of Critchley and Douglas (1987b). However these 
latter experiments were performed using a cell donor of 
blood group B, where D-galactose is the immunodominant 
sugar, and no significant inhibitory effect was noticed 
when D-galactose was added to adhesin assay mixtures.
The reasons for these inconsistencies have yet to be 
determined.
In conclusion, in vitro sugar inhibition tests have 
been widely used to predict the nature of epithelial cell
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receptors for both bacteria and yeasts. The results 
discussed here indicate that such tests can be influenced 
by the ABO blood group of the buccal cell donor. This 
finding should be borne in mind in future work on Candida 
adhesion mechanisms.
A P P E N D I C E S
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I BIOCHEMICAL ASSAYS
A Carbohydrate determination using the phenol-sulphuric 
acid method (Dubois et al., 1956)
Reagents
1 Concentrated sulphuric acid (Reagent grade)
2 5% phenol (v/v)
Procedure
Phenol reagent (0.05 ml) was added to sample (2ml) 
containing 0 - 100 pg ml”  ^ carbohydrate. Reagent grade 
concentrated sulphuric acid (5 ml) was rapidly added and 
samples were left for 30 min at room temperature to allow 
colour development. Samples were read at 485 nm against 
a blank of distilled water in a spectrophotometer 
( Shimatzu PR-1). A standard curve was produced using 
mannose.
B Protein determination using the Lowry method (Lowrv et 
al.. 1951^
Reagents
A 2% NagCOg in 0.1 M NaOH.
B 0.5% Cu S0^.5H20 in 1% sodium tartrate (separate double
strength solutions mixed 1:1 before use).
C Folin-Ciocalteau reagent (Sigma) was diluted 1:1 with
distilled water (to give a total acidity of exactly 
1.0 N).
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D 50 vol of reagent A was mixed with 1 vol of reagent B 
(renewed for each separate assay).
Procedure
Reagent D (5 ml) was added to sample (0,2 ml), 
containing 0 - 100 jjg ml~^ of protein, mixed well and 
left to stand at room temperature for 10 min. Reagent C 
(0.5 ml) was added rapidly with immediate mixing.
Samples were left to stand for 30 min at room temperature 
then read against a reagent blank in a spectrophotometer 
at 75 0 nm with a light path of 1 cm. A standard curve 
was produced using bovine serum albumin.
C Phosphorus determination (Chen et al., 1956)
Reagents
1 Digestion mixture
conc. H2SO^:60% HCIO^ (3:2, v/v).
2 Colour reagent: 1 vol 6N HgSO^
2 vol distilled water 
1 vol 2.5% ammonium molybdate 
1 vol 10% ascorbic acid 
Colour reagent was prepared fresh just before use.
3 Standard KHgPO^ solution (10 pg ml” )^.
Procedure
A few carborundum chips were added to samples (0.2 
ml) containing 0 - 10 pg ml“  ^of phosphorus, in pyrex 
tubes. Digestion mixture (0.1 ml) was added to samples
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which were treated at 140°C for 1 h in an oven. After 
cooling, water (3.9 ml) was added to samples followed by ■ 
colour reagent (4.0 ml). Tubes were covered with 
nescofilm, mixed by inversion and incubated at 37“C for
1.5 h. Samples were read in a spectrophotometer 
(Schimadzu PR-1) at 820 nm against a reagent blank. A 
standard curve was produced using KHgPO^.
II PREPARATION OF STOCK SOLUTION FOR SDS-PAGE 
(Laemmli method)
Separating and stacking gels contained 15% and 5%
(w/v) acrylamide respectively. Gels and electrode 
buffers contained 0.1% (w/v) SDS. Gels were prepared in 
glass moulds and electrophoresis was done in a Pharmacia 
gel electrophoresis unit.
Stock solutions
1 Acrylamide (30.0 g) and NN'methylenebisacrylamide 
(0.8 g) was made up to 100 ml with distilled water. 
This was filtered and stored at 4°C.
2 1 M Tris-HCl buffer (pH 8.8) which was made up with 2 
M Tris (50 ml), 1 N HCl (16.2 ml) and H^O (33.8 ml). 
This was stored at 4°C.
3 0.5 M Tris-HCl buffer (pH 6.8) which was prepared by 
making up 1 M Tris (50 ml) and adding 1 N HCl (45 ml) 
and H^O (up to 100 ml). This was stored at 4*C.
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4 Tris-Glycine buffer (pH 8.3) was made up at 10 times
the required concentration. This was prepared by
adding glycine (144.2 g) and Tris (30.28 g) to 1 1 of 
distilled water.
5 Ammonium persulphate 10% (w/v) was prepared the day 
before use.
6 SDS was made up at 20% (w/v).
7 Bromophenol blue was prepared at 0.1% (w/v).
8 Solubilizing buffer was made up containing the 
following stock solutions: 0.5 M Tris HCl pH 6.8 (25 
ml), SDS (20 ml), /3-mercaptoethanol (10 ml), glycerol 
(20 ml), bromophenol blue (2 ml) and distilled water 
(23 ml).
9 Fixing-staining solution was prepared containing 
Coomassie blue R250 (1.25 g), 50% methanol (454 ml) 
and glacial acetic acid (46 ml).
10 Destaining solution was made up containing methanol 
(50 ml), acetic acid (75 ml) and distilled water (875 
ml ) .
11 Staining reagent for the silver stain was prepared by 
adding 20% silver nitrate (5 ml) to 0.1 M NaOH (28 
ml) and concentrated NH^OH (2 ml) while the solution 
was being mixed. Distilled water (115 ml) was added 
to give 150 ml of staining reagent.
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III CALCULATION OF ADHERENCE INHIBITION INDEX (AID: 
WORKED EXAMPLE
Calculation of the All, based on protein content, for
the L-fucose bound fraction shown in Table 13 (2). The
All is a measure of the relative efficiency with which
each component inhibits adherence as compared with crude
_ 1
EPM. At a concentration of 10 mg ml , crude EPM from C. 
albicans GDH 2023 inhibits adherence of this strain to 
buccal cells by 47.8%. In calculating the All, the 
weight of protein in each component required to inhibit 
adherence by 50% was determined.
For protein eluted from L-fucose column (Table 13, 
experiment 2) 43.8 pg protein inhibited adherence by 
42.5%
. • . 43.8x50
  = 51.5 pg protein are required to
42.5 inhibit adherence by 50%.
To calculate the All value the weight of protein in 
the crude EPM sample is divided by this value
All =   X  887.8 = 17 .2
51.5
Therefore, the component eluted from the L-fucose 
column is 17.2 times more efficient than crude EPM from 
Ç. albicans GDH 2023 at inhibiting adherence of this 
strain to epithelial cells.
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